Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

  • Главная
  • Lta4h inhibitor for the treatment or prevention of hidradenitis suppurativa

Lta4h inhibitor for the treatment or prevention of hidradenitis suppurativa

Номер патента: EP4442315A2
Опубликовано: 09-10-2024
Автор(ы): Carlos Penno, Christian Loesche, Grazyna Wieczorek, Till Roehn
Принадлежит: NOVARTIS AG
Получить PDF файл: Открыть в новом окне

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

LTA4H inhibitors for the treatment of hidradenitis suppurativa

Номер патента: AU2020207638A1. Автор: Till Roehn,Christian Loesche,Grazyna Wieczorek,Carlos Penno. Владелец: NOVARTIS AG. Дата публикации: 2021-07-15.

Lta4h inhibitors for the treatment of hidradenitis suppurativa

Номер патента: US20220117949A1. Автор: Till Roehn,Christian Loesche,Grazyna Wieczorek,Carlos Penno. Владелец: NOVARTIS AG. Дата публикации: 2022-04-21.

Tgf-beta inhibitor for use in the treatment of dedifferentiated liposarcoma

Номер патента: WO2024194692A1. Автор: Sarah Watson,Nadège GRUEL,Chloé QUIGNOT. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-09-26.

Dosing regimen of a csf-1r inhibitor for use in the treatment of amyotrophic lateral sclerosis

Номер патента: WO2024095118A1. Автор: Olivier David,Javier ESTRADA DIEZ,Marie-Emmanuelle Riviere,Huixin YU,Anne GARDIN,Elisa GARCIA GARAYOA,Ram Ron MILLER. Владелец: NOVARTIS AG. Дата публикации: 2024-05-10.

2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef

Номер патента: AU2022270657A1. Автор: Jin Yang,Timothy C. Hoey,Mohammad A. MANDEGAR. Владелец: Tenaya Therapeutics Inc. Дата публикации: 2023-11-16.

2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef

Номер патента: CA3216768A1. Автор: Jin Yang,Timothy C. Hoey,Mohammad A. MANDEGAR. Владелец: Tenaya Therapeutics Inc. Дата публикации: 2022-11-10.

2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef

Номер патента: EP4333841A1. Автор: Jin Yang,Timothy C. Hoey,Mohammad A. MANDEGAR. Владелец: Tenaya Therapeutics Inc. Дата публикации: 2024-03-13.

Cyp11a1 inhibitor for use in the treatment of prostate cancer

Номер патента: CA3232600A1. Автор: Tarja IKONEN,Annamari VUORELA. Владелец: Orion Oyj. Дата публикации: 2023-04-06.

Cyp11a1 inhibitor for use in the treatment of prostate cancer

Номер патента: EP4408426A1. Автор: Tarja IKONEN,Annamari VUORELA. Владелец: Orion Oyj. Дата публикации: 2024-08-07.

Cyp11a1 inhibitor for use in the treatment of prostate cancer

Номер патента: AU2022354149A1. Автор: Tarja IKONEN,Annamari VUORELA. Владелец: Orion Oyj. Дата публикации: 2024-04-04.

Methods for the treatment of dedifferentiated liposarcoma

Номер патента: WO2024194673A1. Автор: Sarah Watson. Владелец: INSTITUT CURIE. Дата публикации: 2024-09-26.

USE OF A CORTICOSTEROID IN COMBINATION WITH DIURETIC AND ANTACID FOR THE TREATMENT OF VASCULAR STENOSIS AND PREVENTION OF VASCULAR RESTENOSIS

Номер патента: RU2007120522A. Автор: Флавио РИБИКИНИ,Корадо ВАССАНЕЛЛИ,Флавио РИБИКИНИ (IT),Корадо ВАССАНЕЛЛИ (IT). Владелец: Университа`Дельи Студи Дель Пьемонте Ориентале "А. Авогардо" (It). Дата публикации: 2008-12-10.

2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef

Номер патента: IL308152A. Автор: Jin Yang,Mohammad A Mandegar,Timothy C Hoey. Владелец: Timothy C Hoey. Дата публикации: 2024-01-01.

Treatment of hidradenitis suppurativa with orismilast

Номер патента: EP4313043A1. Автор: Morten Sommer,Philippe Andres,Anne Weiss,Kim KJØLLER,Elisabeth Hjardem TAUDORF,Gregor B.E. JEMEC. Владелец: Union Therapeutics AS. Дата публикации: 2024-02-07.

Treatment of hidradenitis suppurativa with orismilast

Номер патента: AU2022245186A1. Автор: Morten Sommer,Philippe Andres,Anne Weiss,Kim KJØLLER,Elisabeth Hjardem TAUDORF,Gregor B.E. JEMEC. Владелец: Union Therapeutics AS. Дата публикации: 2023-10-05.

Treatment of hidradenitis suppurativa with orismilast

Номер патента: CA3212316A1. Автор: Morten Sommer,Philippe Andres,Anne Weiss,Kim KJØLLER,Elisabeth Hjardem TAUDORF,Gregor B.E. JEMEC. Владелец: Union Therapeutics AS. Дата публикации: 2022-09-29.

Mdm2 inhibitors for use in the treatment or prevention of hematologic neoplasm relapse after hematopoietic cell transplantation

Номер патента: US20230338374A1. Автор: Hans Dietrich Menssen,Justus Duyster,Robert Zeiser. Владелец: NOVARTIS AG. Дата публикации: 2023-10-26.

Mdm2 inhibitors for use in the treatment or prevention of hematologic neoplasm relapse after hematopoietic cell transplantation

Номер патента: CA3189973A1. Автор: Hans Dietrich Menssen,Justus Duyster,Robert Zeiser. Владелец: NOVARTIS AG. Дата публикации: 2022-03-24.

Mdm2 inhibitors for use in the treatment or prevention of hematologic neoplasm relapse after hematopoietic cell transplantation

Номер патента: EP4213834A1. Автор: Hans Dietrich Menssen,Justus Duyster,Robert Zeiser. Владелец: NOVARTIS AG. Дата публикации: 2023-07-26.

Mdm2 inhibitors for use in the treatment or prevention of hematologic neoplasm relapse after hematopoietic cell transplantation

Номер патента: WO2022058605A1. Автор: Hans Dietrich Menssen,Justus Duyster,Robert Zeiser. Владелец: ALBERT-LUDWIGS-UNIVERSITAT FREIBURG. Дата публикации: 2022-03-24.

Molecules for use in the treatment of viral infections

Номер патента: US20230310421A1. Автор: Piergiuseppe Pelicci,Fabio Santoro,Saverio Minucci,Luca MAZZARELLA,Mauro ROMANENGHI,Paul-Edward MASSA,Bruno ACHUTTI DUSO. Владелец: Istituto Europeo di Oncologia SRL IEO. Дата публикации: 2023-10-05.

Molecules for use in the treatment of viral infections

Номер патента: EP4135679A1. Автор: Piergiuseppe Pelicci,Fabio Santoro,Saverio Minucci,Luca MAZZARELLA,Mauro ROMANENGHI,Paul-Edward MASSA,Bruno ACHUTTI DUSO. Владелец: Istituto Europeo di Oncologia SRL IEO. Дата публикации: 2023-02-22.

Molecules for use in the treatment of viral infections

Номер патента: WO2021209520A1. Автор: Piergiuseppe Pelicci,Fabio Santoro,Saverio Minucci,Luca MAZZARELLA,Mauro ROMANENGHI,Paul-Edward MASSA,Bruno ACHUTTI DUSO. Владелец: Universita' Degli Studi Di Milano. Дата публикации: 2021-10-21.

Lsd1 inhibitors for use in the treatment and prevention of fibrosis of tissues

Номер патента: EP3964204A1. Автор: Michel Puceat. Владелец: Aix Marseille Universite. Дата публикации: 2022-03-09.

Combination of a 5-ht6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of alzheimer's disease in a patient subpopulation carrying apoe4 alleles

Номер патента: SI3630098T1. Автор: Kristian Windfeld. Владелец: H. Lundbeck A/S. Дата публикации: 2021-07-30.

Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer

Номер патента: AU2017232162A1. Автор: Yan Chen,Steven Kovats,Sunkyu Kim,Shivang Doshi,Kristy HAAS,Alan Xizhong HUANG. Владелец: NOVARTIS AG. Дата публикации: 2017-10-12.

Combination of a 5-HT6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of Alzheimer's disease in a patient subpopulation carrying ApoE4 alleles

Номер патента: AU2018272883A1. Автор: Kristian Windfeld. Владелец: H Lundbeck AS. Дата публикации: 2019-11-14.

Combination of a 5-ht6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of alzheimer's disease in a patient subpopulation carrying apoe4 alleles

Номер патента: RS61704B1. Автор: Kristian Windfeld. Владелец: H Lundbeck AS. Дата публикации: 2021-05-31.

Combination of a 5-ht6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of alzheimer's disease in a patient subpopulation carrying apoe4 alleles

Номер патента: EP3630098A1. Автор: Kristian Windfeld. Владелец: H Lundbeck AS. Дата публикации: 2020-04-08.

Combination of a 5-HT6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of Alzheimer's disease in a patient subpopulation carrying ApoE4 alleles

Номер патента: AU2018272883B2. Автор: Kristian Windfeld. Владелец: H Lundbeck AS. Дата публикации: 2024-02-15.

Compositions and methods for treatment of hidradenitis suppurativa

Номер патента: US20240091209A1. Автор: John Mccoy,Ofer A. Goren. Владелец: Suzhou Kintor Pharmaceuticals Inc. Дата публикации: 2024-03-21.

Compositions and methods for treatment of hidradenitis suppurativa

Номер патента: EP4288051A1. Автор: John Mccoy,Ofer A. Goren. Владелец: Suzhou Kintor Pharmaceuticals Inc. Дата публикации: 2023-12-13.

Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis

Номер патента: EP3250205A1. Автор: Stewart Cole,Jan Lars RYBNIKER. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2017-12-06.

Atr inhibitors for use in the treatment of viral infections

Номер патента: EP4232037A1. Автор: Ulrich Betz,Thomas Fuchss. Владелец: Merck Patent GmBH. Дата публикации: 2023-08-30.

Dpp-iv inhibitors for use in the treatment of nafld

Номер патента: CA2726244C. Автор: Thomas Klein,Michael Mark,Leo Thomas,Heiko Niessen. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2018-03-27.

Casein kinase 1 inhibitors for use in the treatment of diseases related to dux4 expression such as muscular dystrophy and cancer

Номер патента: EP3982955A1. Автор: Marcus Geese,Pui Leng Loke,Rolf Hirsch,Joris De Maeyer,Sebastian Monecke. Владелец: Facio Intellectual Property BV. Дата публикации: 2022-04-20.

Casein kinase 1 inhibitors for use in the treatment of diseases related to DUX4 expression such as muscular dystrophy and cancer

Номер патента: AU2020290001A1. Автор: Marcus Geese,Pui Leng Loke,Rolf Hirsch,Joris De Maeyer,Sebastian Monecke. Владелец: Facio Intellectual Property BV. Дата публикации: 2022-01-20.

Composition comprising a first ras inhibitor, second ras inhibitor and a shp2 inhibitor for use in the treatment of cancer

Номер патента: WO2024081363A1. Автор: Steve Kelsey,Elsa QUINTANA,Cristina BLAJ. Владелец: Revolution Medicines, Inc.. Дата публикации: 2024-04-18.

Materials and methods for enhanced treatment and prevention of biofilms

Номер патента: EP3937634A1. Автор: Sean Farmer,Ken Alibek. Владелец: Locus IP Co LLC. Дата публикации: 2022-01-19.

Materials and methods for enhanced treatment and prevention of biofilms

Номер патента: WO2020190699A1. Автор: Sean Farmer,Ken Alibek. Владелец: Locus Ip Company, Llc. Дата публикации: 2020-09-24.

DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS

Номер патента: US20170015653A1. Автор: Meng Wei,Zhao Guohua. Владелец: . Дата публикации: 2017-01-19.

Combination of egfr inhibitor and mek inhibitor for use in the treatment of nras mutated cancer

Номер патента: CA2943402A1. Автор: Catherine Anne Eberlein,Darren Anthony Edward Cross. Владелец: AstraZeneca AB. Дата публикации: 2015-10-08.

Combination of EGFR inhibitor and MEK inhibitor for use in the treatment of NRAS mutated cancer

Номер патента: AU2015242407A1. Автор: Catherine Anne Eberlein,Darren Anthony Edward Cross. Владелец: AstraZeneca AB. Дата публикации: 2016-10-13.

The combination of an EGFR inhibitor and a MEK inhibitor for use in the treatment of cancer caused by mutated NRAS

Номер патента: RU2016140626A. Автор: Даррен Энтони Эдвард КРОСС,Кэтрин Энн ЭБЕРЛЕЙН. Владелец: Астразенека Аб. Дата публикации: 2018-05-07.

Combination of egfr inhibitor and mek inhibitor for use in the treatment of nras mutated cancer

Номер патента: EP3125885A1. Автор: Catherine Anne Eberlein,Darren Anthony Edward Cross. Владелец: AstraZeneca AB. Дата публикации: 2017-02-08.

Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection

Номер патента: CA3199988A1. Автор: Daniel L. Flynn. Владелец: Deciphera Pharmaceuticals LLC. Дата публикации: 2022-06-02.

Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection

Номер патента: EP4251152A1. Автор: Daniel L. Flynn. Владелец: Deciphera Pharmaceuticals LLC. Дата публикации: 2023-10-04.

Cyp11a1 inhibitor for use in the treatment of prostate cancer

Номер патента: IL311668A. Автор: . Владелец: Orion Corp. Дата публикации: 2024-05-01.

Compositions and Methods for the Prevention and Treatment of Hearing Loss

Номер патента: US20230330097A1. Автор: Jian Zuo,Jeff North. Владелец: Ting Therapeutics LLC. Дата публикации: 2023-10-19.

Compositions and methods for the prevention and treatment of hearing loss

Номер патента: EP4214193A1. Автор: Jian Zuo,Marisa Laura Zallocchi,Santanu Hati,Jeff North. Владелец: Ting Therapeutics LLC. Дата публикации: 2023-07-26.

Compositions and methods for the prevention and treatment of hearing loss

Номер патента: WO2022060811A1. Автор: Jian Zuo,Marisa Laura Zallocchi,Santanu Hati,Jeff North. Владелец: Ting Therapeutics LLC. Дата публикации: 2022-03-24.

Compositions and methods for the prevention and treatment of hearing loss

Номер патента: US12070465B2. Автор: Jian Zuo,Marisa Laura Zallocchi,Santanu Hati,Jeff North. Владелец: Ting Therapeutics LLC. Дата публикации: 2024-08-27.

Crystalline forms of a LTA4H inhibitor

Номер патента: US11993582B2. Автор: Andreas Kordikowski,Yanxiang Wu. Владелец: NOVARTIS AG. Дата публикации: 2024-05-28.

Crystalline forms of a lta4h inhibitor

Номер патента: EP4389125A2. Автор: Andreas Kordikowski,Yanxiang Wu. Владелец: NOVARTIS AG. Дата публикации: 2024-06-26.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: US20230285373A1. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2023-09-14.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: EP4234022A2. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2023-08-30.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: US11083718B2. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2021-08-10.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: EP4234022A3. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2023-10-04.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: US20210361632A1. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2021-11-25.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: EP3600276A1. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2020-02-05.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: US11690830B2. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2023-07-04.

Trmt2a inhibitors for use in the treatment of polyglutamine diseases

Номер патента: WO2020109233A2. Автор: Nadim Joni Shah,Jorg Schulz,Elena Davydova,Aaron Voigt,Giulia ROSSETTI,Michael Alois MARGREITER,Dierk NIESSING,Monika WITZENBERGER. Владелец: Forschungszentrum Jülich Gmbh Fachbereich Patente (R-P). Дата публикации: 2020-06-04.

C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain

Номер патента: AU2018385364B2. Автор: Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Thiago Mattar CUNHA. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-04-04.

Non-productive angiogenesis inhibitor for use in the treatment of alzheimer's disease

Номер патента: EP3900788A1. Автор: Alberto Pascual Bravo,Alicia Elena ROSALES NIEVES,María Isabel ÁLVAREZ VERGARA. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2021-10-27.

C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: EP4397306A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-07-10.

C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: WO2024146922A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe' Farmaceutici Spa. Дата публикации: 2024-07-11.

Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy

Номер патента: CA3215958A1. Автор: Jin Yang,Timothy C. Hoey,Mohammad A. MANDEGAR. Владелец: Tenaya Therapeutics Inc. Дата публикации: 2022-10-27.

Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy

Номер патента: EP4326263A1. Автор: Jin Yang,Timothy C. Hoey,Mohammad A. MANDEGAR. Владелец: Tenaya Therapeutics Inc. Дата публикации: 2024-02-28.

Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy

Номер патента: AU2022262655A1. Автор: Jin Yang,Timothy C. Hoey,Mohammad A. MANDEGAR. Владелец: Tenaya Therapeutics Inc. Дата публикации: 2023-11-02.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: EP3256128A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2017-12-20.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: US20180086707A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2018-03-29.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: WO2016151484A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2016-09-29.

Bruton tyrosine kinase inhibitors for use in the treatment of myelin oligodendrocyte glycoprotein antibody disease (mogad)

Номер патента: WO2023220370A1. Автор: Erik Wallstroem,Timothy J. Turner. Владелец: Genzyme Corporation. Дата публикации: 2023-11-16.

Sars-cov-2 main protease inhibitor for use in the treatment of covid 19

Номер патента: WO2024128990A1. Автор: Ugur UZUNER,Selcen CELIK UZUNER,Ebru AKKUS,Abdulkadir KOCAK. Владелец: Karadeniz Teknik Universitesi. Дата публикации: 2024-06-20.

Il-8 inhibitors for use in the treatment of certain urological disorders

Номер патента: EP3322438A1. Автор: Maria Candida Cesta,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Patrizia Angelico. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2018-05-23.

Il-8 inhibitors for use in the treatment of certain urological disorders

Номер патента: NZ739077A. Автор: Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Maria Cesta,Patrizia Angelico. Владелец: Dompe’ Farm S P A. Дата публикации: 2023-12-22.

Il-8 inhibitors for use in the treatment of certain urological disorders

Номер патента: WO2017009323A1. Автор: Maria Candida Cesta,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Patrizia Angelico. Владелец: Dompe' Farmaceutici S.P.A.. Дата публикации: 2017-01-19.

Il-8 inhibitors for use in the treatment of certain urological disorders

Номер патента: NZ739077B2. Автор: Maria Candida Cesta,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Patrizia Angelico. Владелец: Dompe' Farmaceutici Spa. Дата публикации: 2024-03-26.

Gamma-secretase inhibitors for use in the treatment of inherited epidermolysis bullosa

Номер патента: EP4422622A1. Автор: Angelo Giuseppe CONDORELLI,Giovanna Zambruno,May EL HACHEM,Daniele CASTIGLIA,Teresa ODORISIO. Владелец: Fondazione Luigi Maria Monti. Дата публикации: 2024-09-04.

Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders

Номер патента: CA2872216C. Автор: José Ignacio Andrés-Gil,Frederik Jan Rita Rombouts,Andrés Avelino Trabanco-Suárez,Greta Constantia Peter Vanhoof,Antonius Adrianus Hendrikus Petrus Megens,Xavier Jean Michel Langlois,Peter Jacobus Johannes Antonius Buijnsters,Meri De Angelis. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2021-07-20.

Combinations of opiod/TLR4 antagonist and a cyclooxygenase (COX) inhibitor for use in the treatment of pain

Номер патента: US9205081B2. Автор: Annette Channa Toledano. Владелец: Allodynic Therapeutics LLC. Дата публикации: 2015-12-08.

Gamma-secretase inhibitors for use in the treatment of inherited epidermolysis bullosa

Номер патента: WO2024028912A1. Автор: Angelo Giuseppe CONDORELLI,Giovanna Zambruno,May EL HACHEM,Daniele CASTIGLIA,Teresa ODORISIO. Владелец: Fondazione Luigi Maria Monti. Дата публикации: 2024-02-08.

Combination of a nkcc1 protein inhibitor and a microtubule inhibitor for use in the treatment of cancer

Номер патента: EP4311548A1. Автор: Yehezkel Ben-Ari,François Berger. Владелец: B & A Therapeutics. Дата публикации: 2024-01-31.

Combination of bumetanide and a microtubule inhibitor for use in the treatment of cancer

Номер патента: WO2024023353A1. Автор: Yehezkel Ben-Ari,François Berger. Владелец: B&A Oncomedical. Дата публикации: 2024-02-01.

Nox inhibitors for use in the treatment of alport syndrome

Номер патента: WO2023217764A1. Автор: Richard Philipson,Ebticem NOURI,Jonathan BARRATT,Cédric Szyndralewiez. Владелец: Calliditas Therapeutics Suisse Sa. Дата публикации: 2023-11-16.

Mdm2 inhibitors for use in the treatment or prevention of hematologic neoplasm relapse after hematopoietic cell transplantation

Номер патента: IL301105A. Автор: . Владелец: NOVARTIS AG. Дата публикации: 2023-05-01.

Dosing regimen for an nlrp3 inhibitor in the treatment of osteoarthritis

Номер патента: CA3224774A1. Автор: Matthias Schieker,Christopher Farady,Ewa GATLIK,Laura COLEMAN. Владелец: NOVARTIS AG. Дата публикации: 2023-01-26.

Dosing regimen for an nlrp3 inhibitor in the treatment of osteoarthritis

Номер патента: EP4373489A1. Автор: Matthias Schieker,Christopher Farady,Ewa GATLIK,Laura COLEMAN. Владелец: NOVARTIS AG. Дата публикации: 2024-05-29.

1-(5-(2-cyanopyridin-4-yl)oxazole-2-carbonyl)-4-methylhexahydropyrrolo[3,4-b]pyr role-5(1h)-carbonitrile as usp30 inhibitor for use in the treatment of mitochondrial dysfunction, cancer and fibrosis

Номер патента: ZA202213877B. Автор: Mark Ian Kemp,Martin Lee Stockley,Christopher Andrew Luckhurst,Paul William Thompson. Владелец: Mission Therapeutics Ltd. Дата публикации: 2024-07-31.

Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer

Номер патента: US20140107114A1. Автор: Chen Yan,KIM Sunkyu,Doshi Shivang,Haas Kristy,Kovats Steven,Huang Alan Xizhong. Владелец: NOVARTIS AG. Дата публикации: 2014-04-17.

Combination Therapy Comprising A CDK4/6 Inhibitor and a PI3K Inhibitor for Use in the Treatment of Cancer

Номер патента: US20160136171A1. Автор: Chen Yan,KIM Sunkyu,Doshi Shivang,Haas Kristy,Kovats Steven,Huang Alan Xizhong. Владелец: NOVARTIS AG. Дата публикации: 2016-05-19.

1-(5-(2-cyanopyridin-4-yl)oxazole-2-carbonyl)-4-methylhexahydropyrrolo[3,4-b]pyr role-5(1h)-carbonitrile as usp30 inhibitor for use in the treatment of mitochondrial dysfunction, cancer and fibrosis

Номер патента: CA3186148A1. Автор: Mark Ian Kemp,Martin Lee Stockley,Christopher Andrew Luckhurst,Paul William Thompson. Владелец: Mission Therapeutics Ltd. Дата публикации: 2021-12-16.

1-(5-(2-cyanopyridin-4-yl)oxazole-2-carbonyl)-4-methylhexahydropyrrolo[3,4-b]pyr role-5(1h)-carbonitrile as usp30 inhibitor for use in the treatment of mitochondrial dysfunction, cancer and fibrosis

Номер патента: US20230312580A1. Автор: Mark Ian Kemp,Martin Lee Stockley,Christopher Andrew Luckhurst,Paul William Thompson. Владелец: Mission Therapeutics Ltd. Дата публикации: 2023-10-05.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: NZ723645A. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma B V. Дата публикации: 2020-09-25.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: EP3102212A1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma BV. Дата публикации: 2016-12-14.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: US20240024315A1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2024-01-25.

Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: US11642344B2. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2023-05-09.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: IL247037A. Автор: . Владелец: Dezima Pharma B V. Дата публикации: 2017-01-31.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: CA2938718C. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2022-10-18.

Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: AU2014381733B2. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2020-09-03.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: US20210228580A1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma BV. Дата публикации: 2021-07-29.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: PH12016501548A1. Автор: FORD John,ROUND Patrick,KASTELEIN John,KAWAGUCHI Atsuhiro,TOMIYASU Koichi,OKA Kozo. Владелец: Dezima Pharma B V. Дата публикации: 2016-10-03.

Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Номер патента: US20240277680A1. Автор: Paul Andrew Whittaker,Adrian Huw DAVIES,Pui-Man CHOY,Vinay SAUNDERS,Basma BAHSOUN,Surender VASHIST,Neil Edward TORBETT. Владелец: Poolbeg Pharma UK Ltd. Дата публикации: 2024-08-22.

Agent for the treatment and prevention of cancer

Номер патента: WO2015028919A1. Автор: Michele Mercuri. Владелец: Daiichi Sankyo Company, Limited. Дата публикации: 2015-03-05.

Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Номер патента: US11969412B2. Автор: Paul Andrew Whittaker,Adrian Huw DAVIES,Pui-Man CHOY,Vinay SAUNDERS,Basma BAHSOUN,Surender VASHIST,Neil Edward TORBETT. Владелец: Poolbeg Pharma UK Ltd. Дата публикации: 2024-04-30.

Treatment and/or prevention of peanut induced anaphylaxis

Номер патента: US20110217290A1. Автор: Manel Jordana,Katherine Arias,Susan Waserman. Владелец: Individual. Дата публикации: 2011-09-08.

Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: EP4153159A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-03-29.

Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: CA3178137A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-11-25.

MEK-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: AU2021277517A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2022-12-08.

Flt3 receptor inhibitor at low dosage for the treatment of neuropathic pain

Номер патента: US20190298691A1. Автор: Jean Valmier. Владелец: Biodol Therapeutics. Дата публикации: 2019-10-03.

An aurora a kinase inhibitor for use in the treatment of neuroblastoma

Номер патента: US20220000855A1. Автор: Louis Frank Stancato,Michele Suzanne DOWLESS,Xueqian Gong. Владелец: Eli Lilly and Co. Дата публикации: 2022-01-06.

2-(4-((BENZO[B]THIOPHEN-3-YL)-1H-TETRAZOL-1-YL)METHYL)-5-(DIFLUOROMETHYL)-1,3,4-OXADIAZOLE AND SIMILAR COMPOUNDS AS SELECTIVE HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS FOR USE IN THE TREATMENT OF, FOR EXAMPLE, PERIPHERAL NEUROPATHY

Номер патента: BR112023002209A2. Автор: Stevenazzi Andrea,SANDRONE Giovanni,VERGANI Barbara,STEINKÜHLER Christian,FOSSATI Gianluca,Marchini Mattia,Rocchio Ilaria,Kachkovskyi Georgii,Caprini Gianluca. Владелец: ITALFARMACO SPA. Дата публикации: 2023-04-25.

An aurora a kinase inhibitor for use in the treatment of neuroblastoma

Номер патента: CA3121483A1. Автор: Louis Frank Stancato,Michele Suzanne DOWLESS,Xueqian Gong. Владелец: Eli Lilly and Co. Дата публикации: 2020-06-04.

Aurora a kinase inhibitor for use in the treatment of neuroblastoma

Номер патента: JP2023058582A. Автор: Xueqian Gong,スザンヌ ダウレス，ミッシェル,Suzanne Dowless Michele,ゴン，シュエチエン,フランク スタンカト，ルイス,Frank Stancato Louis. Владелец: Eli Lilly and Co. Дата публикации: 2023-04-25.

Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer

Номер патента: EP1343500A2. Автор: Wen Jen Hwu. Владелец: SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH. Дата публикации: 2003-09-17.

Pde5 inhibitor for use in the treatment of medical conditions associated with mitochondrial complex iv deficiency

Номер патента: WO2024200678A1. Автор: Markus Schülke-Gerstenfeld,Alessandro Prigione,Carmen MENACHO. Владелец: Universitätsklinikum Düsseldorf. Дата публикации: 2024-10-03.

Tlr3 inhibitors for use in the treatment of diseases associated with cardiovascular calcification

Номер патента: EP4419098A2. Автор: Johannes HOLFELD,Can GOLLMANN-TEPEKÖYLÜ,Ivan TANCEVSKI. Владелец: Individual. Дата публикации: 2024-08-28.

GlyT1 inhibitors for use in the treatment of hematological disorders

Номер патента: US09877963B2. Автор: Emmanuel Pinard,Michael Winter,Daniela Alberati,Annette KOERNER. Владелец: Hoffmann La Roche Inc. Дата публикации: 2018-01-30.

Il-8 inhibitors for use in the treatment of some sarcomas

Номер патента: US20230248704A1. Автор: Laura Brandolini,Ryan David ROBERTS. Владелец: Research Institute at Nationwide Childrens Hospital. Дата публикации: 2023-08-10.

IL-8 inhibitors for use in the treatment of some sarcomas

Номер патента: AU2018356497B2. Автор: Laura Brandolini,Ryan David ROBERTS. Владелец: Research Institute at Nationwide Childrens Hospital. Дата публикации: 2024-02-29.

Glyt1 inhibitors for use in the treatment of hematological disorders

Номер патента: WO2015165842A1. Автор: Emmanuel Pinard,Michael Winter,Daniela Alberati,Annette KOERNER. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2015-11-05.

Tlr3 inhibitors for use in the treatment of diseases associated with cardiovascular calcification

Номер патента: WO2023066949A3. Автор: Johannes HOLFELD,Can GOLLMANN-TEPEKÖYLÜ,Ivan TANCEVSKI. Владелец: Holfeld Johannes. Дата публикации: 2023-06-22.

Synergistic combination of an alpha-2-delta ligand and a PDEV inhibitor for use in the treatment of pain

Номер патента: NZ537818A. Автор: Mark John Field,Richard Griffith Williams. Владелец: Pfizer. Дата публикации: 2007-07-27.

Combination of substituted 2,4 diamino-quinoline compounds and mek inhibitors for use in the treatment of liver cancers

Номер патента: EP4349336A1. Автор: Agnes MENUT,Philippe Halfon,Jerome Courcambeck,Eloïne BESTION,Soraya MEZOUAR. Владелец: Genoscience Pharma Sas. Дата публикации: 2024-04-10.

Combination of substituted 2,4 diamino-quinoline compounds and mek inhibitors for use in the treatment of liver cancers

Номер патента: WO2024074559A1. Автор: Agnes MENUT,Philippe Halfon,Jerome Courcambeck,Eloïne BESTION,Soraya MEZOUAR. Владелец: GENOSCIENCE PHARMA. Дата публикации: 2024-04-11.

Use of pi3k inibitors for the treatment of obesity, steatosis and ageing

Номер патента: EP2629771A1. Автор: Julen Oyarzabal Santamarina,Sonia Martinez Gonzalez,Joaquin Pastor Fernandez,Ana Ortega Molina,Manuel Serrano Marugan,James R Bischoff. Владелец: Centro Nacional de Investigaciones Oncologicas CNIO. Дата публикации: 2013-08-28.

Use of Pl3K Inhibitors for the Treatment of Obesity, Steatosis and Ageing

Номер патента: US20140154232A1. Автор: Julen Oyarzabal Santamarina,Sonia Martinez Gonzalez,Joaquin Pastor Fernandez,James R. Bischoff,Ana Ortega Molina,Manuel Serrano Marugan. Владелец: Centro Nacional de Investigaciones Oncologicas CNIO. Дата публикации: 2014-06-05.

Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing

Номер патента: US09993554B2. Автор: Julen Oyarzabal Santamarina,Sonia Martinez Gonzalez,Joaquin Pastor Fernandez,James R. Bischoff,Ana Ortega Molina,Manuel Serrano Marugan. Владелец: Centro Nacional de Investigaciones Oncologicas CNIO. Дата публикации: 2018-06-12.

Vps4b inhibitor for use in methods for the treatment of hrd cancer

Номер патента: WO2024194401A1. Автор: Marton Kovacs,Raphael CECCALDI,Marie VALLETTE. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-09-26.

Methods for the treatment of hrd cancer and brca-associated cancer

Номер патента: EP4433089A1. Автор: Raphael CECCALDI,Yucel HATICE,Daniele MUSIANI. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-09-25.

Farnesyl transferase inhibitor for use in methods for the treatment of hrd cancer

Номер патента: WO2024194402A1. Автор: Marton Kovacs,Raphael CECCALDI,Marie VALLETTE. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-09-26.

Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition

Номер патента: CA2328073A1. Автор: Paul D. Rubin. Владелец: Individual. Дата публикации: 1999-10-21.

Synergistic compositions for use in the treatment of cancer

Номер патента: CA3239568A1. Автор: Harri SIHTO,Kirsi TOIVANEN,Tom Bohling. Владелец: Sartar Therapeutics Oy. Дата публикации: 2023-06-15.

Synergistic compositions for use in the treatment of cancer

Номер патента: EP4444314A1. Автор: Harri SIHTO,Kirsi TOIVANEN,Tom Bohling. Владелец: Sartar Therapeutics Oy. Дата публикации: 2024-10-16.

Compounds for the treatment of viral infections

Номер патента: US20230301991A1. Автор: Ulrich Betz,Thomas Fuchss. Владелец: Merck Patent GmBH. Дата публикации: 2023-09-28.

Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from bcl2 inhibitors, bcl2/bclxl inhibitors, and bclxl inhibitors for use in the treatment of cancer

Номер патента: EP3703755B1. Автор: Ping Zhu,Markus Warmuth,Daniel Aird,Silvia Buonamici,Peter Fekkes,Peter Gerard Smith,Laura Corson. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2024-07-31.

MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS

Номер патента: US20130296330A1. Автор: Thuring Johannes Wilhelmus J.. Владелец: ELANCO ANIMAL HEALTH IRELAND LIMITED. Дата публикации: 2013-11-07.

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20130303489A1. Автор: Zhang Huiming,Agoulnik Sergei,Decosta Bruce,Du Hong,Jiang Yimin,Li Xiang-Yi,Nomoto Kenichi,Wang John (Yuan). Владелец: Eisai R&D Management Co., Ltd.. Дата публикации: 2013-11-14.

Novel combinations of a tubulin polymerization inhibitor and a poly (adp-ribose) polymerase (parp) inhibitor for use in the treatment of cancer

Номер патента: US20210052583A1. Автор: Marita Hogberg,Stefan Rehnmark. Владелец: NOVIGA RESEARCH AB. Дата публикации: 2021-02-25.

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20150182496A1. Автор: Zhang Huiming,Agoulnik Sergei,Decosta Bruce,Du Hong,Jiang Yimin,Li Xiang-Yi,Nomoto Kenichi,Wang John (Yuan). Владелец: . Дата публикации: 2015-07-02.

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20180353468A1. Автор: Zhang Huiming,Agoulnik Sergei,Decosta Bruce,Du Hong,Jiang Yimin,Li Xiang-Yi,Nomoto Kenichi,Wang John (Yuan). Владелец: Eisai R&D Management Co., Ltd.. Дата публикации: 2018-12-13.

A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis

Номер патента: WO2013171166A1. Автор: Thomas Klein,Michael Mark,Klaus Dugi,Andreas Daiber,Thomas Muenzel. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-11-21.

Dpp-iv inhibitors for use in the treatment of nafld

Номер патента: WO2009147125A1. Автор: Thomas Klein,Michael Mark,Leo Thomas,Heiko Niessen. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2009-12-10.

DPP-IV inhibitors for use in the treatment of NAFLD

Номер патента: AU2009253937B2. Автор: Thomas Klein,Michael Mark,Leo Thomas,Heiko Niessen. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2015-07-30.

Dpp-iv inhibitors for use in the treatment of non alcoholic fatty liver diseases

Номер патента: EA023207B1. Автор: Лео Томас,Томас Клайн,Михаэль Марк,Хайко Ниссен. Владелец: Бёрингер Ингельхайм Интернациональ Гмбх. Дата публикации: 2016-05-31.

Dpp-iv inhibitors for use in the treatment of nafld

Номер патента: EP3348263A1. Автор: Thomas Klein,Michael Mark,Leo Thomas,Heiko Niessen. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2018-07-18.

Combinations of LSD1 inhibitors for use in the treatment of solid tumors

Номер патента: AU2017233898A1. Автор: Tamara Maes,William Pierceall,Mark DEMARIO,Serena LUNARDI,Fiona MACK. Владелец: Oryzon Genomics SA. Дата публикации: 2018-11-01.

Combinations of lsd1 inhibitors for use in the treatment of solid tumors

Номер патента: CA3017411A1. Автор: Tamara Maes,William Pierceall,Mark DEMARIO,Serena LUNARDI,Fiona MACK. Владелец: Oryzon Genomics SA. Дата публикации: 2017-09-21.

Cxcl8 inhibitors for use in the treatment of covid-19

Номер патента: CA3176715A1. Автор: Marcello Allegretti,Lorenzo Piemonti,Flavio MANTELLI. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2021-09-30.

Dpp-iv inhibitors for use in the treatment of nafld

Номер патента: IL208811A0. Автор: . Владелец: Boehringer Ingelheim Int. Дата публикации: 2011-01-31.

Linagliptin, a xanthine derivative as a dpp-4 inhibitor, for use in the treatment of SIRS and/or sepsis

Номер патента: ES2929025T3. Автор: Thomas Klein,Michael Mark,Klaus Dugi,Andreas Daiber,Thomas Muenzel. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2022-11-24.

Cxcl8 inhibitors for use in the treatment of covid-19

Номер патента: EP4125848A1. Автор: Marcello Allegretti,Lorenzo Piemonti,Flavio MANTELLI. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2023-02-08.

Combinations of lsd1 inhibitors for use in the treatment of solid tumors.

Номер патента: MX2021004639A. Автор: Tamara Maes,William Pierceall,Mark DEMARIO,Serena LUNARDI,Fiona MACK. Владелец: Oryzon Genomics SA. Дата публикации: 2022-02-21.

HDAC Inhibitors for use in the treatment of Gaucher's disease, von Hippel-Lindau disease, phaeochromocytoma and paragangliomas.

Номер патента: EP2714924B1. Автор: Jie Lu,John S. Kovach,Zhengping Zhuang,Chunzhang YANG,Russell LONSER. Владелец: Lixte Biotechnology Inc. Дата публикации: 2018-03-21.

Wnt inhibitors for use in the treatment of fibrosis

Номер патента: EP3475271A1. Автор: Jun Liu,Peter Gergely,Jennifer Leslie Harris,Eric Svensson. Владелец: NOVARTIS AG. Дата публикации: 2019-05-01.

Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus

Номер патента: EP2675803A1. Автор: Johannes Wilhelmus J. Thuring. Владелец: Elanco Animal Health Ireland Ltd. Дата публикации: 2013-12-25.

Dpp-iv inhibitors for use in the treatment of nafld

Номер патента: CA2726244A1. Автор: Thomas Klein,Michael Mark,Leo Thomas,Heiko Niessen. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2009-12-10.

Atr inhibitors for use in the treatment of viral infections

Номер патента: WO2022090063A1. Автор: Ulrich Betz,Thomas Fuchss. Владелец: Merck Patent GmBH. Дата публикации: 2022-05-05.

Dpp-iv inhibitors for use in the treatment of nafld

Номер патента: CN102056606A. Автор: 迈克尔·马克,托马斯·克雷恩,希科·尼森,里奥·托马斯. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2011-05-11.

Wnt inhibitors for use in the treatment of fibrosis

Номер патента: CA3028586A1. Автор: Jun Liu,Peter Gergely,Jennifer Leslie Harris,Eric Svensson. Владелец: NOVARTIS AG. Дата публикации: 2017-12-28.

Novel combinations of a tubulin polymerization inhibitor and a poly (adp-ribose) polymerase (parp) inhibitor for use in the treatment of cancer

Номер патента: EP3773592A1. Автор: Marita Hogberg,Stefan Rehnmark. Владелец: NOVIGA RESEARCH AB. Дата публикации: 2021-02-17.

Novel combinations of a tubulin polymerization inhibitor and a poly (adp-ribose) polymerase (parp) inhibitor for use in the treatment of cancer

Номер патента: US20210052583A1. Автор: Marita Hogberg,Stefan Rehnmark. Владелец: NOVIGA RESEARCH AB. Дата публикации: 2021-02-25.

Atr inhibitors for use in the treatment of viral infections

Номер патента: IL302403A. Автор: Ulrich Betz,Thomas Fuchss. Владелец: Thomas Fuchss. Дата публикации: 2023-06-01.

Casein kinase 1 inhibitors for use in the treatment of diseases related to dux4 expression such as muscular dystrophy and cancer

Номер патента: IL288924A. Автор: Geese Marcus,Hirsch Rolf,De Maeyer Joris,Monecke Sebastian,Leng Loke Pui. Владелец: Facio Intellectual Property B V. Дата публикации: 2022-02-01.

Tryptophan- and phenylethylamine-derived betaxanthins for use in the treatment and/or prevention of cancer

Номер патента: WO2021009029A1. Автор: Francisco Garcia Carmona,Fernando Gandía Herrero,Paula Henarejos Escudero,Samanta Hernández García,María Alejandra Guerrero Rubio. Владелец: Universidad De Murcia. Дата публикации: 2021-01-21.

Use of heterocyclic compounds for iontophoretic treatment or for the production of pharmaceuticals for iontophoretic treatment of malignant tumors as well as lubricants or partingcompounds, anesthetics and prophylactics to be used during this treatment

Номер патента: CA1331567C. Автор: Karl Heinz Thiel. Владелец: Karl Heinz Thiel. Дата публикации: 1994-08-23.

BETAHISTINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A MONOAMINE OXIDASE INHIBITOR, FOR USE IN THE TREATMENT OR PREVENTION OF ONE OR MORE SYMPTOMS OF VERTIGO IN A SUBJECT

Номер патента: US20210085659A1. Автор: Strupp Michael. Владелец: INTRABIO LTD. Дата публикации: 2021-03-25.

PDE3 inhibitors for treating viral infections

Номер патента: US20230270724A1. Автор: Jan Beute,Henricus Bartholomeus Benraad. Владелец: Breakthrough Medical Research BV. Дата публикации: 2023-08-31.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: US20180086707A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2018-03-29.

Combination of EGFR Inhibitor and MEK Inhibitor for use in the treatment of NRAS mutated cancer

Номер патента: US20210177844A1. Автор: Cross Darren Anthony Edward,Eberlein Catherine Anne. Владелец: . Дата публикации: 2021-06-17.

Combination of EGFR Inhibitor and MEK Inhibitor for use in the treatment of NRAS mutated cancer

Номер патента: US20200237758A1. Автор: Edward,Eberlein Catherine Anne,Cross Darren Anthony. Владелец: AstraZeneca AB. Дата публикации: 2020-07-30.

COMBINATION THERAPY WITH MERESTINIB AND ANTI-PD-L1 OR ANTI-PD-1 INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20190269666A1. Автор: YAN Sau-Chi Betty,SCHAER David Arlen,WALGREN Richard A.. Владелец: . Дата публикации: 2019-09-05.

C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN

Номер патента: US20200397725A1. Автор: Allegretti Marcello,BRANDOLINI Laura,ARAMINI Andrea,BIANCHINI Gianluca,Cunha Thiago Mattar. Владелец: . Дата публикации: 2020-12-24.

Combination Therapy of Notch and a PI3K/mTOR Inhibitor for Use in the Treatment of Cancer

Номер патента: KR102418766B1. Автор: 브라빈 쿠마르 파텔,미셸 씨. 스미스. Владелец: 일라이 릴리 앤드 캄파니. Дата публикации: 2022-07-08.

CXCR4 activity inhibitors for use in the treatment of eye disorders

Номер патента: ES2385924T3. Автор: John E. Donello,Anne P. Mclaughlin,Fabien J. Schweighoffer,Florence Mahe,Gerard A. Rodrigues. Владелец: Allergan Inc. Дата публикации: 2012-08-03.

C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain

Номер патента: CA3082762A1. Автор: Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Thiago Mattar CUNHA. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2019-06-20.

Dopamine transporter inhibitors for use in the treatment of movement disorders and other CNS indications

Номер патента: JP5199678B2. Автор: ジェームス アール． ハウスク，. Владелец: プレクサ ファーマシューティカルズ， インコーポレイテッド. Дата публикации: 2013-05-15.

Bace inhibitors for use in the treatment of diabetes

Номер патента: CA2809222A1. Автор: MATTHIAS Nettekoven,Harald Mauser,Sebastien Schmitt. Владелец: F Hoffmann La Roche AG. Дата публикации: 2012-03-08.

Pde4 and pde3/4 inhibitors for use in the treatment of cachexia

Номер патента: US20060079540A1. Автор: Mathias Schmidt. Владелец: ALTANA PHARMA AG. Дата публикации: 2006-04-13.

C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN

Номер патента: MA51128A. Автор: Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti,Thiago Mattar CUNHA. Владелец: Dompe Farm Spa. Дата публикации: 2021-03-24.

Pde4 and pde3/4 inhibitors for use in the treatment of cachexia

Номер патента: EP1567136A1. Автор: Mathias Schmidt. Владелец: ALTANA PHARMA AG. Дата публикации: 2005-08-31.

Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer

Номер патента: CA3205726A1. Автор: Michael Burke,Alfredo C. Castro,Benjamin Amidon,Hyejin FROSCH. Владелец: Ikena Oncology Inc. Дата публикации: 2022-07-28.

Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy

Номер патента: IL307883A. Автор: Jin Yang,Mohammad A Mandegar,Timothy C Hoey. Владелец: Timothy C Hoey. Дата публикации: 2023-12-01.

USE OF ELIPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE PREVENTION OF NEUROPATHIES INDUCED BY CANCER AGENTS

Номер патента: FR2722987B1. Автор: Jesus Benavides,Pascal George,Delphine Lekieffre,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1997-05-16.

USE OF ELIPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE PREVENTION OF NEUROPATHIES INDUCED BY CANCER AGENTS

Номер патента: FR2722987A1. Автор: Jesus Benavides,Pascal George,Delphine Lekieffre,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1996-02-02.

Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy

Номер патента: NZ743344A. Автор: Laura Brandolini,Marcello Allegretti,Pier Ruffini. Владелец: Dompe’ Farm S P A. Дата публикации: 2024-05-31.

Selective pacl inhibitors for use in the treatment of migraine and headaches

Номер патента: WO2009033489A3. Автор: Jes Olesen,Steffen Birk. Владелец: Steffen Birk. Дата публикации: 2009-05-07.

Foxo inhibitors for use in the treatment of diseases caused by abnormal processing of tdp-43 and/or fus proteins

Номер патента: US20240277695A1. Автор: Jesus Maria Aizpurua Iparraguirre,José Ignacio MIRANDA MURUA,Adolfo LÓPEZ DE MUNAIN ARREGUI,Mónica Zufiría García,Gorka Gereñu Lopetegi,Patxi Gil Bea,Sonia Alonso Martin,Jaione Lasa Elgarresta. Владелец: Universidad Del Pais Vasco/Euskal Herriko Unibersitatea. Дата публикации: 2024-08-22.

Combinations comprising mek inhibitors for use in the treatment of cancer

Номер патента: WO2024173761A1. Автор: Alfredo C. Castro,Thomas A. Wynn,Michael J. Burke,Sabine K. RUPPEL,Eric HAINES. Владелец: Ikena Oncology, Inc.. Дата публикации: 2024-08-22.

Myosin inhibitors for use in the treatment of hypertrophic cardiomyopathy

Номер патента: WO2024182469A1. Автор: Jay Edelberg,Carlos DEL RIO,Angelos OIKONOMOPOULOS,Matthew MEALIFFE. Владелец: MyoKardia, Inc.. Дата публикации: 2024-09-06.

Chk1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas

Номер патента: EP3325468A1. Автор: Louis Frank Stancato. Владелец: Eli Lilly and Co. Дата публикации: 2018-05-30.

Chk1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas

Номер патента: US20220378745A1. Автор: Louis Frank Stancato. Владелец: Eli Lilly and Co. Дата публикации: 2022-12-01.

CHK1/2 Inhibitors for Use in the Treatment of Neuroblastomas and/or Soft Tissue Sarcomas

Номер патента: US20180369202A1. Автор: Louis Frank Stancato. Владелец: Eli Lilly and Co. Дата публикации: 2018-12-27.

Sos1 inhibitors and ras inhibitors for use in the treatment of pain

Номер патента: CA3213593A1. Автор: Neil Benson,Alasdair Naylor. Владелец: Sevenless Therapeutics Ltd. Дата публикации: 2022-10-06.

Sos1 inhibitors and ras inhibitors for use in the treatment of pain

Номер патента: EP4313151A1. Автор: Neil Benson,Alasdair Naylor. Владелец: Sevenless Therapeutics Ltd. Дата публикации: 2024-02-07.

Sos1 inhibitors and ras inhibitors for use in the treatment of pain

Номер патента: AU2022250712A1. Автор: Neil Benson,Alasdair Naylor. Владелец: Sevenless Therapeutics Ltd. Дата публикации: 2023-10-05.

Multikinase Inhibitors for Use in the Treatment of Cancer

Номер патента: US20090082313A1. Автор: Yimin Jiang,Xiang-Yi Li,Huiming Zhang,Kenichi Nomoto,Hong Du,Sergei Agoulnik,Bruce DeCosta,John (Yuan) Wang. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2009-03-26.

Composition comprising a TNFR agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma

Номер патента: AU2014210908A1. Автор: Nikolaos GEORGOPOULOS. Владелец: UNIVERSITY OF HUDDERSFIELD. Дата публикации: 2015-09-24.

Composition comprising a tnfr agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma.

Номер патента: EP2950788A1. Автор: Nikolaos GEORGOPOULOS. Владелец: UNIVERSITY OF HUDDERSFIELD. Дата публикации: 2015-12-09.

Kdm subfamily 6 protein inhibitor for use in the treatment of cancer

Номер патента: WO2021105224A1. Автор: Montse SANCHEZ CESPEDES,Octavio ROMERO FERRARO. Владелец: Fundacio Institut De Recerca Contra La Leucemia Josep Carreras. Дата публикации: 2021-06-03.

Foxo inhibitors for use in the treatment of diseases caused by abnormal processing of tdp-43 and/or fus proteins

Номер патента: WO2021239915A1. Автор: Jesus Maria Aizpurua Iparraguirre,José Ignacio MIRANDA MURUA,Adolfo LÓPEZ DE MUNAIN ARREGUI,Mónica Zufiría García,Gorka Gereñu Lopetegi,Patxi Gil Bea,Sonia Alonso Martin,Jaione Lasa Elgarresta. Владелец: Universidad Del Pais Vasco/Euskal Herriko Unibersitatea. Дата публикации: 2021-12-02.

Foxo inhibitors for use in the treatment of diseases caused by abnormal processing of tdp-43 and/or fus proteins

Номер патента: EP4157273A1. Автор: Jesus Maria Aizpurua Iparraguirre,José Ignacio MIRANDA MURUA,Adolfo LÓPEZ DE MUNAIN ARREGUI,Mónica Zufiría García,Gorka Gereñu Lopetegi,Patxi Gil Bea,Sonia Alonso Martin,Jaione Lasa Elgarresta. Владелец: Administracion General De La Comunidad Autonoma De Euskadi. Дата публикации: 2023-04-05.

Foxo1 inhibitor for use in the treatment of latent virus infection

Номер патента: WO2020169707A1. Автор: Marianne Mangeney,Georges Bismuth,Arthur ROUX. Владелец: Université de Paris. Дата публикации: 2020-08-27.

Combination of dcc-3116 and mapkap pathway inhibitors for use in the treatment of cancer

Номер патента: WO2024050351A1. Автор: Matthew L. Sherman,Daniel L. Flynn,Rodrigo Ruiz Soto,Bryan D. Smith,Gada AL-ANI,Madhumita BOGDAN,Fred J. REU. Владелец: DECIPHERA PHARMACEUTICALS, LLC. Дата публикации: 2024-03-07.

Compound for the treatment and prevention of central nervous system disorders

Номер патента: CA3166310A1. Автор: Francisco Javier Garcia-Ladona. Владелец: ABAXYS THERAPEUTICS. Дата публикации: 2021-07-08.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: WO2022200613A3. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Université Paris Cite. Дата публикации: 2022-11-17.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: EP4313025A2. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Universite Paris Saclay. Дата публикации: 2024-02-07.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: WO2022200613A2. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Université Paris Cite. Дата публикации: 2022-09-29.

Arginine methylation inhibitor for treating or preventing cardiovascular disease

Номер патента: WO2018130840A1. Автор: Pedro BELTRAN-ALVAREZ,Francisco RIVERO. Владелец: The University of Hull. Дата публикации: 2018-07-19.

Par1 Inhibitors for Use in the Treatment or Prevention of Paramyxoviridae Infections

Номер патента: US20140378502A1. Автор: BOIVIN Guy,RITEAU Beatrice,Aerts Laetitia,Hamelin Marie-Eve. Владелец: . Дата публикации: 2014-12-25.

Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections

Номер патента: EP2709630A4. Автор: Beatrice Riteau,Guy Boivin,Marie-Eve Hamelin,Laetitia Aerts. Владелец: Institut National de la Recherche Agronomique INRA. Дата публикации: 2014-10-22.

Pharmaceutical combination for the treatment of cancer

Номер патента: US11925618B2. Автор: Owe Orwar,Sreesha SRINIVASA,Prabha MISHRA. Владелец: Piramal Enterprises Ltd. Дата публикации: 2024-03-12.

Pharmaceutical combination for the treatment of melanoma

Номер патента: US11839591B2. Автор: Ankita SRIVASTAVA,Sreesha SRINIVASA,Maggie Rathos,Veena Agarwal,Giridharan Periyasamy. Владелец: Piramal Enterprises Ltd. Дата публикации: 2023-12-12.

Pharmaceutical combination for the treatment of melanoma

Номер патента: US20240165076A1. Автор: Ankita SRIVASTAVA,Sreesha SRINIVASA,Maggie Rathos,Veena Agarwal,Giridharan Periyasamy. Владелец: Piramal Enterprises Ltd. Дата публикации: 2024-05-23.

Compounds for use in the treatment of leukemia

Номер патента: US20230073499A1. Автор: Francesco FAZI,Silvia MASCIARELLI. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2023-03-09.

Compounds for the treatment of viral infections

Номер патента: CA3184498A1. Автор: Ulrich Betz. Владелец: Merck Patent GmBH. Дата публикации: 2021-12-23.

Cyclopenta[4,5]furo[3,2-c]pyridine derivatives as ras inhibitors for use in the treatment of hyperproliferative diseases or genetic disorders

Номер патента: EP4395775A1. Автор: Krishnaraj Rajalingam. Владелец: KHR Biotec GmbH. Дата публикации: 2024-07-10.

APPLICATION OF CYCLETHANIN AND OTHER FUROPYRIDINES FOR THE TREATMENT OF HYPERTENSION WITH THE PREVENTION OF SYTOLIC PRESSURE, ISOLATED SYSTOLIC HYPERTENSION, ENHANCED PULSE ARTERYAL ARMERIAL HYPERTENSION, HYPROPEDIUM ARTHERIC HYPERTENSIA

Номер патента: EA200801305A1. Автор: Гленн КОРНЕТТ,Джим Пейдж,Карен Пейдж. Владелец: Джилиэд Сайенсиз, Инк.. Дата публикации: 2009-06-30.

Quinoline Compounds Which Are Anti-Angiogenic Integrin Alpha5 Beta1 Inhibitors for Use in the Treatment of Fibrosis or Fibrosis-Related Diseases

Номер патента: US20150031723A1. Автор: Cao Yihai. Владелец: . Дата публикации: 2015-01-29.

Synaptojanin-2 inhibitors for use in the treatment of cancer

Номер патента: US20170042857A1. Автор: Yosef Yarden,Nir Ben-Chetrit. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2017-02-16.

Il-8 inhibitors for use in the treatment of some urological disorders

Номер патента: US20190336484A1. Автор: Maria Candida Cesta,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Marcello Allegretti. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2019-11-07.

Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders

Номер патента: US9669035B2. Автор: José Ignacio Andrés-Gil,Antonius Adrianus Hendrikus Petrus Megens,Xavier Jean Michel Langlois. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2017-06-06.

Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological or metabolic disorders

Номер патента: CN104411312A. Автор: A.A.H.P.梅根斯,X.J.M.兰格洛伊斯,G.C.P.范霍夫,J.I.安德雷斯-吉尔,M.德安格里斯,P.J.J.A.布伊恩斯特斯,A.A.特拉班科-苏亚雷兹,F.J.R.罗姆博特斯. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2015-03-11.

Caspase inhibitors for use in the treatment of liver cancer

Номер патента: WO2017079566A1. Автор: Alfred P. Spada. Владелец: Conatus Pharmaceuticals, Inc.. Дата публикации: 2017-05-11.

A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome

Номер патента: WO2013171167A1. Автор: Thomas Klein,Michael Mark,Maximilian von EYNATTEN,Berthold Hocher,Yuliya SHARKOVSKA. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-11-21.

A xanthine derivative as dpp -4 inhibitor for use in the treatment of autoimmune diabetes, particularly lada

Номер патента: WO2013174768A1. Автор: Odd-Erik Johansen,Hans-Juergen Woerle. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-11-28.

Dihydropyridinone mgat2 inhibitors for use in the treatment of metabolic disorders

Номер патента: WO2015134701A1. Автор: Wei Meng,Guohua Zhao. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2015-09-11.

DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection

Номер патента: AU2006297130B2. Автор: Malcolm Allison,Thomas Edward Hughes,Bryan Burkey,Daniel Matthew Kemp. Владелец: NOVARTIS AG. Дата публикации: 2009-12-24.

Dipeptidylpeptidase IV inhibitors for use in the treatment of Type II diabetes

Номер патента: EP2823812A1. Автор: William W. Bachovchin,Andrew G. Plaut,Daniel Drucker. Владелец: 1149336 Ontario Inc. Дата публикации: 2015-01-14.

Il-8 inhibitors for use in the treatment of some sarcomas

Номер патента: WO2019081470A1. Автор: Laura Brandolini,Ryan David ROBERTS. Владелец: Research Institute at Nationwide Children’s Hospital. Дата публикации: 2019-05-02.

Ferroportin inhibitors for use in the treatment of transfusion-dependent beta-thalassemia (TDT)

Номер патента: KR20220042149A. Автор: 바니아 마놀로바,나자 니페네거,패트릭 알터매트,프란츠 뒤렌베르거. Владелец: 비포르 (인터내셔날) 아게. Дата публикации: 2022-04-04.

Combinations of a CBP/p300 bromodomain inhibitor and an EGFR inhibitor for use in the treatment of EGFR-mutant NSCLC

Номер патента: KR20230028512A. Автор: 스테파니 플루키걸-망구얼,도로시아 그루벌,토마스 보나커,마틴 슈윌,데보라 슈미츠-로머,찰스-헨리 파브리티우스,사라 라우다토. Владелец: 톨레모 테라퓨틱스 아게. Дата публикации: 2023-02-28.

Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer

Номер патента: EP4281073A1. Автор: Michael Burke,Alfredo C. Castro,Benjamin Amidon,Hyejin FROSCH. Владелец: Ikena Oncology Inc. Дата публикации: 2023-11-29.

Il-8 inhibitors for use in the treatment of certain urological disorders

Номер патента: ZA201708608B. Автор: Allegretti Marcello,BRANDOLINI Laura,ARAMINI Andrea,BIANCHINI Gianluca,Angelico Patrizia,Candida Cesta Maria. Владелец: Dompe Farm Spa. Дата публикации: 2019-05-29.

Synaptojanin-2 inhibitors for use in the treatment of cancer

Номер патента: US20170042857A1. Автор: Yosef Yarden,Nir Ben-Chetrit. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2017-02-16.

[1,2,4]triazolo[4,3-a]pyrimidin-7(8h)-one as mitochondrial pyruvate carrier inhibitors for use in the treatment of cancer

Номер патента: AU2022327765A1. Автор: Jean-Claude Martinou,Benjamin Perry. Владелец: Mpc Therapeutics Sa. Дата публикации: 2024-03-28.

Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer

Номер патента: IL304492A. Автор: . Владелец: Ikena Oncology Inc. Дата публикации: 2023-09-01.

Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection

Номер патента: EP4251166A1. Автор: Daniel L. Flynn. Владелец: Deciphera Pharmaceuticals LLC. Дата публикации: 2023-10-04.

Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection

Номер патента: EP4251165A1. Автор: Daniel L. Flynn. Владелец: Deciphera Pharmaceuticals LLC. Дата публикации: 2023-10-04.

[1,2,4]triazolo[4,3-a]pyrimidin-7(8h)-one as mitochondrial pyruvate carrier inhibitors for use in the treatment of cancer

Номер патента: CA3227552A1. Автор: Jean-Claude Martinou,Benjamin Perry. Владелец: Individual. Дата публикации: 2023-02-16.

A combination of a cbp/p300 bromodomain inhibitor and an egfr inhibitor for use in treating egfr-mutant nsclc

Номер патента: CA3183982A1. Автор: Martin Schwill,Charles-Henry Fabritius,Stefanie FLÜCKIGER-MANGUAL,Dorothea GRUBER,Thomas Bohnacker,Debora SCHMITZ-ROHMER,Sara Laudato. Владелец: Individual. Дата публикации: 2021-12-30.

Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock

Номер патента: AU2740097A. Автор: Csaba Szabo,Andrew L Salzman. Владелец: Cincinnati Childrens Hospital Medical Center. Дата публикации: 1997-11-26.

[1,2,4]triazolo[4,3-a]pyrimidin-7(8h)-one as mitochondrial pyruvate carrier inhibitors for use in the treatment of cancer

Номер патента: EP4384167A1. Автор: Jean-Claude Martinou,Benjamin Perry. Владелец: Mpc Therapeutics Sa. Дата публикации: 2024-06-19.

Inhibitor of cellular purine nucleotide salvage pathway enzyme for use in the treatment and/or prevention of helicobacter pylori infection and/or disease associated with such infection and pharmaceutical composition comprising the same

Номер патента: WO2023177312A2. Автор: Biserka Zinic,Maria Agnieszka BZOWSKA,Marta WOJTYŚ,Katarzyna JAGUSZTYN-KRYNICKA,Marta NARCZYK,Ivana LEŠČIĆ AŠLER,Zoran ŠTEFANIĆ,Marija LUIĊ,Weronika MAKSYMIUK. Владелец: RUDER BOSKOVIC INSTITUTE. Дата публикации: 2023-09-21.

Inhibitor of cellular purine nucleotide salvage pathway enzyme for use in the treatment and/or prevention of helicobacter pylori infection and/or disease associated with such infection and pharmaceutical composition comprising the same

Номер патента: WO2023177312A3. Автор: Biserka Zinic,Maria Agnieszka BZOWSKA,Marta WOJTYŚ,Katarzyna JAGUSZTYN-KRYNICKA,Marta NARCZYK,Ivana LEŠČIĆ AŠLER,Zoran ŠTEFANIĆ,Marija LUIĊ,Weronika MAKSYMIUK. Владелец: RUDER BOSKOVIC INSTITUTE. Дата публикации: 2023-10-26.

Bisdiazabicyclo-compound for treatment and / or prevention of diseases or disorders associated with the hepatitis virus

Номер патента: RU2749730C1. Автор: Сяоюн ЧЖАН,Ифань Чжай,Цзиньлинь ХОУ,Дацзюнь Ян. Владелец: Хелтквест Фарма Инк.. Дата публикации: 2021-06-16.

KDM1A inhibitors for the treatment of disease

Номер патента: AU2019265022B2. Автор: Cassandra Celatka,Michael Clare,Amy E. Tapper,Hugh Y. REINHOFF Jr. Владелец: Imago Biosciences Inc. Дата публикации: 2024-08-15.

Capsid inhibitors for the treatment of hiv

Номер патента: US20230312567A1. Автор: Darryl Kato,John O. Link,Scott E. Lazerwith,Winston C. Tse,Scott D. Schroeder,Jennifer R. Zhang,Chienhung CHOU. Владелец: Gilead Sciences Inc. Дата публикации: 2023-10-05.

Capsid inhibitors for the treatment of HIV

Номер патента: AU2021296607B2. Автор: Darryl Kato,John O. Link,Scott E. Lazerwith,Winston C. Tse,Scott D. Schroeder,Jennifer R. Zhang,Chienhung CHOU. Владелец: Gilead Sciences Inc. Дата публикации: 2024-07-25.

Capsid inhibitors for the treatment of HIV

Номер патента: US12077537B2. Автор: John O. Link,Scott E. Lazerwith,Winston C. Tse,Scott D. Schroeder,Jennifer R. Zhang,Chienhung CHOU. Владелец: Gilead Sciences Inc. Дата публикации: 2024-09-03.

Lysine demethylase inhibitors for myeloproliferative disorders

Номер патента: US09908859B2. Автор: Matthew Colin Thor Fyfe,Marc Martinell Pedemonte,Tamara Maes,Jonathan Alleman Baker,Julio CASTRO PALOMINO. Владелец: Oryzon Genomics SA. Дата публикации: 2018-03-06.

Compounds and compositions for the treatment of mpnst

Номер патента: US20240238284A1. Автор: Huaixiang Hao,Jiawan WANG,Susan Elizabeth MOODY,Christine A. PRATILAS. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2024-07-18.

Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: TW201613597A. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma B V. Дата публикации: 2016-04-16.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: ZA201605490B. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma B V. Дата публикации: 2018-05-30.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: SG11201605956RA. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma B V. Дата публикации: 2016-08-30.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: AP2016009359A0. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma B V. Дата публикации: 2016-08-31.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: EP3102212B1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma BV. Дата публикации: 2018-11-07.

Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-resistant depression

Номер патента: AU2022409230A1. Автор: Christopher Brown,David E. Nichols,Stephen Wright,Julian Scott Northen,Derek John Londesbrough,Gillian Moore,Hemant Kashinath Patil,Megan CROAL,Hans Åke ERIKSSON,George GOLDSMITH,Molly Tabitha HICKEY,Shaun Hurley,Ekaterina MALIEVSKAIA,Lindsey MARWOOD,Drummond E-Wen Joe MCCULLOCH,Laurie Emma MEDHURST,Nathan POULSEN,Aslihan SELIMBEYOGLU,Anaïs SOULA,Amanda Tan SHUXIANG,Manon Cecile Elisabeth VERAART,Tobias Patrick WHELAN,Lars Christian WILDE. Владелец: Compass Pathfinder Ltd. Дата публикации: 2024-06-20.

Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-resistant depression

Номер патента: EP4447948A1. Автор: Christopher Brown,David E. Nichols,Stephen Wright,Julian Scott Northen,Derek John Londesbrough,Gillian Moore,Hemant Kashinath Patil,Megan CROAL,Hans Åke ERIKSSON,George GOLDSMITH,Molly Tabitha HICKEY,Shaun Hurley,Ekaterina MALIEVSKAIA,Lindsey MARWOOD,Drummond E-Wen Joe MCCULLOCH,Laurie Emma MEDHURST,Nathan POULSEN,Aslihan SELIMBEYOGLU,Anaïs SOULA,Amanda Tan SHUXIANG,Manon Cecile Elisabeth VERAART,Tobias Patrick WHELAN,Lars Christian WILDE. Владелец: Compass Pathfinder Ltd. Дата публикации: 2024-10-23.

Pharmaceutical combinations of statins and fibrates for the treatment and prevention of hyperlipidemias and cardiovascular disease

Номер патента: US20230355578A1. Автор: Jorge Alejandro GONZÁLEZ CANUDAS,Sixto Serafin Espinoza Leon,Paola Yazmin Ollervides Rubio,Claudia Delfina FARFÁN SALAZAR. Владелец: Laboratorios Silanes SA de CV. Дата публикации: 2023-11-09.

Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-resistant depression

Номер патента: CA3240774A1. Автор: Christopher Brown,David E. Nichols,Stephen Wright,Julian Scott Northen,Derek John Londesbrough,Gillian Moore,Hemant Kashinath Patil,Megan CROAL,Hans Åke ERIKSSON,George GOLDSMITH,Molly Tabitha HICKEY,Shaun Hurley,Ekaterina MALIEVSKAIA,Lindsey MARWOOD,Drummond E-Wen Joe MCCULLOCH,Laurie Emma MEDHURST,Nathan POULSEN,Aslihan SELIMBEYOGLU,Anaïs SOULA,Amanda Tan SHUXIANG,Manon Cecile Elisabeth VERAART,Tobias Patrick WHELAN,Lars Christian WILDE. Владелец: Compass Pathfinder Ltd. Дата публикации: 2023-06-22.

Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-resistant depression

Номер патента: WO2023114097A9. Автор: Christopher Brown,David E. Nichols,Stephen Wright,Julian Scott Northen,Derek John Londesbrough,Gillian Moore,Hemant Kashinath Patil,Megan CROAL,Hans Åke ERIKSSON,George GOLDSMITH,Molly Tabitha HICKEY,Shaun Hurley,Ekaterina MALIEVSKAIA,Lindsey MARWOOD,Drummond E-Wen Joe MCCULLOCH,Laurie Emma MEDHURST,Nathan POULSEN,Aslihan SELIMBEYOGLU,Anaïs SOULA,Amanda Tan SHUXIANG,Manon Cecile Elisabeth VERAART,Tobias Patrick WHELAN,Lars Christian WILDE. Владелец: COMPASS PATHFINDER LIMITED. Дата публикации: 2024-07-11.

Nitroxides for use in treating or preventing diabetes

Номер патента: WO2006084041A3. Автор: Louis Habash,Clarence Jones. Владелец: Mitos Inc. Дата публикации: 2007-04-19.

Use of Gemfibrozil and derivative thereof for treatment and/or prevention of neurodegenerative disease

Номер патента: US12048680B2. Автор: JING Yang,Guiyu Li,Yonggang Yao,Dengfeng Zhang,Rongcan LUO,Lingyan SU. Владелец: Kunming Institute of Zoology of CAS. Дата публикации: 2024-07-30.

Nitroxides for use in treating or preventing diabetes and obesity

Номер патента: US20150359782A1. Автор: Louis Habash,Clarence Jones. Владелец: Mitos Pharmaceuticals Inc. Дата публикации: 2015-12-17.

Nitroxides for use in treating or preventing diabetes and obesity

Номер патента: US20140045891A1. Автор: Louis Habash,Clarence Jones. Владелец: Mitos Pharmaceuticals Inc. Дата публикации: 2014-02-13.

Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv

Номер патента: US20240352013A1. Автор: Richard PLEMPER,Julien SOURIMANT. Владелец: Georgia State University Research Foundation Inc. Дата публикации: 2024-10-24.

Method for treatment or prevention of atherosclerotic disorders and/or coronary heart disease

Номер патента: GB2155334B. Автор: Vanessa Pierce. Владелец: John Wyeth and Brother Ltd. Дата публикации: 1987-12-16.

Treatment/prevention of atherosclerotic disorders

Номер патента: GB8505879D0. Автор: . Владелец: John Wyeth and Brother Ltd. Дата публикации: 1985-04-11.

Inhibitor of deoxyhypusine hydroxylase for the treatment and prevention of respiratory virus infections

Номер патента: WO2023230435A1. Автор: Winston C. Tse,Istvan Bartha,Johannes Grosse,Amalio Telenti,Leah B. SORIAGA,Arthur CHASE,Neil Robert Stokes. Владелец: Glaxo Wellcome Uk Limited. Дата публикации: 2023-11-30.

Inhibitor of deoxyhypusine hydroxylase for the treatment and prevention of respiratory virus infections

Номер патента: WO2023230435A9. Автор: Winston C. Tse,Istvan Bartha,Johannes Grosse,Amalio Telenti,Leah B. SORIAGA,Arthur CHASE,Neil Robert Stokes. Владелец: Glaxo Wellcome Uk Limited. Дата публикации: 2024-03-14.

Vcp inhibitors for use in treating amyotrophic lateral sclerosis

Номер патента: EP4366738A2. Автор: Rickie PATANI,Jasmine HARLEY. Владелец: Francis Crick Institute Ltd. Дата публикации: 2024-05-15.

Vcp inhibitors for use in treating amyotrophic lateral sclerosis

Номер патента: AU2022309123A1. Автор: Rickie PATANI,Jasmine HARLEY. Владелец: Francis Crick Institute Ltd. Дата публикации: 2024-01-25.

Vcp inhibitors for use in treating amyotrophic lateral sclerosis

Номер патента: WO2023281030A3. Автор: Rickie PATANI,Jasmine HARLEY. Владелец: The Francis Crick Institute Limited. Дата публикации: 2023-03-09.

Compounds for the treatment of myotonic dystrophy

Номер патента: WO2024074483A1. Автор: Jonathan Hall,Alok Kumar BEHERA. Владелец: ETH Zurich. Дата публикации: 2024-04-11.

Nhe-1 inhibitors for the treatment of coronavirus infections

Номер патента: US20240041804A1. Автор: Caroline KANT MAREDA,Florence Porte Thomé,Caroline Durand Avallone,Jiri Mareda,Sameera Allie. Владелец: Fondation Esperare. Дата публикации: 2024-02-08.

Nhe-1 inhibitors for the treatment of coronavirus infections

Номер патента: EP4203930A1. Автор: Caroline KANT MAREDA,Florence Porte Thomé,Caroline Durand Avallone,Jiri Mareda,Sameera Allie. Владелец: Fondation Esperare. Дата публикации: 2023-07-05.

Nhe-1 inhibitors for the treatment of coronavirus infections

Номер патента: CA3187903A1. Автор: Caroline KANT MAREDA,Florence Porte Thomé,Caroline Durand Avallone,Jiri Mareda,Sameera Allie. Владелец: Fondation Esperare. Дата публикации: 2022-03-03.

USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES

Номер патента: WO2007024472A3. Автор: John Thomas Brandt,Kenneth John Winters,Victor Leonid Serebruany. Владелец: Victor Leonid Serebruany. Дата публикации: 2007-06-07.

Carbonic anhydrase 1 (ca1) inhibitors for the treatment or prevention of myeloproliferative disorders and other hematopoietic malignancies, and as biomarker of myeloproliferative disorders and other hematopoietic malignancies

Номер патента: US20240180930A1. Автор: Shohei Murakami,Daniel Lewandowski,Paul-Henri Romeo,Vilma BARROCA. Владелец: Universite Paris Saclay. Дата публикации: 2024-06-06.

Asbt inhibitors in the treatment of renal diseases

Номер патента: WO2024121434A1. Автор: Erik LINDSTRÖM,Jan Hengstler,Ellen STRÄNGBERG,Ahmed GHALLAB. Владелец: ALBIREO AB. Дата публикации: 2024-06-13.

Novel glucose uptake inhibitors for use in the treatment of cancer

Номер патента: US20240252508A1. Автор: Johan Thevelein,Ward VANTHIENEN. Владелец: Novelyeast BV. Дата публикации: 2024-08-01.

Hdac inhibitors for the treatment of diabetic peripheral neuropathy

Номер патента: US20190106392A1. Автор: Matthew B. Jarpe,Olga Golonzhka. Владелец: Regenacy Pharmaceuticals Inc. Дата публикации: 2019-04-11.

Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes

Номер патента: US20130203786A1. Автор: Ping Chen,Tesfaye Biftu,Robert R. Wilkening,Xiaoxia Qian,Jacqueline D. Hicks. Владелец: Individual. Дата публикации: 2013-08-08.

Tlr3 inhibitors for use in the treatment of diseases associated with cardiovascular calcification

Номер патента: IL311893A. Автор: . Владелец: Holfeld Johannes. Дата публикации: 2024-06-01.

N-(phenyl)-5-(phenyl)-1h-pyrazol-3-amine derivatives as tnik inhibitors for use in the treatment of cancer

Номер патента: EP3749648B1. Автор: Sung Soo Kim,Ki Young Kim,Hyuk Lee,Seong Hwan Kim,Jung Nyoung Heo,Bum Tae Kim,Sung Youn Chang,Hwan Jung LIM,Sang Joon Shin,Sang Youn Park. Владелец: Industry Academic Cooperation Foundation of Yonsei University. Дата публикации: 2024-10-30.

Phosphoinositide 3-kinase and src inhibitors for treatment of pancreatic cancer

Номер патента: US20220016123A1. Автор: DEEPAK SHARMA,Vijay Singh,Manoj Kumar,Priyam SINGH,Om Sharma,Ishita Mallick,Amit Choudhari,Vivekanand Patil,Dinesh Solanke,Pulkit Anupam Srivastava,Adity Shandilya. Владелец: Innoplexus AG. Дата публикации: 2022-01-20.

Treatment of hidradenitis suppurativa using jak inhibitors

Номер патента: EP4424328A2. Автор: Paul Smith,Michael D. Howell. Владелец: Incyte Corp. Дата публикации: 2024-09-04.

Asbt inhibitors in the treatment of renal diseases

Номер патента: US20240207286A1. Автор: Erik LINDSTRÖM,Jan Hengstler,Ellen STRÄNGBERG,Ahmed GHALLAB. Владелец: ALBIREO AB. Дата публикации: 2024-06-27.

Use of tocotrienols in the treatment or prevention of ulcerative colitis

Номер патента: WO2015060789A1. Автор: Chee Wai FONG,Tzuen Yih SAW. Владелец: Davos Life Science Pte. Ltd.. Дата публикации: 2015-04-30.

Treatment of hidradenitis suppurativa using jak inhibitors

Номер патента: ZA202202361B. Автор: Paul Smith,Michael D Howell. Владелец: Incyte Corp. Дата публикации: 2024-09-25.

GLYT1 INHIBITORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS

Номер патента: US20170042888A1. Автор: Pinard Emmanuel,Winter Michael,Alberati Daniela,Koerner Annette. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2017-02-16.

FATTY ACID SYNTHASE INHIBITOR FOR USE IN THE TREATMENT OF DRUG RESISTANT CANCER

Номер патента: US20170273964A1. Автор: HEUER Timothy Sean. Владелец: . Дата публикации: 2017-09-28.

COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS

Номер патента: US20170281567A1. Автор: Maes Tamara,DeMario Mark D.,LUNARDI Serena,PIERCEALL William E.,MACK Fiona. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2017-10-05.

WNT INHIBITORS FOR USE IN THE TREATMENT OF FIBROSIS

Номер патента: US20200306244A1. Автор: Liu Jun,GERGELY Peter,Harris Jennifer Leslie,SVENSSON Eric. Владелец: NOVARTIS AG. Дата публикации: 2020-10-01.

GLyT1 inhibitors for use in the treatment of blood disorders

Номер патента: ES2683184T3. Автор: Emmanuel Pinard,Michael Winter,Daniela Alberati,Annette KOERNER. Владелец: F Hoffmann La Roche AG. Дата публикации: 2018-09-25.

SYNERGISTIC ASSOCIATION OF AN ALPHA-2-DELTA LIGAND AND A PDEV INHIBITOR FOR USE IN THE TREATMENT OF PAIN

Номер патента: MA27381A1. Автор: Mark John Field,Richard Griffith Williams. Владелец: Pfizer. Дата публикации: 2005-06-01.

Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain

Номер патента: PL375553A1. Автор: Mark John Field,Richard Griffith Williams. Владелец: PFIZER INC.. Дата публикации: 2005-11-28.

Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders

Номер патента: CA2814436C. Автор: Joelle Le,Robert David Willacy,Nigel James Parr,Suzanne Elaine Keeling,Julie Nicole Hamblin,Paul Spencer Jones. Владелец: Glaxo Group Ltd. Дата публикации: 2019-03-19.

Glyt1 inhibitors for use in the treatment of hematological disorders

Номер патента: PT3137073T. Автор: Pinard Emmanuel,Winter Michael,Alberati Daniela,Koerner Annette. Владелец: Hoffmann La Roche. Дата публикации: 2018-07-27.

6- (1H-Indol-4-yl) -4- (5-{[4- (1-methylethyl) -1-piperazinyl)] methyl as a P13K inhibitor for use in the treatment of respiratory diseases and the like } -1,3-oxazol-2-yl) -1H-indazole polymorphs and salts

Номер патента: JP2013540790A. Автор: レー，ジョエル,ニコル ハンブリン，ジュリー,スペンサー ジョーンズ，ポール,エレイン キーリング，スザンヌ,ジェームズ パー，ナイジェル,デーヴィッド ウィラシー，ロバート. Владелец: Glaxo Group Ltd. Дата публикации: 2013-11-07.

Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders

Номер патента: CA2814436A1. Автор: Joelle Le,Robert David Willacy,Nigel James Parr,Suzanne Elaine Keeling,Julie Nicole Hamblin,Paul Spencer Jones. Владелец: Glaxo Group Ltd. Дата публикации: 2012-05-03.

Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain

Номер патента: KR20070009746A. Автор: 마크 존 필드,리차드 그리피쓰 윌리암스. Владелец: 화이자 인코포레이티드. Дата публикации: 2007-01-18.

Glyt1 inhibitors for use in the treatment of hematological disorders

Номер патента: PH12016501784B1. Автор: Emmanuel Pinard,Michael Winter,Daniela Alberati,Annette KOERNER. Владелец: Hoffmann La Roche. Дата публикации: 2016-11-07.

Synergistic combination of an alpha-2-delta ligand and a PDEV inhibitor for use in the treatment of pain

Номер патента: AU2003249476B2. Автор: Mark John Field,Richard Griffith Williams. Владелец: PFIZER INC. Дата публикации: 2008-06-26.

Treatment of hidradenitis suppurativa using JAK inhibitors

Номер патента: AU2019245420B2. Автор: Paul Smith,Michael D. Howell. Владелец: Incyte Corp. Дата публикации: 2024-10-10.

Treatment of hidradenitis suppurativa using jak inhibitors

Номер патента: AU2024219822A1. Автор: Paul Smith,Michael D. Howell. Владелец: Incyte Corp. Дата публикации: 2024-10-10.

Treatment and prevention of anaemia of inflammation

Номер патента: CA3201648A1. Автор: Robin VAN BRUGGEN,Thomas Robert Leon KLEI. Владелец: Sanquin Ip BV. Дата публикации: 2022-06-16.

Palm for the treatment of chemotherapy-induced peripheral neuropathy incidental to the treatment of cancer

Номер патента: US20240189230A1. Автор: Reynold Homan. Владелец: Peptinovo Biopharma Inc. Дата публикации: 2024-06-13.

Treatment and prevention of anaemia of inflammation

Номер патента: AU2021398521A9. Автор: Robin VAN BRUGGEN,Thomas Robert Leon KLEI. Владелец: Sanquin Ip BV. Дата публикации: 2024-09-26.

Kinurenin 3-hydroxilase inhibitors for treating diabetes

Номер патента: RU2351329C2. Автор: Валери ОТЬЕ,Мишлин КЕРГОА,Катрин КАРГАР,Анник АРБЕЛЛО-ДЕ-ВАККЕ,Доминик МАРАИ,Жерар МУЭНЕ. Владелец: Мерк Патент Гмбх. Дата публикации: 2009-04-10.

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

Номер патента: WO2017060388A1. Автор: Arne Dessen,Philip Rye. Владелец: ALGIPHARMA AS. Дата публикации: 2017-04-13.

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

Номер патента: CA3001047A1. Автор: Arne Dessen,Philip Rye. Владелец: ALGIPHARMA AS. Дата публикации: 2017-04-13.

Inhibitors of deoxyhypusine synthase for the treatment and prevention of respiratory virus infections

Номер патента: WO2023230431A1. Автор: Winston C. Tse,Istvan Bartha,Johannes Grosse,Amalio Telenti,Leah B. SORIAGA,Arthur CHASE,Neil Robert Stokes. Владелец: Glaxo Wellcome Uk Limited. Дата публикации: 2023-11-30.

Agents for use in the treatment of cardiovascular and inflammatory diseases structurally based on 4(1 h)-quinolone

Номер патента: EP3145914A1. Автор: David Selwood,Adrian HOBBS. Владелец: UCL BUSINESS LTD. Дата публикации: 2017-03-29.

Combination therapy using liposomal irinotecan and parp inhibitor for the treatment of cancer

Номер патента: RU2760185C2. Автор: Джонатан Бэзил Фицджеральд,Виктор Мойо,Дэрил С. ДРАММОНД,Сара Ф. БЛАНШЕТТ. Владелец: Ипсен Биофарм Лтд.. Дата публикации: 2021-11-22.

Pde5 inhibitor for use in the treatment of anterior ischemic optic neuropathy

Номер патента: EP4233867A1. Автор: Elena Bastia,Francesco Impagnatiello,Gael Ronsin. Владелец: Nicox Sa. Дата публикации: 2023-08-30.

Pde5 inhibitor for use in the treatment of anterior ischemic optic neuropathy

Номер патента: WO2023161314A1. Автор: Elena Bastia,Francesco Impagnatiello,Gael Ronsin. Владелец: Nicox Sa. Дата публикации: 2023-08-31.

Gata-3 inhibitors for use in the treatment of th2-driven asthma

Номер патента: NZ736807A. Автор: Joachim BILLE,Jonas Renz. Владелец: Sterna Biologicals GmbH. Дата публикации: 2024-08-30.

Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient

Номер патента: US09901579B2. Автор: Heikki Joensuu,Olli Kallioniemi,Harri SIHTO,Olli-Pekka PULKKA. Владелец: Sartar Therapeutics Ltd. Дата публикации: 2018-02-27.

Triazolopyrazines as brd4 inhibitors for use in the treatment of cancer

Номер патента: CA2891193C. Автор: Harald Engelhardt,Christian Smethurst,Davide GIANNI. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2021-03-23.

Gata-3 inhibitors for use in the treatment of th2-driven asthma

Номер патента: CA2985858C. Автор: Joachim BILLE,Jonas Renz. Владелец: Sterna Biologicals GmbH. Дата публикации: 2023-10-10.

Extract of vegetation waters for use in the treatment and/or in the prevention of prostate cancer

Номер патента: CA3099447A1. Автор: Adriana Albini,Gianni LO FRANCO,Antonino BRUNO,Antonio LO FRANCO,Bandino LO FRANCO,Denisa BACI,Douglas Noonan,Matilde Elena Tramacere. Владелец: Individual. Дата публикации: 2019-11-14.

Extract of vegetation waters for use in the treatment and/or in the prevention of prostate cancer

Номер патента: EP3790570A1. Автор: Adriana Albini,Gianni LO FRANCO,Antonino BRUNO,Antonio LO FRANCO,Bandino LO FRANCO,Denisa BACI,Douglas Noonan,Matilde Elena Tramacere. Владелец: Fattoria La Vialla di Gianni Antonio e Bandino Lo Franco Societa Agricola Semplice. Дата публикации: 2021-03-17.

Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient

Номер патента: CA2927708C. Автор: Heikki Joensuu,Olli Kallioniemi,Harri SIHTO,Olli-Pekka PULKKA. Владелец: Sartar Therapeutics Ltd. Дата публикации: 2021-05-25.

FGFR inhibitor for use in the treatment of hypophosphatemic disorders

Номер патента: AU2013241664A1. Автор: Vito Guagnano,Michaela Kneissel,Diana Graus Porta,Simon Wohrle. Владелец: NOVARTIS AG. Дата публикации: 2014-10-02.

Fgfr inhibitor for use in the treatment of hypophosphatemic disorders

Номер патента: CA2866229C. Автор: Vito Guagnano,Michaela Kneissel,Diana Graus Porta,Simon Wohrle. Владелец: NOVARTIS AG. Дата публикации: 2020-09-15.

Bcl-2 inhibitors for use in the treatment of a bcl-2 mediated cancer carrying the gly101val mutation

Номер патента: CA3139009C. Автор: Frederic Colland,James Murray,Audrey CLAPERON. Владелец: Laboratoires Servier SAS. Дата публикации: 2024-06-11.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders

Номер патента: WO2015140658A1. Автор: Kentaro Futatsugi,Suvi Tuula Marjukka Orr,Kim Huard,David Hepworth,Daniel Wei-Shung Kung,Shawn Cabral,Kun SONG. Владелец: PFIZER INC.. Дата публикации: 2015-09-24.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders

Номер патента: AU2015233094A1. Автор: Kentaro Futatsugi,Suvi Tuula Marjukka Orr,Kim Huard,David Hepworth,Daniel Wei-Shung Kung,Shawn Cabral,Kun SONG. Владелец: PFIZER INC. Дата публикации: 2016-09-01.

Means and methods for cancer treatment and/or prevention depending on natural ahr ligand

Номер патента: RU2640913C2. Автор: Вольфганг ВИК,Михаель ПЛАТТЕН,Кристиан ОПИТЦ,Ульрике ЛИТЦЕНБУРГЕР. Владелец: Дойчес Кребсфоршунгсцентрум. Дата публикации: 2018-01-12.

Epac1 inhibitors for the treatment of idiopathic pulmonary fibrosis

Номер патента: WO2021116389A1. Автор: Frank Lezoualc'h,Malik BISSERIER,Lahouaria HADRI. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2021-06-17.

Epac1 inhibitors for the treatment of idiopathic pulmonary fibrosis

Номер патента: US20230030517A1. Автор: Frank Lezoualc'h,Malik BISSERIER,Lahouaria HADRI. Владелец: Universite Toulouse III Paul Sabatier. Дата публикации: 2023-02-02.

use of a compound in the treatment or amelioration of migraine, in the treatment, suppression and/or prevention of cortical depression and in the treatment or amelioration of a traumatic brain injury

Номер патента: BR112016030375A2. Автор: Patric STANTON,Joseph R Moskal. Владелец: Naurex Inc. Дата публикации: 2017-08-15.

Prmt5 inhibitor for use in cancer therapy

Номер патента: WO2024170488A1. Автор: James Thomas Lynch. Владелец: AstraZeneca AB. Дата публикации: 2024-08-22.

Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the nrf2-beta-trcp interaction for use in the treatment of nrf2-related diseases

Номер патента: EP4029500A1. Автор: Rafael Leon Martinez,Manuela Garcia Lopez,María Isabel RODRIGUEZ FRANCO,Antonio CUADRADO PASTOR,Raquel FERNÁNDEZ GINÉS,José Antonio ENCINAR,Juan Felipe FRANCO GONZÁLEZ,Ana Isabel ROJO SANCHÍS. Владелец: Universidad Miguel Hernandez de Elche UMH. Дата публикации: 2022-07-20.

IL-8 INHIBITORS FOR USE IN THE TREATMENT AND/OR PREVENTION OF BACTERIAL SECONDARY INFECTIONS

Номер патента: US20200101046A1. Автор: Allegretti Marcello,BRANDOLINI Laura,TEIXEIRA Mauro Martins. Владелец: . Дата публикации: 2020-04-02.

Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections

Номер патента: IL270976A. Автор: . Владелец: Dompe Farm Spa. Дата публикации: 2020-01-30.

Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: EP4397305A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-07-10.

Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: WO2024146918A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe' Farmaceutici Spa. Дата публикации: 2024-07-11.

Combination of gold complexes with olaparib or other parp1/2 inhibitors for use in the treatment of cancer resistant to said parp1/2 inhibitors

Номер патента: CA3118820A1. Автор: James Harrison,Melinda DUER,Uliana BASHTANOVA. Владелец: Varsity Pharmaceuticals Ltd. Дата публикации: 2021-04-01.

Combination of gold complexes with olaparib or other parp1/2 inhibitors for use in the treatment of cancer resistant to said parp1/2 inhibitors

Номер патента: EP3852741A1. Автор: James Harrison,Melinda DUER,Uliana BASHTANOVA. Владелец: Varsity Pharmaceuticals Ltd. Дата публикации: 2021-07-28.

Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence

Номер патента: CA2102072C. Автор: Jurgen Engel,Bernd Nickel,Peter Emig,Michael Lobisch,Stefan Szelenyi,Gabriela Pergande. Владелец: AWD Pharma GmbH and Co KG. Дата публикации: 2005-01-04.

Combinations of ctps1 inhibitor with iap inhibitor for use in the treatment of cancer

Номер патента: WO2024133721A1. Автор: Andrew Parker,Philip BEER. Владелец: Step Pharma S.A.S.. Дата публикации: 2024-06-27.

Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer

Номер патента: AU2022210800A1. Автор: Michael Burke,Alfredo C. Castro,Benjamin Amidon,Hyejin FROSCH. Владелец: Ikena Oncology Inc. Дата публикации: 2023-08-10.

Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer

Номер патента: US20240261288A1. Автор: Michael Burke,Alfredo C. Castro,Benjamin Amidon,Hyejin FROSCH. Владелец: Lkena Oncology Inc. Дата публикации: 2024-08-08.

Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer

Номер патента: AU2022210800A9. Автор: Michael Burke,Alfredo C. Castro,Benjamin Amidon,Hyejin FROSCH. Владелец: Ikena Oncology Inc. Дата публикации: 2024-10-17.

Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence

Номер патента: CA2102072A1. Автор: Jurgen Engel,Bernd Nickel,Peter Emig,Michael Lobisch,Stefan Szelenyi,Gabriela Pergande. Владелец: Individual. Дата публикации: 1994-05-01.

Methods and composition of IGF1R inhibitors for treating or preventing cancer

Номер патента: NZ561648A. Автор: Ming Liu,Yan Wang,Yaolin Wang,Jonathan A Pachter,Walter R Bishop. Владелец: Schering Corp. Дата публикации: 2009-11-27.

AGENT FOR THE TREATMENT OF ARTERYOS SCLEROSIS AND PREVENTION OF Platelet coagulation

Номер патента: DK453387A. Автор: Jiro Horiuchi,Tetsuzo Kato,Yoshiyasu Shitori,Nobuya Katagiri,Ryuji Niwa. Владелец: KANTO ISHI PHARMA CO Ltd. Дата публикации: 1988-02-29.

Mta-cooperative prmt5 inhibitors for use in the treatment of cancer

Номер патента: WO2024038004A1. Автор: Ho Man Chan,James Thomas Lynch. Владелец: AstraZeneca AB. Дата публикации: 2024-02-22.

V-atpase inhibitors for use in the treatment of septic shock

Номер патента: WO2007048848A2. Автор: Carlo Farina,Paola Misiano,Gabriela Constantin,Carlo Laudanna. Владелец: Brane Discovery S.R.L.. Дата публикации: 2007-05-03.

V-atpase inhibitors for use in the treatment of septic shock

Номер патента: EP1945204A2. Автор: Carlo Farina,Paola Misiano,Gabriela Constantin,Carlo Laudanna. Владелец: Brane Discovery Srl. Дата публикации: 2008-07-23.

Syk inhibitors for use in the treatment of cancer

Номер патента: WO2024037910A1. Автор: Pierre Martineau,Piona Dariavach. Владелец: Institut Regional du Cancer de Montpellier. Дата публикации: 2024-02-22.

Combination of gold complexes with olaparib or other parp1/2 inhibitors for use in the treatment of cancer resistant to said parp1/2 inhibitors

Номер патента: WO2021058967A1. Автор: James Harrison,Melinda DUER,Uliana BASHTANOVA. Владелец: Varsity Pharmaceuticals Limited. Дата публикации: 2021-04-01.

IL-8 INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

Номер патента: US20190015391A1. Автор: Allegretti Marcello,Ruffini Pier Adelchi,BRANDOLINI Laura. Владелец: . Дата публикации: 2019-01-17.

CALCINEURIN INHIBITORS FOR USE IN THE TREATMENT OF LESIONAL VESTIBULAR DISORDERS

Номер патента: US20150057233A1. Автор: DYHRFJELD-JOHNSEN Jonas. Владелец: . Дата публикации: 2015-02-26.

TRIPLE COMBINATION OF AN ERK1/2 INHIBITOR WITH A BRAF INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF BRAFv6ooE COLORECTAL CANCER

Номер патента: US20220168250A1. Автор: Joseph Sajan,BHAGWAT Shripad Venkatraman,TIU Ramon Velasquez. Владелец: . Дата публикации: 2022-06-02.

COMBINATIONS OF OPIOID/TLR4 ANTAGONIST AND A CYCLOOXYGENASE (COX) INHIBITOR FOR USE IN THE TREATMENT OF PAIN

Номер патента: US20160158222A1. Автор: Toledano Annette Channa. Владелец: . Дата публикации: 2016-06-09.

Combinations of Opioid/TLR4 Antagonist and a Cyclooxygenase (COX) Inhibitor for Use in the Treatment of Pain

Номер патента: US20140275142A1. Автор: Toledano Annette Channa. Владелец: . Дата публикации: 2014-09-18.

IL-8 INHIBITORS FOR USE IN THE TREATMENT OF SOME SARCOMAS

Номер патента: US20210361627A1. Автор: BRANDOLINI Laura,Roberts Ryan David. Владелец: . Дата публикации: 2021-11-25.

COMPOSITION COMPRISING A TNFR AGONIST AND AT LEAST ONE THIOREDOXIN INHIBITOR FOR USE IN THE TREATMENT OF CARCINOMA

Номер патента: US20150366844A1. Автор: Georgopoulos Nikolaos. Владелец: UNIVERSITY OF HUDDERSFIELD. Дата публикации: 2015-12-24.

CHK1/2 Inhibitors for Use in the Treatment of Neuroblastomas and/or Soft Tissue Sarcomas

Номер патента: US20180369202A1. Автор: STANCATO Louis Frank. Владелец: . Дата публикации: 2018-12-27.

Thieno [3,2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer

Номер патента: KR101639642B1. Автор: 마이클 알. 마이클라이즈,마이클 엘. 커틴,로빈 알. 프레이. Владелец: 애브비 바하마스 리미티드. Дата публикации: 2016-07-14.

Multikinase Inhibitors For Use In The Treatment Of Cancer

Номер патента: CN105748465A. Автор: 布鲁斯·德科斯塔,江逸民,张慧明,杜红,谢尔盖·阿古尔尼克,李祥逸,野本见,野本见一,约翰(元)·王. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2016-07-13.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: US8609640B2. Автор: Yimin Jiang,Xiang-Yi Li,Huiming Zhang,Kenichi Nomoto,Hong Du,Sergei Agoulnik,Bruce DeCosta,John (Yuan) Wang,Jiayi Wu. Владелец: Eisai Inc. Дата публикации: 2013-12-17.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: US8937056B2. Автор: Yimin Jiang,Xiang-Yi Li,Huiming Zhang,Kenichi Nomoto,Hong Du,Sergei Agoulnik,Bruce DeCosta,John (Yuan) Wang. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2015-01-20.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: US11160783B2. Автор: Yimin Jiang,Xiang-Yi Li,Huiming Zhang,Kenichi Nomoto,Hong Du,Sergei Agoulnik,Bruce DeCosta,John (Yuan) Wang. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2021-11-02.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: CN101778627A. Автор: 布鲁斯·德科斯塔,江逸民,张慧明,杜红,谢尔盖·阿古尔尼克,李祥逸,野本见一,约翰(元)·王. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2010-07-14.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: KR101721161B1. Автор: 이민 지앙,세르게이 아고울닉,부르스 데코스타,홍 두,시앙-이 리,겐이치 노모토,존 왕 (위안),후이밍 장. Владелец: 에자이 알앤드디 매니지먼트 가부시키가이샤. Дата публикации: 2017-03-29.

IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy

Номер патента: ES2893701T3. Автор: Laura Brandolini,Marcello Allegretti,Pier Adelchi Ruffini. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2022-02-09.

Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer

Номер патента: WO2010065825A3. Автор: Michael R. Michaelides. Владелец: ABBOTT LABORATORIES. Дата публикации: 2010-08-26.

Calcineurin inhibitors for use in the treatment of lesional vestibular disorders

Номер патента: US10188695B2. Автор: Jonas Dyhrfjeld-Johnsen. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2019-01-29.

Normal;heading 1;heading 2;heading 3;THIENO[3,2-c]PYRIDINE DERIVATIVES AS KINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Номер патента: UA103351C2. Автор: Майкл Р. Мікаелідес,Майкл Л. Кертін,Робін Р. Фрей. Владелец: Ебботт Леборетріз. Дата публикации: 2013-10-10.

Dihydropyridinone mgat2 inhibitors for use in the treatment of metabolic disorders

Номер патента: KR20160120790A. Автор: 웨이 멍,궈화 자오. Владелец: 브리스톨-마이어스 스큅 컴퍼니. Дата публикации: 2016-10-18.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: CA2698271A1. Автор: Yimin Jiang,Xiang-Yi Li,Huiming Zhang,Kenichi Nomoto,Hong Du,Sergei Agoulnik,Bruce DeCosta,John Wang (Yuan). Владелец: John Wang (Yuan). Дата публикации: 2009-01-29.

Multikinase inhibitors for use in the treatment of cancer

Номер патента: IL202307A0. Автор: . Владелец: Eisai R&D Man Co Ltd. Дата публикации: 2010-06-30.

Dna polymerase theta inhibitor for treatment of cancer

Номер патента: US20240327431A1. Автор: Jonathan Mark Bentley,Ian Andrew YULE,Stuart Robert FLANAGAN,Andrea Guerrero Corella,Jonathan Hollick,Julien Gilbert Jacques Malassis,Matthew Raymond Smith. Владелец: Breakpoint Therapeutics GmbH. Дата публикации: 2024-10-03.

Compounds useful in the treatment or prevention of a prmt5-mediated disorder

Номер патента: US20240287036A1. Автор: Andrew Morley,Nicholas La Thangue,Shonagh MUNRO. Владелец: Argonaut Therapeutics Ltd. Дата публикации: 2024-08-29.

Treatment or prevention of sars-cov-2 infection using (s)-crizotinib

Номер патента: WO2023015197A1. Автор: Bellur Prabhakar,Sandra Smieszek,Vuk Koprivica,Bartlomiej PRZYCHODZEN,Prabhakaran KUMAR. Владелец: Vanda Pharmaceuticals Inc.. Дата публикации: 2023-02-09.

Compounds and methods for the treatment of dermal and ocular disorders

Номер патента: WO2024134272A2. Автор: Yair Alster,Charles Bosworth,Omer Rafaeli,Ian Holmes,Marc GLEESON,Luba LITINETSKY. Владелец: Azura Ophthalmics Ltd.. Дата публикации: 2024-06-27.

Compounds and methods for the treatment of dermal and ocular disorders

Номер патента: WO2024134272A3. Автор: Yair Alster,Charles Bosworth,Omer Rafaeli,Ian Holmes,Marc GLEESON,Luba LITINETSKY. Владелец: Azura Ophthalmics Ltd.. Дата публикации: 2024-08-08.

Treatment or prevention of sars-cov-2 infection using (s)-crizotinib

Номер патента: US20240342153A1. Автор: Bellur Prabhakar,Sandra Smieszek,Vuk Koprivica,Bartlomiej PRZYCHODZEN,Prabhakaran KUMAR. Владелец: University of Illinois at Urbana Champaign. Дата публикации: 2024-10-17.

Compositions and methods for the treatment and/or prevention of type 1 diabetes

Номер патента: WO2024150110A1. Автор: Christopher Banfield,Jeremy GALE,Michael Steven Vincent. Владелец: PFIZER INC.. Дата публикации: 2024-07-18.

Compounds for use in the treatment of fascioliasis

Номер патента: US12060355B2. Автор: Andrew Simon Bell,John Mark Francis Gardner. Владелец: Merck Patent GmBH. Дата публикации: 2024-08-13.

Emulsion for use in the treatment of rosacea

Номер патента: US20240299378A1. Автор: Frédéric Lallemand,Mathieu SCHMITT. Владелец: Exinov. Дата публикации: 2024-09-12.

1,3-substituted 2-aminoindole derivatives and analogues useful in the treatment or prevention of diabetes mellitus, obesity and inflammatory bowel disease

Номер патента: EP3160955A1. Автор: William Farnaby,David Harrison,Richard Davenport,Susanne WRIGHT,Jonathan DUNN,Duncan Hannah. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2017-05-03.

Formulations for use in the treatment or in the prevention of urological diseases

Номер патента: EP3448372A1. Автор: Simone Castelli,Giuseppe SAMARITANI,Vincenzo COSENTINO. Владелец: Inpha Duemila Srl. Дата публикации: 2019-03-06.

Formulations for use in the treatment or in the prevention of urological diseases

Номер патента: WO2017187302A1. Автор: Simone Castelli,Giuseppe SAMARITANI,Vincenzo COSENTINO. Владелец: Inpha Duemila S.R.L.. Дата публикации: 2017-11-02.

Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia

Номер патента: US20210363121A1. Автор: Mattia MORI,Bruno Botta,Francesca GHIRGA,Cinzia INGALLINA,Deborah QUAGLIO,Isabella Screpanti,Luca Tottone,Nadezda Zhdanoskaya,Francesca Giulimondi,Rocco Palermo. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2021-11-25.

Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia

Номер патента: EP3562803A1. Автор: Mattia MORI,Bruno Botta,Francesca GHIRGA,Cinzia INGALLINA,Deborah QUAGLIO,Isabella Screpanti,Luca Tottone,Nadezda Zhdanoskaya,Francesca Giulimondi,Rocco Palermo. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2019-11-06.

Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia

Номер патента: WO2018122689A1. Автор: Mattia MORI,Bruno Botta,Francesca GHIRGA,Cinzia INGALLINA,Deborah QUAGLIO,Isabella Screpanti,Luca Tottone,Nadezda Zhdanoskaya,Francesca Giulimondi,Rocco Palermo. Владелец: Università Degli Studi Di Roma "La Sapienza". Дата публикации: 2018-07-05.

An sglt-2 inhibitor for use in the treatment of a metabolic disorder in feline animals

Номер патента: EP4285995A3. Автор: Saskia Kley,Silke HAAG-DIERGARTEN,Leah Jeanette Hennings,Anna Michelle Traas,Daniela Birte REICHE. Владелец: BOEHRINGER INGELHEIM VETMEDICA GMBH. Дата публикации: 2024-02-28.

An sglt-2 inhibitor for use in the treatment of a metabolic disorder in feline animals

Номер патента: EP4285995A2. Автор: Saskia Kley,Silke HAAG-DIERGARTEN,Leah Jeanette Hennings,Anna Michelle Traas,Daniela Birte REICHE. Владелец: BOEHRINGER INGELHEIM VETMEDICA GMBH. Дата публикации: 2023-12-06.

Fibronectin or ilk inhibitors for use in the treatment of leukemia

Номер патента: US20190374618A1. Автор: Rahul Kumar,Daniela KRAUSE,Melanie MEISTER. Владелец: Chemotherapeutisches Forschungsinstitut Georg Speyer Haus. Дата публикации: 2019-12-12.

Fibronectin or ilk inhibitors for use in the treatment of leukemia

Номер патента: EP3509626A1. Автор: Rahul Kumar,Daniela KRAUSE,Melanie MEISTER. Владелец: Chemotherapeutisches Forschungsinstitut Georg Speyer Haus. Дата публикации: 2019-07-17.

Cd93 inhibitors for use in the treatment of cancer

Номер патента: WO2021089845A1. Автор: Carsten Riether,Adrian Ochsenbein. Владелец: UNIVERSITÄT BERN. Дата публикации: 2021-05-14.

Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Номер патента: GB2600384A. Автор: Saint-Mezard Pierre,Picard Damien. Владелец: Vaderis Therapeutics AG. Дата публикации: 2022-05-04.

P38 map kinase inhibitors for use in the treatment of colorectal cancer

Номер патента: WO2023186881A1. Автор: Stefan Laufer,Lars Zender,Daniel Dauch,Michael Forster,Vanessa HALLER,Jule HARBIG,Mark KUDOLO,Philipp NAHIDINO,Tatu Pantsar. Владелец: BADEN-WURTTEMBERG STIFTUNG GGMBH. Дата публикации: 2023-10-05.

Allosteric akt inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Номер патента: US20240092801A1. Автор: Pierre Saint-Mezard,Damien PICARD. Владелец: Vaderis Therapeutics AG. Дата публикации: 2024-03-21.

Allosteric akt inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Номер патента: EP4221713A1. Автор: Pierre Saint-Mezard,Damien PICARD. Владелец: Vaderis Therapeutics AG. Дата публикации: 2023-08-09.

Allosteric akt inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Номер патента: AU2021352108A9. Автор: Pierre Saint-Mezard,Damien PICARD. Владелец: Vaderis Therapeutics AG. Дата публикации: 2024-05-23.

Sglt-2 inhibitor for use in the treatment of a metabolic myopathy

Номер патента: EP3362055A1. Автор: Eric Williams MAYOUX. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2018-08-22.

Inhibitors of the sting pathway for the treatment of hidradenitis suppurativa

Номер патента: WO2021013911A1. Автор: Yves Levy,Sophie HUE,Jean-Louis FRANCETTE,Cindy ORVAIN. Владелец: Assistance Publique-Hôpitaux De Paris (Aphp). Дата публикации: 2021-01-28.

Triple kinase inhibition for the treatment of type i interferon response associated disorders

Номер патента: WO2024170776A1. Автор: Manolis PASPARAKIS,Remzi Onur EREN,Simone WOLF. Владелец: Universität zu Köln. Дата публикации: 2024-08-22.

A pharmaceutical composition for the treatment or prevention of allergic diseases, use thereof, and a method for treatment or prevention of allergic diseases

Номер патента: WO2007108633A1. Автор: Sook-Yeong Jeon,Dong-Ho Nahm. Владелец: Dong-Ho Nahm. Дата публикации: 2007-09-27.

Pharmaceutical composition for treating or preventing alcoholic liver diseases, containing cilostazol as active ingredient

Номер патента: US20130267558A1. Автор: Jong-Yeon Kim,Jong-Ryul Eun,Youn-Ju Lee. Владелец: Industry Academic Cooperation Foundation Of Yeungnam University. Дата публикации: 2013-10-10.

Methods of treatment or prevention of acute brain or nerve injuries

Номер патента: US12042482B2. Автор: Maria Maccecchini. Владелец: Annovis Bio Inc. Дата публикации: 2024-07-23.

Gap junction modulators and their use for the treatment of age-related macular degeneration

Номер патента: CA3240515A1. Автор: Ulrik Mouritzen,Bradford YOUNG. Владелец: Breye Therapeutics ApS. Дата публикации: 2023-06-29.

Drug for treatment or prevention of cerebral hemorrhage, and method for treatment or prevention of cerebral hemorrhage using said drug

Номер патента: AU2020387174A1. Автор: Teiji Tominaga,Kuniyasu NIIZUMA. Владелец: Ji Xing Pharmaceuticals Hong Kong Ltd. Дата публикации: 2022-06-16.

Compositions and methods for the treatment or prevention of preterm labor

Номер патента: AU2021380039A9. Автор: Jean-Pierre Gotteland. Владелец: Xoma US LLC. Дата публикации: 2024-09-19.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: US20220387368A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: UNIVERSITE DU LUXEMBOURG. Дата публикации: 2022-12-08.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: LU101477B1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: Univ Luxembourg. Дата публикации: 2021-05-14.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: CA3157474A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: Individual. Дата публикации: 2021-05-20.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: EP4058008A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: UNIVERSITE DU LUXEMBOURG. Дата публикации: 2022-09-21.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: WO2021094424A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: UNIVERSITE DU LUXEMBOURG. Дата публикации: 2021-05-20.

Modulators of airway basal cells for the treatment or prevention of lung diseases

Номер патента: US12036218B2. Автор: Antje Prasse,Jonas SCHUPP. Владелец: Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV. Дата публикации: 2024-07-16.

Aminotetrahydropyranes as dipeptidylpeptidase-iv inhibitors for treating or preventing diabetes

Номер патента: RU2550508C2. Автор: Тесфайе БИФТУ,Сяося ЦЯНЬ,Пин Чэнь,Даньцин ФЭН. Владелец: Мерк Шарп И Доум Корп.. Дата публикации: 2015-05-10.

Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors

Номер патента: EP1418902A1. Автор: Stephen Maxwell Taylor,Ian Alexander Shiels,David Paul Fairlie. Владелец: University of Queensland UQ. Дата публикации: 2004-05-19.

Treatment or prevention of leukaemia

Номер патента: US20240299349A1. Автор: Hans-René Bjørsvik,Bjorn Tore Gjertsen. Владелец: VESTLANDETS INNOVASJONSSELSKAP AS. Дата публикации: 2024-09-12.

Aralkyl bensyl ethers, methods of synthesis thereof, intermediate compounds and their use, methods for treatment and/or prevention, pharmaceutical composition and drug on basis of these compounds

Номер патента: RU2548009C2. Автор: Артур Франц КЕППЛЕР,Серджио Луис САКУРАИ,Марсио Генрик ЗАИМ,Карлос Эдуардо да Коста ТУЗАРИМ. Владелец: Биолэб Санус Фармасьютика Лтда.. Дата публикации: 2015-04-10.

Method for the treatment or prevention of lower urinary tract symptoms

Номер патента: US09993442B2. Автор: Risto Santti,Tomi Streng. Владелец: Hormos Medical Ltd. Дата публикации: 2018-06-12.

Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv

Номер патента: EP4384168A1. Автор: Richard PLEMPER,Julien SOURIMANT. Владелец: Georgia State University Research Foundation Inc. Дата публикации: 2024-06-19.

(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancer

Номер патента: US12102626B2. Автор: Tom Yao-Hsiang Wu,Qihui Jin. Владелец: Nexys Therapeutics Inc. Дата публикации: 2024-10-01.

Compositions for the prevention and treatment of acute renal injury

Номер патента: US20210330649A1. Автор: Lars Otto Uttenthal. Владелец: Aki Therapeutics Aps. Дата публикации: 2021-10-28.

Compositions for the prevention and treatment of acute renal injury

Номер патента: EP3641798A1. Автор: Lars Otto Uttenthal. Владелец: Aki Therapeutics Aps. Дата публикации: 2020-04-29.

Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors

Номер патента: US20040247639A1. Автор: Stephen Taylor,David Fairlie,Ian Shiels. Владелец: Individual. Дата публикации: 2004-12-09.

Medicament for the treatment of liver fibrosis and cirrhosis of liver

Номер патента: WO2019121764A1. Автор: Jochen Hampe,Clemens Schafmeyer,Raghavan THANGAPANDI,Mario BROSCH. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2019-06-27.

Conjugate, medication and methods of treatment and/or prevention of depression and disease associated with lewy bodies concretion

Номер патента: RU2664452C2. Автор: УРБИНА Габриэль АЛЬВАРАДО,ПЕРЕС Франсеск АРТИГАС,БИАССОНИ Аналия БОРТОЛОССИ,БОВЕР Микель ВИЛА,Андрес Пабло МОНТЕФЕЛЬТРО. Владелец: Нлифе Терапеутикс, С.Л.. Дата публикации: 2018-08-17.

Maxi-k potassium channel openers for the treatment of fragile x associated disorders

Номер патента: CA3177423A1. Автор: John Proudfoot,Roman FLECK. Владелец: Kaerus Bioscience Ltd. Дата публикации: 2021-11-25.

Maxi-K potassium channel openers for the treatment of fragile X associated disorders

Номер патента: AU2021274879A1. Автор: John Proudfoot,Roman FLECK. Владелец: Kaerus Bioscience Ltd. Дата публикации: 2022-12-08.

Aleglitazar for the treatment of diabetic kidney disease

Номер патента: EP3402482A1. Автор: Jin Tian,Regina DUTTLINGER MADDUX,Carl Anders SVENSSON,Harold V. BARRON. Владелец: F Hoffmann La Roche AG. Дата публикации: 2018-11-21.

Maxi-k potassium channel openers for the treatment of fragile x associated disorders

Номер патента: US20240351994A1. Автор: John Proudfoot,Roman FLECK. Владелец: Kaerus Bioscience Ltd. Дата публикации: 2024-10-24.

Methods and compositions for the treatment or prophylaxis of an ectoparasitic infestation

Номер патента: WO2017214683A1. Автор: Christopher Richards,Alistair Cumming,Grant Richards. Владелец: Gretals Australia Pty Ltd. Дата публикации: 2017-12-21.

Use of compound 1 in treatment or prevention of renal fibrosis and other diseases

Номер патента: WO2024149364A1. Автор: FENG Jin,WEI Hu,Zhenwei Li,Tianyuan Zhang,Xun He,Yuhan GUO,Baoru LV. Владелец: Shenzhen Newdel Biotech Co., Ltd.. Дата публикации: 2024-07-18.

Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders

Номер патента: CA2877589C. Автор: Mirko Zaja,Johann Leban. Владелец: 4SC AG. Дата публикации: 2019-11-26.

Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders

Номер патента: EP2867237A1. Автор: Mirko Zaja,Johann Leban. Владелец: 4SC Discovery GmbH. Дата публикации: 2015-05-06.

Nitroxoline for use in the treatment or prevention of a malignant peripheral nerve sheath tumour

Номер патента: WO2024121571A1. Автор: David Brown. Владелец: Healx Ltd. Дата публикации: 2024-06-13.

Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma

Номер патента: AU2022392456A1. Автор: David Brown. Владелец: Healx Ltd. Дата публикации: 2024-05-23.

Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma

Номер патента: CA3238805A1. Автор: David Brown. Владелец: Healx Ltd. Дата публикации: 2023-05-25.

Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma

Номер патента: WO2023089328A1. Автор: David Brown. Владелец: Healx Ltd. Дата публикации: 2023-05-25.

Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma

Номер патента: EP4433054A1. Автор: David Brown. Владелец: Healx Ltd. Дата публикации: 2024-09-25.

Rock inhibitors for use in treating or preventing pulmonary edema

Номер патента: EP4138846A1. Автор: Stephan Pleschka,John Ziebuhr,Susanne HEROLD,Christin PETERANDERL,Irina Kuznetsova. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-03-01.

Rock inhibitors for use in treating or preventing pulmonary edema

Номер патента: WO2021214200A1. Автор: Stephan Pleschka,John Ziebuhr,Susanne HEROLD,Christin PETERANDERL,Irina Kuznetsova. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-10-28.

Novel MEK-inhibitor for the treatment of viral and bacterial infections

Номер патента: AU2020258002A1. Автор: Oliver Planz. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-11-18.

Novel mek-inhibitor for the treatment of viral and bacterial infections

Номер патента: EP3955908A1. Автор: Oliver Planz. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2022-02-23.

Mek-inhibitor for the treatment of viral and bacterial infections

Номер патента: CA3136171A1. Автор: Oliver Planz. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2020-10-22.

Local delivery of growth and repair promoting compounds for treating, reducing and/or preventing stress urinary incontinence and fecal incontinence

Номер патента: EP4398875A1. Автор: Ebrahim Versi,Nicholas SIDDLE. Владелец: Statera Pharma Inc. Дата публикации: 2024-07-17.

Local delivery of growth and repair promoting compounds for treating, reducing and/or preventing stress urinary incontinence and fecal incontinence

Номер патента: CA3231270A1. Автор: Ebrahim Versi,Nicholas SIDDLE. Владелец: Statera Pharma Inc. Дата публикации: 2023-03-16.

Compounds for the treatment of glioblastoma

Номер патента: EP4346829A1. Автор: Michael Weller,Ilhan Celik,Claudia-Nanette GANN,Nazanin MAJD,John Frederick DE GROOT. Владелец: Merck Patent GmBH. Дата публикации: 2024-04-10.

Compounds for the treatment of glioblastoma

Номер патента: CA3222061A1. Автор: Michael Weller,Ilhan Celik,Claudia-Nanette GANN,Nazanin MAJD,John Frederick DE GROOT. Владелец: Merck Patent GmBH. Дата публикации: 2022-12-08.

Compounds for the treatment of glioblastoma

Номер патента: AU2022286643A1. Автор: Michael Weller,Ilhan Celik,Claudia-Nanette GANN,Nazanin MAJD,John Frederick DE GROOT. Владелец: Merck Patent GmBH. Дата публикации: 2024-01-18.

Heterocyclic egfr inhibitors for use in the treatment of cancer

Номер патента: US20240308981A1. Автор: Natasja Brooijmans,Joseph L. Kim,John Emmerson Campbell,Kevin J. Wilson,Emanuele Perola,Meredith Suzanne Eno,Douglas Wilson,Brett D. WILLIAMS,Christopher De Savi,Thomas A. DINEEN,Aysegul OZEN. Владелец: Blueprint Medicines Corp. Дата публикации: 2024-09-19.

Stat3 inhibitors for use in the treatment of non-viral liver cancer

Номер патента: WO2024129619A9. Автор: Imran ALIBHAI,Sofia De Achaval. Владелец: Tvardi Therapeutics, Inc.. Дата публикации: 2024-07-18.

Combined use of a trka inhibitor and an epha2 inhibitor for using in the treatment of solid cancers, and method for the prognosis of survival of a patient who has a solid cancer

Номер патента: US20170258871A1. Автор: Matthieu Guilbert,Robert Toillon,Cyril Corbet,Leo Aubert,Xuefen Le Bourhis. Владелец: Universite De Lille 1 Sciences Et Technologies. Дата публикации: 2017-09-14.

OXYGEN CARRIER SUBSTANCE BASED ON HEMOGLOBIN CONTAINING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER AND THE PREVENTION OF CANCER RECURRENCE

Номер патента: UY35082A. Автор: Bing Lou Wong,Norman Fung Man WAI,Sui Yi Kwok,Sze Hang Lau. Владелец: VISION GLOBAL HOLDINGS Ltd. Дата публикации: 2014-07-31.

EXTRACT OF VEGETATION WATERS FOR USE IN THE TREATMENT AND/OR IN THE PREVENTION OF PROSTATE CANCER

Номер патента: US20210228671A1. Автор: LO FRANCO Gianni,LO FRANCO Antonio,LO FRANCO Bandino,ALBINI Adriana,BACI Denisa,BRUNO Antonino,NOONAN Douglas,TRAMACERE Matilde Elena. Владелец: FATTORIA LA VIALLA DI GIANNI, ANTONIO E BANDINO LO FRANCO - SOCIETA' AGRICOLA SEMPLICE. Дата публикации: 2021-07-29.

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

Номер патента: US20170007606A1. Автор: GUAGNANO Vito,KNEISSEL Michaela,GRAUS PORTA Diana,Wöhrle Simon. Владелец: NOVARTIS AG. Дата публикации: 2017-01-12.

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

Номер патента: US20150072019A1. Автор: KNEISSEL Michaela,GRAUS PORTA Diana,Wöhrle Simon,Gaugnano Vito. Владелец: . Дата публикации: 2015-03-12.

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

Номер патента: US20210308132A1. Автор: GUAGNANO Vito,KNEISSEL Michaela,GRAUS PORTA Diana,Wöhrle Simon. Владелец: . Дата публикации: 2021-10-07.

Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient

Номер патента: US20160354376A1. Автор: Joensuu Heikki,Sihto Harri,Pulkka Olli-Pekka,Kallioniemi Olli. Владелец: . Дата публикации: 2016-12-08.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related diseases.

Номер патента: TR201809388T4. Автор: Hepworth David,Futatsugi Kentaro,Huard Kim,SONG Kun,CABRAL SHAWN,Wei-Shung Kung Daniel,Tuula Marjukka Orr Suvi. Владелец: Pfizer. Дата публикации: 2018-07-23.

JOINT USE OF A TRKA INHIBITOR AND AN EPHA2 INHIBITOR FOR USE IN THE TREATMENT OF CANCERS

Номер патента: FR3025717A1. Автор: Matthieu Guilbert,Robert Toillon,Bourhis Xuefen Le,Cyril Corbet,Leo Aubert. Владелец: Universite De Lille 1 Sciences Et Technologies. Дата публикации: 2016-03-18.

Gata-3 inhibitors for use in the treatment of th2-driven asthma

Номер патента: EP3093022B1. Автор: Joachim BILLE,Jonas Renz. Владелец: Sterna Biologicals GmbH and Co KG. Дата публикации: 2019-08-07.

GATA-3 inhibitors for use in the treatment of Th2-driven asthma

Номер патента: AU2016264772A1. Автор: Joachim BILLE,Jonas Renz. Владелец: Sterna Biologicals GmbH and Co KG. Дата публикации: 2017-11-16.

GATA-3 inhibitors for use in the treatment of TH2-induced asthma

Номер патента: KR20180004816A. Автор: 요아힘 빌레,요나스 렌츠. Владелец: 스터나 바이올로지칼스 게엠바하 운트 콤파니 카게. Дата публикации: 2018-01-12.

Fgfr inhibitor for use in the treatment of hypophosphatemic disorders

Номер патента: CA2866229A1. Автор: Vito Guagnano,Michaela Kneissel,Diana Graus Porta,Simon Wohrle. Владелец: NOVARTIS AG. Дата публикации: 2013-10-03.

Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient

Номер патента: WO2015055898A2. Автор: Heikki Joensuu,Olli Kallioniemi,Harri SIHTO,Olli-Pekka PULKKA. Владелец: Olli Kallioniemi. Дата публикации: 2015-04-23.

Fgfr inhibitor for use in the treatment of hypophosphatemic disorders

Номер патента: KR102126092B1. Автор: 비토 구아그나노,미카엘라 나이젤,다이아나 그라우스 포르타,사이몬 뵈를레. Владелец: 노파르티스 아게. Дата публикации: 2020-06-24.

GATA-3 INHIBITORS FOR USE IN THE TREATMENT OF TH2-INDUCED ASTHMA

Номер патента: RU2017143014A. Автор: Йоахим БИЛЛЕ,Йонас РЕНЦ. Владелец: ШТЕРНА БИОЛОГИКАЛС ГМБХ энд КО. КГ. Дата публикации: 2019-06-17.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders

Номер патента: PL3119757T3. Автор: Kentaro Futatsugi,Suvi Tuula Marjukka Orr,Kim Huard,David Hepworth,Daniel Wei-Shung Kung,Shawn Cabral,Kun SONG. Владелец: PFIZER INC.. Дата публикации: 2018-09-28.

THIOREDOXIN REDUCTASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Номер патента: MA51821A. Автор: Owe Orwar,Max Davidson. Владелец: Cinda Pharma Ab. Дата публикации: 2020-12-23.

Usp30 inhibitors for use in the treatment of parkinson's disease

Номер патента: EP2895183B1. Автор: Yingnan Zhang,Jacob Corn,Baris BINGOL. Владелец: F Hoffmann La Roche AG. Дата публикации: 2018-10-24.

Erbb3 inhibitors for use in the treatment of triple negative and basal-like breast cancers

Номер патента: IL221693A. Автор: . Владелец: Merrimack Pharmaceuticals Inc. Дата публикации: 2015-10-29.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders

Номер патента: MD20160099A2. Автор: Кентаро Футацуги,Дэвид Хепуорт,Шон КАБРАЛ,Ким ХАРД,Дэниел Вэй-Шун КУН,Суви Туула Марьюкка Орр,Кунь СУН. Владелец: PFIZER INC.. Дата публикации: 2017-02-28.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders.

Номер патента: MX2016012008A. Автор: Hepworth David,Futatsugi Kentaro,Huard Kim,SONG Kun,CABRAL SHAWN,Tuula Marjukka Orr Suvi,Wei- Shung Kung Daniel. Владелец: Pfizer. Дата публикации: 2016-12-07.

FGFR inhibitors for use in the treatment of hypophosphatemic disorders

Номер патента: JP6190871B2. Автор: クナイスル，ミカエラ,グアンナノ，ビト,ポルタ，ダイアナ グラウス,ウォール，サイモン. Владелец: ノバルティス アーゲー. Дата публикации: 2017-08-30.

FGFR inhibitor for use in the treatment of hypophosphatemic disorders

Номер патента: CN104321058A. Автор: D·格罗斯波塔,M·内塞尔,V·瓜格纳诺,S·沃勒. Владелец: NOVARTIS AG. Дата публикации: 2015-01-28.

Benzodiazepine bromodomain inhibitor for use in the treatment of cancer

Номер патента: IL219253A. Автор: . Владелец: GlaxoSmithKline LLC. Дата публикации: 2015-11-30.

Fgfr inhibitor for use in the treatment of hypophosphatemic disorders

Номер патента: EP2830626A1. Автор: Vito Guagnano,Michaela Kneissel,Diana Graus Porta,Simon Wohrle. Владелец: NOVARTIS AG. Дата публикации: 2015-02-04.

Bcl-2 inhibitors for use in the treatment of a bcl-2 mediated cancer carrying the gly101val mutation

Номер патента: EP3969000B1. Автор: Frederic Colland,James Murray,Audrey CLAPERON. Владелец: Laboratoires Servier SAS. Дата публикации: 2023-08-30.

4-chromone derivatives as n-polymerase inhibitors for use in the treatment platinum resistant metastatic neoplasm

Номер патента: WO2023203535A1. Автор: Marco De Vivo,Nicoletta Brindani,Federico MUNAFO',Michela NIGRO. Владелец: Alma Mater Studiorum-Universita' Di Bolona. Дата публикации: 2023-10-26.

Combination therapy with a raf inhibitor and a cdk4/6 inhibitor for use in the treatment of cancer

Номер патента: IL283937A. Автор: . Владелец: NOVARTIS AG. Дата публикации: 2021-07-29.

Stat3 inhibitors for use in the treatment of non-viral liver cancer

Номер патента: WO2024129619A1. Автор: Imran ALIBHAI,Sofia De Achaval. Владелец: Tvardi Therapeutics, Inc.. Дата публикации: 2024-06-20.

BAY1895344 ATR KINASE INHIBITOR FOR USE IN THE TREATMENT OF A HYPER-PROLIFERATIVE DISEASE

Номер патента: MA54928A. Автор: Michael Krause,Peter Serno,Antje Margret Wengner,Michaela Bairlein,Pardis ASSI,Dennis KRICKAU,Eleni LAGKADINOU,Siobhan WATTERS,Gary WILKINSON. Владелец: Bayer AG. Дата публикации: 2021-12-22.

A medicinal product for use in administering in the treatment, control and/or prevention of pain

Номер патента: WO2024153981A1. Автор: Vyacheslav Stanislavovich KOSORUKOV,Guzal Rafailovna Abuzarova,Olesya Yuryevna Gamzeleva. Владелец: PVP LABS PTE. LTD.. Дата публикации: 2024-07-25.

A glun2d inhibitor for use in the treatment or relapse prevention of a depressive episode

Номер патента: AU2023210727A1. Автор: Claus NORMANN,Stefan VESTRING. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2024-07-11.

A medicinal product for use in administering in the treatment, control and/or prevention of pain

Номер патента: EP4403181A1. Автор: Vyacheslav Stanislavovich KOSORUKOV,Guzal Rafailovna Abuzarova,Olesya Yuryevna Gamzeleva. Владелец: PVP Labs Pte Ltd. Дата публикации: 2024-07-24.

A glun2d inhibitor for use in the treatment or relapse prevention of a depressive episode

Номер патента: CA3241056A1. Автор: Claus NORMANN,Stefan VESTRING. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2023-08-03.

Lsd1 inhibitor and prmt6 inhibitor for use in the treatment of a disease associated with gain-of-function of androgen receptor (ar) and/or with overexpression of an ar coactivator

Номер патента: WO2024134525A1. Автор: Andrea Contestabile,Giuseppe Ronzitti,Maria PENNUTO,Manuela BASSO. Владелец: Université D'Évry-Val D'essonne. Дата публикации: 2024-06-27.

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism

Номер патента: NZ727053A. Автор: Wynne H Weston-Davies. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2023-10-27.

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism

Номер патента: NZ727053B2. Автор: Davies Wynne H Weston. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2024-01-30.

Remibrutinib for use in the treatment of hidradenitis suppurativa

Номер патента: AU2023225222A1. Автор: Bruno Bieth,Karin Rapp,Christian Loesche,Souvik Bhattacharya,Bruno CENNI,Gordon Graham,Michael Juhnke,Kim-Hien SIN,Jonas Benjamin ZIERER. Владелец: NOVARTIS AG. Дата публикации: 2024-07-25.

Stat3 inhibition for treatment and prevention of human coronavirus infection

Номер патента: US20230192786A1. Автор: Richard Gabriel,Hector J. Gomez. Владелец: Glg Pharma Llc. Дата публикации: 2023-06-22.

Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Номер патента: EP1253926A1. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Juvanita Pharma Ltd Oy. Дата публикации: 2002-11-06.

Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Номер патента: WO2001058454A1. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Oy Juvantia Pharma Ltd. Дата публикации: 2001-08-16.

Methods for treating or preventing acute respiratory distress syndrome

Номер патента: AU2021408085A1. Автор: Angel Francisco Lopez,Ian Keith Campbell,Steven BOZINOVSKI,Catherine Mary Owczarek,Karolina KRSTEVSKI,Damon John TUMES. Владелец: CSL Innovation Pty Ltd. Дата публикации: 2023-06-22.

Methods for treating or preventing acute respiratory distress syndrome

Номер патента: AU2021408085A9. Автор: Angel Francisco Lopez,Ian Keith Campbell,Steven BOZINOVSKI,Catherine Mary Owczarek,Karolina KRSTEVSKI,Damon John TUMES. Владелец: CSL Innovation Pty Ltd. Дата публикации: 2024-10-24.

Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes

Номер патента: US6576669B2. Автор: Birgit Jung,Ralf Anderskewitz,Franz Birke,Hans Michael Jennewein,Christopher J. Montague Meade. Владелец: Boehringer Ingelheim Pharma GmbH and Co KG. Дата публикации: 2003-06-10.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: WO2023052520A1. Автор: Günter Scherr,Ulrich Mrowietz. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2023-04-06.

Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes

Номер патента: US20020137792A1. Автор: Birgit Jung,Christopher Meade,Ralf Anderskewitz,Franz Birke,Hans Jennewein. Владелец: Individual. Дата публикации: 2002-09-26.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: EP4408440A1. Автор: Günter Scherr,Ulrich Mrowietz. Владелец: Christian Albrechts Universitaet Kiel. Дата публикации: 2024-08-07.

The use of carrimycin and its pharmaceutically acceptable salts for the production of medicines for treatment and / or tumor prevention

Номер патента: RU2746047C1. Автор: Енхонг ДЖИАНГ,Ксюнлей ДЖИАНГ,Мингью КСИА,Ксюндонг ДЖИАНГ. Владелец: Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд.. Дата публикации: 2021-04-06.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: WO2023051925A1. Автор: Ulrich Mrowietz,Günther SCHERR. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2023-04-06.

Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflamation

Номер патента: US20040248863A1. Автор: Samuel Wright. Владелец: Individual. Дата публикации: 2004-12-09.

Inebilizumab and methods of using the same in the treatment or prevention of igg4-related disease

Номер патента: US20240301058A1. Автор: Jorn DRAPPA,Daniel M. Cimbora,Eliezer Katz,Judith FALLOON. Владелец: Viela Bio Inc. Дата публикации: 2024-09-12.

Sulfonamides useful for the treatment or prevention of a disease i.e. vascular and coronary heart disease mediated by the alpha-2B-adrenoceptor

Номер патента: NZ520500A. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Juvantia Pharma Ltd Oy. Дата публикации: 2005-01-28.

Use of doxycycline, resveratrol, ivermectin, and related chemically modified compounds to treat or prevent viral infections

Номер патента: US20230089605A1. Автор: Howard Tenenbaum. Владелец: Ardestat Biologics LLC. Дата публикации: 2023-03-23.

Method for the treatment of overactive bladder

Номер патента: US20030139433A1. Автор: Keith Russell,Peter Bernstein,Russell Bialecki,William Rumsey,David Aharony. Владелец: AstraZeneca AB. Дата публикации: 2003-07-24.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US11759442B2. Автор: Ira C. Spector,Mark A. Feitelson,Alla Arzumanyan. Владелец: Temple University of Commonwealth System of Higher Education. Дата публикации: 2023-09-19.

Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor

Номер патента: US20020058618A1. Автор: Siegfried Wurster,Mia Engstrom,Liisa Huovinen,Sari Kalliokoski,Leila Kelanne,Eeva-Liisa Savola. Владелец: Juvanita Pharma Ltd Oy. Дата публикации: 2002-05-16.

Soce facilitators for use in treating or preventing viral infections

Номер патента: WO2019193343A1. Автор: Kin-Chow CHANG,Leah Victoria GOULDING. Владелец: THE UNIVERSITY OF NOTTINGHAM. Дата публикации: 2019-10-10.

Composition for the treatment and/or prevention of lower urinary tract symptoms

Номер патента: US12109246B2. Автор: Sossio Morra. Владелец: Serelys Pharma SAM. Дата публикации: 2024-10-08.

Nitric oxide-generating compositions, kits and combinations for use in the treatment, amelioration or prevention of infectious or inflammatory diseases or disorders

Номер патента: WO2024170893A1. Автор: Hugh Semple Munro,Nicholas David Boote,Keith Lipman. Владелец: Thirty Therapeutics Limited. Дата публикации: 2024-08-22.

Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain

Номер патента: WO2004039371A3. Автор: Raymond Y Cheung. Владелец: Raymond Y Cheung. Дата публикации: 2004-06-17.

A composition for the treatment and/or prevention of neurodegenerative diseases

Номер патента: EP3700631A1. Автор: Umberto DI MAIO. Владелец: Neilos SRL. Дата публикации: 2020-09-02.

Combination for use for the treatment of hypercholesterolemia, hyperlipidemia, cardiovascular disease and metabolic syndrome

Номер патента: CA3225798A1. Автор: Andrea Zanardi,Franco Gasparri,Elena GELFI,Manuel MOSCONI. Владелец: Individual. Дата публикации: 2023-01-26.

Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes

Номер патента: WO2002055065A3. Автор: Birgit Jung,Christopher John Montagu Meade,Ralf Anderskewitz,Franz Birke,Hans Michael Jennewein. Владелец: Hans Michael Jennewein. Дата публикации: 2003-02-06.

Nitric oxide-generating compositions, kits and combinations for use in the treatment, amelioration or prevention of respiratory diseases or disorders

Номер патента: WO2024170892A1. Автор: Hugh Semple Munro,Nicholas David Boote,Keith Lipman. Владелец: Thirty Respiratory Limited. Дата публикации: 2024-08-22.

Sglt2 inhibitors for treatment of metabolic disorders in canine animals

Номер патента: EP4234012A3. Автор: Saskia Kley,Dania Birte REICHE. Владелец: BOEHRINGER INGELHEIM VETMEDICA GMBH. Дата публикации: 2023-09-20.

Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders

Номер патента: CA2382580A1. Автор: Walter Elger,Gerd Schubert,Kristof Chwalisz. Владелец: Jenapharm Gmbh & Co. Kg. Дата публикации: 2001-03-08.

Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders

Номер патента: CA2382580C. Автор: Walter Elger,Gerd Schubert,Kristof Chwalisz. Владелец: Bayer Schering Pharma AG. Дата публикации: 2009-05-19.

3-hydroxydodecanoic acid for the treatment of cancer

Номер патента: WO2022223831A3. Автор: Michael Scharl,Yasser MORSY,Ana MONTALBAN-ARQUES,Egle KATKEVICIUTE. Владелец: UNIVERSITAT ZURICH. Дата публикации: 2023-02-09.

1, 3, 4, 5-Tetrahydro-2H-Pyrido[4,3-B]Indole Derivatives For The Treatment, Alleviation Or Prevention Of Disorders Associated With Tau Aggregates Like Alzheimer's Disease

Номер патента: AU2021203340A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2021-06-24.

1, 3, 4, 5-tetrahydro-2H-pyrido(4,3-b)indole derivatives for the treatment, alleviation or prevention of disorders associated with Tau aggregates like Alzheimer's disease

Номер патента: AU2019205087A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2020-07-02.

Mek inhibitors for the prevention and treatment of long covid syndrome

Номер патента: EP4186500A1. Автор: Oliver Planz,Yvonne FÜLL. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-05-31.

Purine nucleoside phosphorylase inhibitors for the treatment of metabolic syndrome and associated conditions

Номер патента: WO2024126630A1. Автор: Thomas Mehrling,Shanta Bantia. Владелец: Metashape Pharma Ag. Дата публикации: 2024-06-20.

Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds

Номер патента: WO2008151833A3. Автор: Petra Kioschis-Schneider,Mathias Hafner,Sandra Ritz,Andreas Holloschi,Manuel Ammerschlaeger,Erich E Wanker. Владелец: Max Delbrueck Ct Fuer Molekura. Дата публикации: 2009-07-09.

Compositions of flavonoids and flavonoid-containing extracts and the treatment of diseases

Номер патента: WO2005020881A3. Автор: Ren Jin,Bang Qiang Gong,Han Xin Chun. Владелец: Shanghai Comman Pharmaceutical. Дата публикации: 2005-07-28.

Use of ibat inhibitor for treating and preventing constipation

Номер патента: RU2482850C2. Автор: Хассе Роланд АБРАХАМССОН,Пер-Горан ГИЛЛБЕРГ. Владелец: Альбиеро АБ. Дата публикации: 2013-05-27.

Mek inhibitors for the prevention and treatment of long covid syndrome

Номер патента: WO2023094556A1. Автор: Oliver Planz,Yvonne FÜLL. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-06-01.

Bet inhibitors for treating pab1 deficient cancer

Номер патента: EP4401715A1. Автор: Raphaël MARGUERON,Ming-Kang Lee. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-07-24.

Use of mnk inhibitors for the treatment of alzheimer's disease

Номер патента: US20100247517A1. Автор: Martin Schneider,Matthias Austen,Marcus Geese. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2010-09-30.

Combination of a paclitaxel with a PI3 kinase inhibitor for use in the treatment or prevention of head and neck cancer

Номер патента: JP6643978B2. Автор: ヒラワット，サミット,マセシ，クリスチャン,ディトマソ，エマニュエル. Владелец: ノバルティス アーゲー. Дата публикации: 2020-02-12.

Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases

Номер патента: US20170182048A1. Автор: FORD John,ROUND Patrick,KASTELEIN John,KAWAGUCHI Atsuhiro,TOMIYASU Koichi,OKA Kozo. Владелец: Amgen Inc.. Дата публикации: 2017-06-29.

CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES

Номер патента: US20210228580A1. Автор: FORD John,ROUND Patrick,KASTELEIN John,KAWAGUCHI Atsuhiro,TOMIYASU Koichi,OKA Kozo. Владелец: DEZIMA PHARMA B.V.. Дата публикации: 2021-07-29.

Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases

Номер патента: US20200230138A1. Автор: FORD John,ROUND Patrick,KASTELEIN John,KAWAGUCHI Atsuhiro,TOMIYASU Koichi,OKA Kozo. Владелец: DEZIMA PHARMA B.V.. Дата публикации: 2020-07-23.

Use of ADAMTS13 for the treatment, amelioration, and/or prevention of vascular occlusive crises in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome

Номер патента: KR102537083B1. Автор: 프리드리히 샤이플링거,브루스 에벤스타인,브람 골드스타인,베르나드 마제르,파올로 로싸토,마리에타 투레첵. Владелец: 다케다 파머수티컬 컴패니 리미티드. Дата публикации: 2023-05-25.

Compounds derived from substituted pyrazolo-pyrimidines; pharmaceutical composition and combination that comprise them; and its use as inhibitors of pde9 for the treatment, relief and / or prevention of cognitive impairments related to perception, Alzheimer's, sleep disorders, bipolar disorder, diabetes mellitus.

Номер патента: CL2011000488A1. Автор: Klaus Fuchs,Martin Hendrix,Cornelia Dorner-Ciossek,Holger Rosenbrock,Niklas Heine,Schae,Riccardo Giovaninini. Владелец: Boehringer Ingelheim Int. Дата публикации: 2011-11-11.

Novel mixtures as ras inhibitors for use in the treatment of proliferative and genetic diseases

Номер патента: WO2024156704A1. Автор: Krishnaraj Rajalingam. Владелец: KHR Biotec GmbH. Дата публикации: 2024-08-02.

The method for the treatment of and/or preventing infections in infants delivered via caesarean section

Номер патента: CN103230005B. Автор: G·伯姆,B·斯塔尔,J·诺尔. Владелец: Nutricia NV. Дата публикации: 2016-03-16.

cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION

Номер патента: WO2000037061A3. Автор: Reto Naef. Владелец: Reto Naef. Дата публикации: 2000-10-26.

cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION

Номер патента: EP1140044A2. Автор: Reto Naef. Владелец: Novartis Erfindungen Verwaltungs GmbH. Дата публикации: 2001-10-10.

cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION

Номер патента: EP1140044B1. Автор: Reto Naef. Владелец: Novartis Pharma Gmbh. Дата публикации: 2006-03-15.

cGMP PDE 5 Inhibitors for inhalation in the treatment of sexual dysfunction

Номер патента: US20010055570A1. Автор: Reto Naef. Владелец: Individual. Дата публикации: 2001-12-27.

Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cance

Номер патента: CA3229150A1. Автор: Nan-Horng Lin,Heow Tan,Thomas Butler,Taisei Kinoshita,Daniel Lu,James T. Palmer,Brian Law,Hongyan He,Siyi JAING,Priyanka SOMANATH,Angelina Sau Man WONG. Владелец: Biomea Fusion Inc. Дата публикации: 2023-02-23.

Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer

Номер патента: AU2022331496A1. Автор: Nan-Horng Lin,Heow Tan,Thomas Butler,Taisei Kinoshita,Daniel Lu,James T. Palmer,Brian Law,Hongyan He,Siyi JAING,Priyanka SOMANATH,Angelina Sau Man WONG. Владелец: Biomea Fusion Inc. Дата публикации: 2024-02-29.

Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer

Номер патента: EP4387972A1. Автор: Nan-Horng Lin,Heow Tan,Thomas Butler,Taisei Kinoshita,Daniel Lu,James T. Palmer,Brian Law,Hongyan He,Siyi JAING,Priyanka SOMANATH,Angelina Sau Man WONG. Владелец: Biomea Fusion Inc. Дата публикации: 2024-06-26.

Compounds for the treatment of viral infections

Номер патента: WO2022079250A1. Автор: Markus Klein,Ulrich Betz,Dirk Finsinger,Lars Burgdorf,Sven Carsten POETZSCH. Владелец: Merck Patent GmBH. Дата публикации: 2022-04-21.

Heterocyclic egfr inhibitors for use in the treatment of cancer

Номер патента: US20240299387A1. Автор: Natasja Brooijmans,Joseph L. Kim,Jason D. Brubaker,John Emmerson Campbell,Kevin J. Wilson,Emanuele Perola,Meredith Suzanne Eno,Douglas Wilson,Brett D. WILLIAMS,Christopher De Savi,Thomas A. DINEEN,Aysegul OZEN. Владелец: Blueprint Medicines Corp. Дата публикации: 2024-09-12.

Ip4-4,6 substituted derivative compounds for use in the treatment, inhibition of progression, and prevention of ectopic calcification

Номер патента: WO2024023359A1. Автор: Carolina Salcedo Roca,Joan Perello Bestard,Miquel David Ferrer Reynes,Mohamad Firas BASSISSI,María Del Mar PÉREZ FERRER,Marc BLASCO FERRER,Alexander M. GOLD. Владелец: SANIFIT THERAPEUTICS, S.A.. Дата публикации: 2024-02-01.

Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer

Номер патента: WO2024133730A1. Автор: Andrew Parker,Philip BEER. Владелец: Step Pharma S.A.S.. Дата публикации: 2024-06-27.

Cdc-42 inhibitors for use in the treatment of age-related depression, sarcopenia or frailty

Номер патента: EP4013402B1. Автор: Yi Zheng,Hartmut Geiger,Maria Carolina FLORIAN. Владелец: Cincinnati Childrens Hospital Medical Center. Дата публикации: 2024-11-06.

Sik3 inhibitors for treating diseases resistant to death receptor signalling

Номер патента: WO2023194544A1. Автор: Stefan BISSINGER,Petra MASER. Владелец: iOmx Therapeutics AG. Дата публикации: 2023-10-12.

Sik3 inhibitors for treating diseases resistant to death receptor signalling

Номер патента: EP4257132A1. Автор: Stefan BISSINGER,Petra MASER. Владелец: iOmx Therapeutics AG. Дата публикации: 2023-10-11.

Immune-checkpoint inhibitors for use in the treatment of blood-borne cancers

Номер патента: CA2996015A1. Автор: Walter Fiedler,Jasmin Wellbrock,Hauke Stamm,Felix Klingler. Владелец: Amgen Research Munich GmbH. Дата публикации: 2017-02-09.

IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS

Номер патента: US20170037133A1. Автор: Fiedler Walter,Wellbrock Jasmin,Stamm Hauke,Klingler Felix. Владелец: . Дата публикации: 2017-02-09.

IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS

Номер патента: US20190077869A1. Автор: Fiedler Walter,Wellbrock Jasmin,Stamm Hauke,Klingler Felix. Владелец: . Дата публикации: 2019-03-14.

DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA

Номер патента: US20200113923A1. Автор: Pollock Roy M.,Daigle Scott R.. Владелец: . Дата публикации: 2020-04-16.

SELECTIVE ADRENORECEPTOR ALPHA2C RECEPTOR ANTAGONISTS ALONE, OR IN COMBINATION WITH CHYMASE INHIBITORS FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF PERIPHERAL ARTERY DISEASES (PAD)

Номер патента: US20200230136A1. Автор: Fürstner Chantal,Schmeck Carsten,Otto Christiane,TINEL Hanna,BECKER-PELSTER Eva Maria. Владелец: Bayer Aktiengesellschaft. Дата публикации: 2020-07-23.

DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA

Номер патента: US20150342979A1. Автор: Pollock Roy M.,Daigle Scott R.. Владелец: . Дата публикации: 2015-12-03.

COMBINATIONS COMPRISING PDE 2 INHIBITORS SUCH AS 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO-[4,3-A]]QUINOXALINE COMPOUNDS AND PDE 10 INHIBITORS FOR USE IN THE TREATMENT OF NEUROLOGICAL OF METABOLIC DISORDERS

Номер патента: US20150366873A1. Автор: Trabanco-Suárez Andrés Avelino,Andrés-Gil José Ignacio,Rombouts Frederik Jan Rita,De Angelis Meri,Vanhoof Greta Constantia Peter,Langlois Xavier Jean Michel,Megens Antonius Adrianus Hendrikus Petrus,Buijinsters Peter Jacobus Johannes Antonius. Владелец: . Дата публикации: 2015-12-24.

FIBRONECTIN OR ILK INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA

Номер патента: US20190374618A1. Автор: Kumar Rahul,Krause Daniela,Meister Melanie. Владелец: . Дата публикации: 2019-12-12.

Traf2 inhibitors for use in the treatment of a cancer

Номер патента: WO2020002592A1. Автор: Daniel Simon Peeper,Thomas KUILMAN,David Willem VREDEVOOGD. Владелец: Stichting het Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis. Дата публикации: 2020-01-02.

Immune-checkpoint inhibitors for use in the treatment of blood-borne cancers cancers

Номер патента: JO3620B1. Автор: Fiedler Walter,Wellbrock Jasmin,Stamm Hauke,Klingler Felix. Владелец: Amgen Res Munich Gmbh. Дата публикации: 2020-08-27.

Phthalazine derivatives of formula (i) as pcaf and gcn5 inhibitors for use in the treatment of cancer

Номер патента: WO2016036954A1. Автор: Yves LeBlanc,Martin Duplessis,Andrew Charles Good,Brian K. Albrecht,Alexandre Cote,F. Anthony Romero,Richard Pastor,Terry CRAWFORD,Alexander M. Taylor,Christopher G. Nasveschuk,Steven Magnuson. Владелец: CONSTELLATION PHARMACEUTICALS, INC.. Дата публикации: 2016-03-10.

Usp7 inhibitor for use in the treatment of cancer

Номер патента: WO2021161047A1. Автор: Xavier Jacq,Ian Thomas LOBB,Mark WAPPETT,Anamarija JURISIC,James Samuel Shane Rountree,Matthew Duncan HELM. Владелец: ALMAC DISCOVERY LIMITED. Дата публикации: 2021-08-19.

Immune-checkpoint inhibitors for use in the treatment of blood-borne cancers

Номер патента: UA125375C2. Автор: Вальтер Фідлер,Вальтер Фидлер,Ясмін Веллброк,Ясмин Велброк,Гауке Штамм,Гауке Штам,Фелікс Клінґлер,Феликс Клинглер. Владелец: Эмджен Рисерч (Мюник) Гмбг. Дата публикации: 2022-03-02.

Immune-checkpoint inhibitors for use in the treatment of blood-borne cancers

Номер патента: HK1249524A1. Автор: Walter Fiedler,Jasmin Wellbrock,Hauke Stamm,Felix Klingler. Владелец: Amgen Res Munich Gmbh. Дата публикации: 2018-11-02.

DOT1 L inhibitors for use in the treatment of leukemia

Номер патента: AU2013361076B2. Автор: Roy M. Pollock,Scott R. Daigle. Владелец: Epizyme Inc. Дата публикации: 2018-08-30.

Quinazoline-derived hck inhibitors for use in the treatment of myd88 mutated diseases

Номер патента: EP4161651A1. Автор: Li Tan,Nathanael S. Gray,Guang Yang,Sara Jean Buhrlage,Steven P. TREON,Jinhua Wang,Zachary R. HUNTER. Владелец: Dana Farber Cancer Institute Inc. Дата публикации: 2023-04-12.

Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: EP3472153B1. Автор: Joseph P. Lyssikatos,Javier De Vicente Fidalgo,Anthony A. ESTRADA,Jianwen A. FENG,Zachary K. Sweeney. Владелец: Denali Therapeutics Inc. Дата публикации: 2021-09-22.

Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: UA126231C2. Автор: Джозеф П. ЛИССИКАТОС,ВИСЕНТЕ ФИДАЛЬГО Хавьер ДЕ,Ентоні А. Естрада,Энтони А. Эстрада,Цзяньвень А. Фен,Джозеф П. Ліссікатос,Захарі К. Свіні,Захари К. Свини,Вісенте Фідальго Хавьєр де. Владелец: Деналі Терапьютікс Інк.. Дата публикации: 2022-09-07.

AKAP-PKA interaction inhibitors for use in the treatment of heart diseases

Номер патента: EP2098226A1. Автор: Christian Frank,Walter Rosenthal,Hans-Gottfried Genieser,Bastian Zimmermann,Enno Dr. Klussmann,Marta Dr. Szaszak. Владелец: Forschungsverbund Berlin FVB eV. Дата публикации: 2009-09-09.

Macrocyclic fluorine substituted indole derivatives as mcl-1 inhibitors, for use in the treatment of cancer

Номер патента: EP3710449B1. Автор: GUO Wei,Ulrich Klar,Sarah Anna Liesa Johannes,Anne Mengel,Kai Thede,Ursula MÖNNING,Amaury Ernesto FERNANDEZ-MONTALVAN,Stefan KAULFUSS,Joachim Kuhnke,Nicolas WERBECK,Kiel LAZARSKI,Philipp BUCHGRABER,Michael H. Serrano-Wu,Clara CHRIST,David McKinney,Mark Fitzgerald,Chris Lemke,Christopher Nasveschuk,Laura Furst,Ulrike SACK,Steven James Ferrara,Patrick Ryan Mccarren. Владелец: Broad Institute Inc. Дата публикации: 2022-07-06.

Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders

Номер патента: KR20160115997A. Автор: 숀 카브랄,수비 툴라 마르주카 오르,킴 하드,켄타로 후타츠기,데이비드 햅워스,다니엘 웨이-성 쿵,쿤 송. Владелец: 화이자 인코포레이티드. Дата публикации: 2016-10-06.

Histone H3 deacetylase inhibitor for use in the treatment of lung, prostate and cervical carcinomas

Номер патента: EP2114442B1. Автор: Wilfred A. Jefferies,Muriel D. David,Robyn P. Seipp,Jennifer Hartikainen,Rayshad Gopaul,Alverina F. Setiadi. Владелец: BIOMMUNE TECHNOLOGIES Inc. Дата публикации: 2016-12-07.

Immune-checkpoint inhibitors for use in the treatment of blood-borne cancers

Номер патента: IL256874A. Автор: . Владелец: Amgen Res Munich Gmbh. Дата публикации: 2018-03-29.

Pi3k inhibitor for use in the treatment of bone cancer or for preventing metastatic dissemination primary cancer cells into the bone.

Номер патента: MX2014002470A. Автор: Patrizia Nanni,Carla De Giovanni,Pier-Luigi Lollini. Владелец: NOVARTIS AG. Дата публикации: 2014-07-24.

Pi3k inhibitor for use in the treatment of bone cancer or for preventing metastatic dissemination primary cancer cells into the bone

Номер патента: CN103764130A. Автор: C·德吉奥瓦尼,P-L·洛利尼,P·南尼. Владелец: NOVARTIS AG. Дата публикации: 2014-04-30.

Trps1 inhibitor for use in the treatment of rhabdomyosarcoma

Номер патента: WO2023057653A1. Автор: Julia VON MALTZAHN,Sören HÜTTNER,Björn VON EYSS. Владелец: Leibniz-Institut Für Alternsforschung - Fritz-Lipmann-Institut E.V. (Fli). Дата публикации: 2023-04-13.

Selective adrenoreceptor .alpha.2c receptor antagonists alone, or in combination with chymase inhibitors for use in the treatment and/or prophylaxis of peripheral artery diseases (pad)

Номер патента: CA3061444A1. Автор: Carsten Schmeck,Eva María Becker-Pelster,Christiane Otto,Hanna Tinel,Chantal FÜRSTNER. Владелец: Bayer AG. Дата публикации: 2018-11-01.

Phthalazine derivatives of formula (i) as pcaf and gcn5 inhibitors for use in the treatment of cancer

Номер патента: EP3189049B1. Автор: Yves LeBlanc,Martin Duplessis,Andrew Charles Good,Brian K. Albrecht,Alexandre Cote,F. Anthony Romero,Richard Pastor,Terry CRAWFORD,Alexander M. Taylor,Christopher G. Nasveschuk,Steven Magnuson. Владелец: Constellation Pharmaceuticals Inc. Дата публикации: 2024-03-20.

Allosteric akt inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Номер патента: IL301466A. Автор: . Владелец: Vaderis Therapeutics AG. Дата публикации: 2023-05-01.

An sglt-2 inhibitor for use in the treatment of a metabolic disorder in feline animals

Номер патента: EP3862003B1. Автор: Saskia Kley,Silke HAAG-DIERGARTEN,Leah Jeanette Hennings,Anna Michelle Traas,Daniela Birte REICHE. Владелец: BOEHRINGER INGELHEIM VETMEDICA GMBH. Дата публикации: 2023-10-25.

Quinazoline-derived hck inhibitors for use in the treatment of myd88 mutated diseases

Номер патента: US20230339865A1. Автор: Li Tan,Nathanael S. Gray,Guang Yang,Sara Jean Buhrlage,Steven P. TREON,Jinhua Wang,Zachary R. HUNTER. Владелец: Dana Farber Cancer Institute Inc. Дата публикации: 2023-10-26.

Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders

Номер патента: WO2011135520A8. Автор: Vladimir Cmiljanovic,Matthias Wymann,Natasa Cmiljanovic,Bernd Giese. Владелец: UNIVERSITY OF BASEL. Дата публикации: 2012-09-27.

Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders

Номер патента: SG185067A1. Автор: Vladimir Cmiljanovic,Matthias Wymann,Natasa Cmiljanovic,Bernd Giese. Владелец: Univ Basel. Дата публикации: 2012-12-28.

Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders

Номер патента: NZ603859A. Автор: Vladimir Cmiljanovic,Matthias Wymann,Natasa Cmiljanovic,Bernd Giese. Владелец: Univ Basel. Дата публикации: 2014-07-25.

Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders

Номер патента: EP2563368A1. Автор: Vladimir Cmiljanovic,Matthias Wymann,Natasa Cmiljanovic,Bernd Giese. Владелец: UNIVERSITAET BASEL. Дата публикации: 2013-03-06.

Fibronectin or ilk inhibitors for use in the treatment of leukemia

Номер патента: EP3509626B1. Автор: Rahul Kumar,Daniela KRAUSE,Melanie MEISTER. Владелец: Chemotherapeutisches Forschungsinstitut Georg Speyer Haus. Дата публикации: 2021-10-13.

Use of buspirone for the treatment of functional dizziness

Номер патента: RU2660583C1. Автор: Максим Валерьевич Замерград. Владелец: Общество С Ограниченной Ответственностью "Валента - Интеллект". Дата публикации: 2018-07-06.

Peroral solid dosage form with mycophenolic acid or its salt for use as an immunodepressant for treatment or prevention of organ or tissue transplant rejection and method for production thereof

Номер патента: RU2670447C2. Автор: Елена Сергеевна Хазанова,Сергей Юрьевич Ногай,Евгения Александровна Филиппова. Владелец: Общество с ограниченной ответственностью "Изварино Фарма". Дата публикации: 2018-10-23.

Composition for the prevention and treatment of folate and/or vitamin b12 deficiency conditions, particularly hyperhomocysteinemia

Номер патента: CA3182363A1. Автор: Simone Castelli,Giuseppe SAMARITANI,Andrea Fratter. Владелец: Inpha Research Srl. Дата публикации: 2021-11-11.

Composition for the prevention and treatment of folate and/or vitamin b12 deficiency conditions, particularly hyperhomocysteinemia

Номер патента: EP4146167A1. Автор: Simone Castelli,Giuseppe SAMARITANI,Andrea Fratter. Владелец: Inpha Research Srl. Дата публикации: 2023-03-15.

Unsaturated Hydroxamic Acid Derivatives and Their Use for the Treatment and Prevention of an Ammonia-Associated Disease or Disorder

Номер патента: US20240293344A1. Автор: Jean-Christophe Leroux,Filip Ilievski,Diana EVSTAFEVA. Владелец: Versantis AG. Дата публикации: 2024-09-05.

4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-3,6-dihydropyridine-1-(2h)-carboxamide derivatives as limk and/or rock kinases inhibitors for use in the treatment of cancer

Номер патента: US20230312576A1. Автор: Sylvain Routier,Christian Andres,Pascal Bonnet,Helene Benedetti,Samia ACI-SECHE,Karen PLÉ,Sandrine RUCHAUD,Abdennour BRAKA,Anthony CHAMPIRÉ,Béatrice LÉE-MÉHEUST,Patrick VOURC'H. Владелец: Universite de Tours. Дата публикации: 2023-10-05.

Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting

Номер патента: CA2102195A1. Автор: Alfred L. Goldberg. Владелец: Individual. Дата публикации: 1992-11-14.

Proteases inhibitors for use in the treatment of infections caused by sars coronaviruses

Номер патента: EP3960239A1. Автор: Thomas Böttcher,Lilian PENALVER. Владелец: Universitaet Konstanz. Дата публикации: 2022-03-02.

CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS

Номер патента: US20070072869A1. Автор: Daniel SÄLL,Christopher Murray,Stephen Young,Michael Wiley,Jolie Bastian. Владелец: Individual. Дата публикации: 2007-03-29.

Pharmaceutical composition for the treatment and prevention of degenerative neurological disorders which comprises, as an active ingredient, a mixed root extract of the tree peony root, the root of dahuric angelica and the root of thorowax or its fraction

Номер патента: RU2668135C1. Автор: Ми Вон СОН,Янг Воонг ЧО,Санг Зин ЧОЙ,Дзин Сеок ДЗЕОНГ,Янгми КИМ,Миунг Соок ОХ,Сеон-Пио ХОНГ,Хай Хуа ЦЗЯН,Эундзин КИМ,Дза Янг РИУ,Сяо Фэй Ду,Дзеонг Соо КИМ,Биоунг Моон КИМ. Владелец: Юниверсити-Индастри Кооперейшн Груп Оф Киунг Хее Юниверсити. Дата публикации: 2018-09-26.

Pharmaceutical combinations comprising (a) the cyclin dependent kinase 4/6 (cdk4/6) inhibitor lee011 (=ribociclib), and (b) the epidermal growth factor receptor (egfr) inhibitor erlotinib, for the treatment or prevention of cancer

Номер патента: EP3340990A1. Автор: Joseph Lehar,Giordano Caponigro,Thomas HORN-SPIROHN. Владелец: NOVARTIS AG. Дата публикации: 2018-07-04.

A hydroxycarboxylic acid for the treatment of cancer

Номер патента: US20240217911A1. Автор: Michael Scharl,Yasser MORSY,Ana MONTALBAN-ARQUES,Egle KATKEVICIUTE. Владелец: Universitaet Zuerich. Дата публикации: 2024-07-04.

Cranberry Extract Useful in the Treatment and Prevention of Urinary Infections

Номер патента: US20150126598A1. Автор: Patrice Thomas,Philippe Sanoner,Bénédicte LASTIQUE,Valerie Bochard,Lucie Charissou,Morgane Jacob. Владелец: Diana Naturals SAS. Дата публикации: 2015-05-07.

Cranberry extract useful in the treatment and prevention of urinary infections

Номер патента: US10092539B2. Автор: Patrice Thomas,Philippe Sanoner,Bénédicte LASTIQUE,Valerie Bochard,Lucie Charissou,Morgane Jacob. Владелец: Diana Naturals SAS. Дата публикации: 2018-10-09.

Cranberry Extract Useful in the Treatment and Prevention of Urinary Infections

Номер патента: US20190038595A1. Автор: Patrice Thomas,Philippe Sanoner,Bénédicte LASTIQUE,Valerie Bochard,Lucie Charissou,Morgane Jacob. Владелец: Diana Naturals SAS. Дата публикации: 2019-02-07.

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

Номер патента: US12059418B2. Автор: Sanjay A. Desai. Владелец: US Department of Health and Human Services. Дата публикации: 2024-08-13.

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

Номер патента: US09808458B2. Автор: Sanjay A. Desai. Владелец: US Department of Health and Human Services. Дата публикации: 2017-11-07.

Methods, compositions and modes of delivery for the treatment of emphysema using 13-cis-retinoic acid

Номер патента: US20020049252A1. Автор: Paula Belloni. Владелец: Syntex USA LLC. Дата публикации: 2002-04-25.

Use of a birnavirus alone or in combination therapy for the treatment of cancer

Номер патента: US20240299476A1. Автор: Shimon Slavin,Imre Kovesdi,Volker Sandig,Tibor Bakács,Alexander Karlas,Sven KRÜGENER,Deborah Horn,Wolfgang W. RENZ. Владелец: PROBIOGEN AG. Дата публикации: 2024-09-12.

Composition for the treatment of osteoarthritis

Номер патента: EP2301554A8. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Ana Maria Torrent Gibert,Pere Dalmau Castañares. Владелец: Bioiberica SA. Дата публикации: 2011-10-26.

Use of lambda interferons in the treatment of obesity-related disorders and related diseases

Номер патента: CA3093480A1. Автор: Evangelos Andreakos,Maria Salagianni. Владелец: BIOMEDICAL RESEARCH FOUNDATION OF ACADEMY OF ATHENS. Дата публикации: 2018-09-20.

Use of lambda interferons in the treatment of obesity-related disorders and related diseases

Номер патента: US20200157167A1. Автор: Evangelos Andreakos,Maria Salagianni. Владелец: Individual. Дата публикации: 2020-05-21.

Use of lambda interferons in the treatment of obesity-related disorders and related diseases

Номер патента: US12121564B2. Автор: Evangelos Andreakos,Maria Salagianni. Владелец: BIOMEDICAL RESEARCH FOUNDATION OF ACADEMY OF ATHENS. Дата публикации: 2024-10-22.

Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck

Номер патента: US09913846B2. Автор: Samit Hirawat,Cristian Massacesi,Emmanuelle DI TOMASO. Владелец: NOVARTIS AG. Дата публикации: 2018-03-13.

Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis

Номер патента: WO2000032201A3. Автор: James Martin Frincke,Patrick T Prendergast,Clarence Nathaniel Ahlem. Владелец: Hollis Eden Pharmaceuticals. Дата публикации: 2000-12-21.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: WO2003047562A1. Автор: Julian Garcia-Rafanell,Genis Muñoz Orti,Jose Carlos Navas Ramirez,Jose Ignacio Izquierdo Pulido. Владелец: J. Uriach & Cia. S.A.. Дата публикации: 2003-06-12.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoro-methylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: EP1453499A1. Автор: Julian Garcia-Rafanell,Genis Muñoz Orti,Jose Carlos Navas Ramirez,Jose Ignacio Izquierdo Pulido. Владелец: J Uriach y Cia SA. Дата публикации: 2004-09-08.

Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Номер патента: US20030162756A1. Автор: José Pulido,Jose Ramirez,Julian Garcia-Rafanell,Genis Orti. Владелец: J Uriach y Cia SA. Дата публикации: 2003-08-28.

Composition for the treatment of osteoarthritis

Номер патента: EP2252302A1. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Ana Maria Torrent Gibert,Pere Dalmau Castañares. Владелец: Bioiberica SA. Дата публикации: 2010-11-24.

Composition for the treatment of osteoarthritis

Номер патента: WO2009083444A1. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Ana Maria Torrent Gibert,Pere Dalmau Castañares. Владелец: BIOIBERICA, S.A.. Дата публикации: 2009-07-09.

Use of leptin for the treatment or prevention of parkinson's disease

Номер патента: WO2008115880A3. Автор: Wei Zhang,Xin-Yun Lu. Владелец: The Board of Regents of the University of Texas System. Дата публикации: 2009-09-11.

Method for the prognosis and treatment of metastasis in breast cancer

Номер патента: WO2013011153A3. Автор: Verena STRESING,Angels Sierra Jimenez,Eder BALTZISKUETA FLOREZ. Владелец: Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell). Дата публикации: 2013-04-04.

Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis

Номер патента: EP1135138A2. Автор: James Martin Frincke,Patrick T. Prendergast,Clarence Nathaniel Ahlem. Владелец: Colthurst Ltd. Дата публикации: 2001-09-26.

Methods for the treatment and prevention of asbestos-related diseases

Номер патента: EP3223828A1. Автор: Anthony George,Jason RAVASINI. Владелец: UNIVERSITY OF TECHNOLOGY SYDNEY. Дата публикации: 2017-10-04.

Methods for the Treatment and Prevention of Asbestos-Related Diseases

Номер патента: US20170258829A1. Автор: Anthony George,Jason RAVASINI. Владелец: Technology Sydney (abn 77 257 686 961) Of Po Box 123, University of. Дата публикации: 2017-09-14.

Methods for the treatment and prevention of asbestos-related diseases

Номер патента: WO2016081993A1. Автор: Anthony George,Jason RAVASINI. Владелец: UNIVERSITY OF TECHNOLOGY, SYDNEY. Дата публикации: 2016-06-02.

Methods for the treatment and prevention of asbestos-related diseases

Номер патента: AU2015354399B2. Автор: Anthony George,Jason RAVASINI. Владелец: Bio Latem Tech Pty Ltd. Дата публикации: 2020-05-14.

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Номер патента: US09943591B2. Автор: David Apelian,Zhimin Guo,Claire Coeshott,Thomas H. King. Владелец: Globeimmune Inc. Дата публикации: 2018-04-17.

Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions

Номер патента: EP1567159A1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gyula Simig,Péter Kotay Nagy,György Lévay,András Egyed,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Janos Wellmann,Eva Schmidt,Csilla Leveleki,Aniko Miklosne Kovacs,Bernadett MARKÓ. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2005-08-31.

Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions

Номер патента: US20060211703A1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gyula Simig,Péter Kotay Nagy,György Lévay,András Egyed,Hajnalka Kompagne,Gábor SZÉNÁSI,Janos Wellmann,Eva Schmidt,Laszlo Harsing,Csilla Leveleki,Bernadett MARKÓ,Aniko Miklosne Koivacs. Владелец: EGIS PHARMACEUTICALS PLC. Дата публикации: 2006-09-21.

Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions

Номер патента: WO2004043465A1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gyula Simig,Péter Kotay Nagy,György Lévay,András Egyed,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Janos Wellmann,Eva Schmidt,Csilla Leveleki,Aniko Miklosne Kovacs,Bernadett MARKÓ. Владелец: Egis Gyogyszergyar Rt.. Дата публикации: 2004-05-27.

Medicament containing taraxacum plant root extract for treatment or prevention of cancer, and method for preparing same

Номер патента: CA2863838C. Автор: Siyaram Pandey,Pamela Uzuazo Ovadje,Caroline Marie Hamm. Владелец: UNIVERSITY OF WINDSOR. Дата публикации: 2021-03-23.

Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders

Номер патента: US20080319071A1. Автор: Daniel Raederstorff,Joseph Schwager,Goede Schueler. Владелец: DSM IP ASSETS BV. Дата публикации: 2008-12-25.

Combination of nitroprusside and a sulfide salt as an hno-releasing therapeutic for the treatment or prevention of cardiovascular diseases

Номер патента: US20150374749A1. Автор: Ivana Ivanovic-Burmazovic,Milos Filipovic. Владелец: Friedrich Alexander Univeritaet Erlangen Nuernberg FAU. Дата публикации: 2015-12-31.

Combination of nitroprusside and a sulfide salt as an hno-releasing therapeutic for the treatment or prevention of cardiovascular diseases

Номер патента: WO2014122074A1. Автор: Ivana Ivanovic-Burmazovic,Milos Filipovic. Владелец: Friedrich-Alexander-Universität Erlangen-Nürnberg. Дата публикации: 2014-08-14.

Nucleoside drugs for the treatment or prevention of coronavirus infection and their uses

Номер патента: US20240252527A9. Автор: Xiaolin Li,Longwu Qi,Nana Du,Shusen Xu. Владелец: Miracure Biotechnology Ltd. Дата публикации: 2024-08-01.

Composition containing lysine for the treatment of poison ivy, composition containing lysine for the prevention of poison ivy, processes, and method of use

Номер патента: US20240226046A1. Автор: Douglas J. Tataryn. Владелец: Individual. Дата публикации: 2024-07-11.

Medicament containing taraxacum plant root extract for treatment or prevention of cancer, and method for preparing same

Номер патента: EP2817017A1. Автор: Siyaram Pandey,Pamela Uzuazo Ovadje,Caroline Marie Hamm. Владелец: UNIVERSITY OF WINDSOR. Дата публикации: 2014-12-31.

Hydrogen sulphide (h2s) generating compounds for use in the treatment of preeclampsia and related disorders in obese pregnant women

Номер патента: WO2024126977A1. Автор: Asif AHMED. Владелец: Mirzyme Therapeutics Limited. Дата публикации: 2024-06-20.

Composition containing lysine for the treatment of poison ivy, composition containing lysine for the prevention of poison ivy, processes, and method of use

Номер патента: WO2024150066A1. Автор: Douglas J. Tataryn. Владелец: Tataryn Douglas J. Дата публикации: 2024-07-18.

Faecalibacterium prausnitzii and desulfovibrio piger for use in treatment or prevention of diabetes and intestinal diseases

Номер патента: RU2754367C2. Автор: Мухаммад-Танвир КХАН,Фредрик БЕКХЕД. Владелец: Метабоген Аб. Дата публикации: 2021-09-01.

Topical veterinary compositions and methods for the treatment and prevention of infection

Номер патента: EP1651255A1. Автор: Michael D. White,Michael S. Tyndall,John M. Cunningham. Владелец: KO Manufacturing Inc. Дата публикации: 2006-05-03.

Topical veterinary compositions and methods for the treatment and prevention of infection

Номер патента: WO2005016377A1. Автор: Michael D. White,Michael S. Tyndall,John M. Cunningham. Владелец: Ko Manufacturing, Inc.. Дата публикации: 2005-02-24.

Method for treatment or prevention of osteoporosis in individuals with high bone turnover

Номер патента: WO2005079776A1. Автор: Risto Lammintausta,Lauri Kangas,Taru Blom. Владелец: Hormos Medical LTD.. Дата публикации: 2005-09-01.

Cyclic apelin derivatives for the treatment of heart failure

Номер патента: US09908919B2. Автор: Frédéric ZECRI,Jun Yuan,Kayo Yasoshima,Philipp Grosche,Hongjuan Zhao. Владелец: NOVARTIS AG. Дата публикации: 2018-03-06.

Lactobacillus salivarius for the treatment of mastitis

Номер патента: RU2684600C1. Автор: Ян КНОЛ,КИНТАНА Эстер Антония ХИМЕНЕС,АЛЬВАРЕС Леонидес ФЕРНАНДЕС,ГОМЕС Хуан Мигель РОДРИГЕС,Росио МАРТИН,МАРТОС Ирене ЭСПИНОСА. Владелец: Н.В. Нютрисиа. Дата публикации: 2019-04-09.

Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases

Номер патента: EP3925961A1. Автор: Chae Wook Kim. Владелец: Fusion Biotechnology Co Ltd. Дата публикации: 2021-12-22.

Composition comprising pasteurized akkermansia muciniphila for the treatment or prevention of gut contractility disorders, in particular duodenal contraction amplitude disorder

Номер патента: WO2023020831A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: The Akkermansia Company. Дата публикации: 2023-02-23.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: EP2049113A2. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,György Lévay,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Marta Agoston. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2009-04-22.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: EP2049113B1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,György Lévay,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Marta Agoston. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2010-05-26.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: IL196315A0. Автор: . Владелец: Egis Gyogyszergyar Nyilvanosan. Дата публикации: 2009-09-22.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: WO2008004013A8. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Gyoergy Levay,Marta Agoston. Владелец: Marta Agoston. Дата публикации: 2009-07-02.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: IL196315A. Автор: . Владелец: Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag. Дата публикации: 2014-09-30.

Medicament for the enhancement of cognitive function and neuroprotection

Номер патента: AU2007270910A1. Автор: Jozsef Barkoczy,Istvan Gacsalyi,Gabor Gigler,Gyula Simig,György Lévay,Hajnalka Kompagne,Gábor SZÉNÁSI,László Gábor HÁRSING,Krisztina Moricz,Szabolcs Kertesz,Marta Agoston. Владелец: Egyt Gyogyszervegyeszeti Gyar. Дата публикации: 2008-01-10.

Tetrahydropyranopyrazole derivatives for the treatment of cancer and viral infections

Номер патента: AU2023211112A1. Автор: Tjeerd Barf,Lars Sandberg,Ulrika Yngve,Sonia Lain,Christoffer Bengtsson. Владелец: Genase Therapeutics BV. Дата публикации: 2024-08-15.

Use of3-amino chromans or thiocromans for the treatment of prostate cancer

Номер патента: WO2005039560A1. Автор: Per-Anders Abrahamsson. Владелец: AstraZeneca AB. Дата публикации: 2005-05-06.

Composition comprising pasteurized akkermansia muciniphila for the treatment or prevention of gut contractility disorders, in particular duodenal contraction amplitude disorder

Номер патента: US20240350560A1. Автор: Patrice Cani,Amandine BROCHOT. Владелец: Akkermansia Co. Дата публикации: 2024-10-24.

Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid

Номер патента: US09867868B2. Автор: Sin Wook Kang,Kyoungsun Kim,Ji Hye SUNG. Владелец: G TreeBNT Co Ltd. Дата публикации: 2018-01-16.

Method of treating or preventing disease associated with deposit of amyloid proteins (versions)

Номер патента: RU2533806C2. Автор: БАРРИО Х. Мануэль САРАСА. Владелец: Араклон Байотек С.Л.. Дата публикации: 2014-11-20.

Azaquinazoline derivatives for use in treating or preventing dirofilaria infection in a mammal

Номер патента: US20240108629A1. Автор: Mark J. Taylor,Joseph D. Turner,Stephen A. Ward,Paul M. O'NEILL,Weiquan David Hong. Владелец: Liverpool Foundation Building, University of. Дата публикации: 2024-04-04.

Azaquinazoline derivatives for use in treating or preventing dirofilaria infection in a mammal

Номер патента: EP4277631A1. Автор: Mark J. Taylor,Joseph D. Turner,Stephen A. Ward,Weiqian David HONG,Paul M. O'NEILL. Владелец: University of Liverpool. Дата публикации: 2023-11-22.

Method for prevention of using corticosteroids

Номер патента: RU2500408C2. Автор: Бернд ШТАЛЬ,Гюнтер БЕМ,Юрген ЙЕЛИНЕК. Владелец: Н.В. Нютрисиа. Дата публикации: 2013-12-10.

Arginase inhibitors for treating depression

Номер патента: RU2488390C2. Автор: Валло ВОЛКЕ,Мааря КРАСС,Анника ВОЛКЕ,Ээро ВАЗАР. Владелец: Тартуский Университет. Дата публикации: 2013-07-27.

Ppar-alpha ligands for the treatment or prevention of cachexia

Номер патента: US20040167107A1. Автор: Samuel Wright. Владелец: Individual. Дата публикации: 2004-08-26.

S-substituted quinazolines and their therapeutic applications for the treatment of diseases mediated by pde7

Номер патента: US20160340320A1. Автор: Ana Martinez Gil,Daniel Ignacio Perez Fernandez,Carmen Belén GIL AYUSO-GONTAN,Ana María GARCÍA FERNÁNDEZ. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2016-11-24.

Ppar-alpha ligands for the treatment or prevention of cachexia

Номер патента: WO2003000182A3. Автор: Samuel D Wright. Владелец: Samuel D Wright. Дата публикации: 2003-05-08.

Pharmaceutical Composition for the Treatment of Solar Urticaria

Номер патента: US20110294894A1. Автор: Martin Metz,Marcus MAURER,Karoline Krause. Владелец: Individual. Дата публикации: 2011-12-01.

2-[2-({12,12-dimethyl-4-oxo-6-phenyl-3,11-dioxatricyclo[8.4.0.0,2,7]tetradeca-1,5,7,9-tetraen-8-yl}oxy)acetamido]benzamide and derivatives as inhibitor of clock:bmal1 interaction for the treatment of circadian rhythm diseases and disorders

Номер патента: US20230078642A1. Автор: Ibrahim Halil KAVAKLI,Metin TURKAY,Yağmur Umay DORUK,Darya YARPARVAR. Владелец: KOC Universitesi. Дата публикации: 2023-03-16.

Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatmentof malaria and the treatment of African and American trypanosomiasis.

Номер патента: OA11715A. Автор: James Martin Frincke,Patrick T Prendergast,Clarence Nathaniel Ahlem. Владелец: Hollis Eden Pharmaceuticals. Дата публикации: 2005-03-14.

Hydrogel composition for the treatment of peritoneal diseases

Номер патента: WO2024172648A1. Автор: Patricia Yvonne Wilhelmina Dankers,Peter Paul Kathleen Hubert FRANSEN,Gerardus Cornelis VAN ALMEN. Владелец: Upyther B.V.. Дата публикации: 2024-08-22.

Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health

Номер патента: AU2023202398A1. Автор: Owen John Catchpole,Amanda Jan SUDDES. Владелец: Manuka Health New Zealand Ltd. Дата публикации: 2023-05-11.

6-(4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3h)-one derivatives and related compounds as ptpn11 (shp2) inhibitors for treating cancer

Номер патента: ZA202101449B. Автор: Philip Jones,Jason Cross,Barbara Czako,Pijus Mandal,Christopher L Carroll. Владелец: Navire Pharma Inc. Дата публикации: 2024-08-28.

Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health

Номер патента: EP3169321A1. Автор: Owen John Catchpole,Amanda Jan SUDDES. Владелец: Manuka Health New Zealand Ltd. Дата публикации: 2017-05-24.

Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health

Номер патента: NZ727844A. Автор: Owen John Catchpole,Amanda Jan SUDDES. Владелец: Manuka Health New Zealand Ltd. Дата публикации: 2024-04-26.

Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health

Номер патента: NZ727844B2. Автор: Owen John Catchpole,Amanda Jan SUDDES. Владелец: Manuka Health New Zealand Limited. Дата публикации: 2024-07-30.

Esters of short chains fatty acids for use in the treatment of immunogenic disorders

Номер патента: US09884032B2. Автор: Bettina ERNST. Владелец: Proponent Biotech GmbH. Дата публикации: 2018-02-06.

Pharmaceutical composition for treatment and/or prevention of cancer

Номер патента: US09862774B2. Автор: Takanori Saito,Fumiyoshi Okano,Takayoshi Ido,Yoshitaka Minamida. Владелец: TORAY INDUSTRIES INC. Дата публикации: 2018-01-09.

Compositions for the treatment of parasitic and fungal infections

Номер патента: CA2206511A1. Автор: Ronald P. Mccaffrey,Hans L. R. Wigzell,Alan M. Sugar. Владелец: Individual. Дата публикации: 1996-06-06.

Treatment and/or prevention of a disease or a syndrome related to a virus infection

Номер патента: US20230302104A1. Автор: Nikolay ZHUKOVSKY. Владелец: Atlas Biotechnology SA. Дата публикации: 2023-09-28.

Methods and compositions for the treatment of als

Номер патента: US20230270766A1. Автор: Ethan Russo. Владелец: Credo Science LLC. Дата публикации: 2023-08-31.

Compositions for the skin

Номер патента: EP3445377A1. Автор: José ESCAICH FERRER,Sergi SEGARRA LÓPEZ,Alfonso VELASCO FRANCO,Javier CÓRDOBA LUCIO,Jorge FLORES GARCÍA. Владелец: Bioiberica SA. Дата публикации: 2019-02-27.

Compositions for the skin

Номер патента: WO2017182379A1. Автор: José ESCAICH FERRER,Sergi SEGARRA LÓPEZ,Alfonso VELASCO FRANCO,Javier CÓRDOBA LUCIO,Jorge FLORES GARCÍA. Владелец: BIOIBERICA, S.A.U.. Дата публикации: 2017-10-26.

Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion

Номер патента: EP3057584A1. Автор: Gerard Cros,Richard Magous,Alan Crozier,Margherita Dall'asta,Daniele Del Rio,Catherine Oiry. Владелец: Universita degli Studi di Parma. Дата публикации: 2016-08-24.

Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion

Номер патента: US10583114B2. Автор: Gerard Cros,Richard Magous,Alan Crozier,Margherita Dall'asta,Daniele Del Rio,Catherine Oiry. Владелец: Universita degli Studi di Parma. Дата публикации: 2020-03-10.

Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion

Номер патента: WO2015055736A1. Автор: Gerard Cros,Richard Magous,Alan Crozier,Margherita Dall'asta,Daniele Del Rio,Catherine Oiry. Владелец: University Of Parma. Дата публикации: 2015-04-23.

Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion

Номер патента: US20200155504A1. Автор: Gerard Cros,Richard Magous,Alan Crozier,Margherita Dall'asta,Daniele Del Rio,Catherine Oiry. Владелец: Universita degli Studi di Parma. Дата публикации: 2020-05-21.

Pharmaceutical composition for use in the treatment or prevention of calcium release-activated calcium channel or discoidin domain receptor 2 related disorders or conditions

Номер патента: WO2024153190A1. Автор: Yi-Chun Yeh,Yu-Fen Chang. Владелец: Lumistar Biotechnology, Inc.. Дата публикации: 2024-07-25.

Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases

Номер патента: US09872882B2. Автор: Pei-Wen Hsieh,Hung-I Yeh,Shih-Wei Wang,Ching-Hu Chung. Владелец: MACKAY MEDICAL COLLEGE. Дата публикации: 2018-01-23.

Inhibitor of integrin for the treatment or prevention of tumours

Номер патента: EP2917241A1. Автор: Mauro Biffoni,Ruggero De Maria Marchiano,Tobias Longin HAAS,Lucia RICCI VITIANI. Владелец: Istituti Fisioterapici Ospitalieri IFO. Дата публикации: 2015-09-16.

Compounds for the treatment of mitochondrial diseases

Номер патента: US20170266136A1. Автор: Vincent Procaccio,Agnès DELAHODDE,Agnès RÖTIG,Enrico BARUFFINI,Tiziana LODI,Laras Ajeng PITAYU. Владелец: Centre Hospitalier Universitaire dAngers. Дата публикации: 2017-09-21.

Compounds for the treatment of mitochondrial diseases

Номер патента: US10639287B2. Автор: Vincent Procaccio,Agnès DELAHODDE,Agnès RÖTIG,Enrico BARUFFINI,Tiziana LODI,Laras Ajeng PITAYU. Владелец: Centre Hospitalier Universitaire dAngers. Дата публикации: 2020-05-05.

Use of estrogen derivatives for the manufacture of pharmaceutical products useful for the prophylaxis and/or treatment of psychiatric diseases

Номер патента: WO2013098570A1. Автор: Lajos Istvan Nagy,Laszlo Puskas,Tibor HAJSZÁN,Béla ÓZSVÁRI. Владелец: "Avidin" Kutató, Fejlesztö és Kereskedelmi Korlátolt Felelösségü Társaság. Дата публикации: 2013-07-04.

Use of probucol, ascorbic acid, vitamin E, dipyridamole and mopidamol for treatment and prevention of NO-dependent microcirculation disorders

Номер патента: NZ529115A. Автор: Wolfgang Eisert. Владелец: BOEHRINGER INGELHEIM PHARMA. Дата публикации: 2005-08-26.

Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring

Номер патента: EP2307439A1. Автор: Norbert Schmees,Christiane Otto,Thorsten Blume,Joachim Kuhnke,Dieter Heldmann,Tim Wintermantel. Владелец: Bayer Schering Pharma AG. Дата публикации: 2011-04-13.

Thiophene derivatives for the treatment of disorders caused by IgE

Номер патента: AU2019291111B9. Автор: James Madden,Alistair James Henry,Zhaoning Zhu,Matthew Duncan Selby,Timothy John Norman,William Ross Pitt,Oliver Philps,Richard Jeremy Franklin,Giancarlo Trani,Judi Charlotte Neuss,Gregory William HASLETT,Prafulkumar Tulshibhai Chovatia,Rickki Lee Connelly,Konstantinos Rampalakos,Suganthan Selvaratnam. Владелец: UCB Biopharma SRL. Дата публикации: 2023-08-24.

Dopamine receptor agonists in the treatment and prevention of hiv-induced dementia

Номер патента: WO2006119353A2. Автор: Rosemarie M. Booze,Charles Mactutus. Владелец: UNIVERSITY OF SOUTH CAROLINA. Дата публикации: 2006-11-09.

Drug delivery system for the delivery of antiviral agents and contraceptives

Номер патента: WO2021225869A8. Автор: Stephanie Elizabeth Barrett,Ryan S. Teller,Seth P. Forster,Athanas Koynov,Morgan B. GILES. Владелец: Merck Sharp & Dohme LLC. Дата публикации: 2022-08-11.

Drug delivery system for the delivery of antiviral agents and contraceptives

Номер патента: AU2021268584A1. Автор: Stephanie Elizabeth Barrett,Ryan S. Teller,Seth P. Forster,Athanas Koynov,Morgan B. GILES. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2022-12-01.

Dopamine receptor agonists in the treatment and prevention of hiv-induced dementia

Номер патента: WO2006119353A3. Автор: Charles Mactutus,Rosemarie M Booze. Владелец: Rosemarie M Booze. Дата публикации: 2007-05-24.

Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

Номер патента: US20170035760A1. Автор: Li Liu,Martin J. Walsh,Min Shen,Matthew B. Boxer,Douglas S. Auld,Kent Lai,Manshu Tang,Cordelle D. Tanega. Владелец: University of Utah Research Foundation UURF. Дата публикации: 2017-02-09.

Treatment or prevention of hiv infection

Номер патента: AU2021383922A9. Автор: René HOLM,Steven M. VESOLE,Nico Rudolph Niemeijer,Guenter Karl Wilhelm KRAUS,Iwan Caroline F. VERVOORT,Herta Maria Ludovica CRAUWELS. Владелец: Janssen Sciences Ireland ULC. Дата публикации: 2024-10-24.

Preparation and method for use in the treatment of respiratory diseases

Номер патента: US09944610B2. Автор: Yvon Cormier,Pierre Lavallee,Bildad NYAMBURA,Evelyne Israel-Assayag. Владелец: UNIVERSITE LAVAL. Дата публикации: 2018-04-17.

Composition comprising a complex of (+)-catechin and amino acid for the treatment and prevention of cancer

Номер патента: US09844595B2. Автор: Bruno Schoentjes,Paul Niebes,Saïd Rachidi,Julien Estager,Bronislav Henric May. Владелец: VALORE. Дата публикации: 2017-12-19.

Methods and compositions for the treatment of disorders characterized by a kidins220 dysfunction in a subject

Номер патента: US20240226062A1. Автор: Teresa IGLESIAS VACAS,Miguel R CAMPANERO GARCÍA,Julia POSE UTRILLA,Ana SIMÓN GARCÍA,Celia LÓPEZ MENÉNDEZ,Luis SÁNCHEZ-MIRANDA PAJUELO,Ana María DEL PUERTO DEL PINO. Владелец: Consorcio Centro de Investigacion Biomedica en Red MP. Дата публикации: 2024-07-11.

Ophthalmic composition for the treatment of visual disorders

Номер патента: EP4382098A1. Автор: Cynthia CANO-SARMIENTO,Ana Guadalupe CASTILLO-OLMOS,Hugo Sergio GARCÍA-GALINDO,Mizraim MORALES-MENDOZA. Владелец: Foodvica SA de CV. Дата публикации: 2024-06-12.

Methods and compositions for the treatment of inflammation

Номер патента: WO2005077056A3. Автор: Michael M Koganov. Владелец: Michael M Koganov. Дата публикации: 2006-03-02.

Use of compound 1 in treatment or prevention of atopic dermatitis

Номер патента: WO2024149362A1. Автор: FENG Jin,WEI Hu,Ying Zhang,Zhenwei Li,Tianyuan Zhang,Xun He,Yuhan GUO,Baoru LV. Владелец: Shenzhen Newdel Biotech Co., Ltd.. Дата публикации: 2024-07-18.

Methods and compositions for the treatment of inflammation

Номер патента: EP1720563A2. Автор: Michael M. Koganov. Владелец: Integrated Botanical Technologies. Дата публикации: 2006-11-15.

Ophthalmic composition for the treatment of visual disorders

Номер патента: US20240335458A1. Автор: Cynthia CANO-SARMIENTO,Ana Guadalupe CASTILLO-OLMOS,Hugo Sergio GARCÍA-GALINDO,Mizraim MORALES-MENDOZA. Владелец: Foodvica SA de CV. Дата публикации: 2024-10-10.

Compositions comprising fungal bioactive compounds, and related apparatus and methods to treat, ameliorate or prevent depression or diseases and/or conditions with allergic responses

Номер патента: AU2023285828A1. Автор: Julian Mitchell,Thomas Loussier. Владелец: Rembiotics Pty Ltd. Дата публикации: 2024-07-25.

Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

Номер патента: US11357778B2. Автор: Arnold Munnich,Laurence LEGEAI-MALLET,Patricia BUSCA,Florent BARBAULT. Владелец: IMAGINE. Дата публикации: 2022-06-14.

Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3

Номер патента: US20230075776A1. Автор: Arnold Munnich,Laurence LEGEAI-MALLET,Patricia BUSCA,Florent BARBAULT. Владелец: IMAGINE. Дата публикации: 2023-03-09.

Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3

Номер патента: EP2790718A1. Автор: Laurence LEGEAI-MALLET. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2014-10-22.

Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

Номер патента: US09931341B2. Автор: Arnold Munnich,Laurence LEGEAI-MALLET,Patricia BUSCA,Florent BARBAULT. Владелец: Universite Paris 5 Rene Descartes. Дата публикации: 2018-04-03.

N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity

Номер патента: WO2002078627A3. Автор: Leonard A Herzenberg,James Andrus,Leonore A Herzenberg,Rosa Stephen C De. Владелец: Bioadvantex Pharma Inc. Дата публикации: 2003-09-18.

Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection

Номер патента: WO2024133596A1. Автор: Philippe Langella,Jean-Marc CHATEL,Harry SOKOL,Pauline RUFFIE,Benjamin HADIDA,Séverine PECHINE,Camille CAMPIDELLI,Claire JANOIR. Владелец: Exeliom Biosciences. Дата публикации: 2024-06-27.

Methods of treating or preventing a proteopathy

Номер патента: US20240279229A1. Автор: David Saperstein. Владелец: Usher III Initiative Inc. Дата публикации: 2024-08-22.

3-hydroxydodecanoic acid for the treatment of cancer

Номер патента: EP4326248A2. Автор: Michael Scharl,Yasser MORSY,Ana MONTALBAN-ARQUES,Egle KATKEVICIUTE. Владелец: Universitaet Zuerich. Дата публикации: 2024-02-28.

Compounds selected from clarithromycin and lexithromycin for the treatment and prevention of viral infections caused by coronaviruses

Номер патента: WO2022002789A1. Автор: Jose María BENLLOCH BAVIERA,María GALVEZ LLOMPART,Jorge GALVEZ ÁLVAREZ,Riccardo ZANNI. Владелец: UNIVERSITAT DE VALENCIA. Дата публикации: 2022-01-06.

Inhibitor of integrin for the treatment or prevention of tumours

Номер патента: US20150315276A1. Автор: Mauro Biffoni,Ruggero De Maria Marchiano,Tobias Longin HAAS,Lucia RICCI VITIANI. Владелец: Istituti Fisioterapici Ospitalieri IFO. Дата публикации: 2015-11-05.

Methods and compounds for the treatment or prevention of severe influenza

Номер патента: EP3478322A1. Автор: Paul Andrew Whittaker,Neil Edward TORBETT. Владелец: hVivo Services Ltd. Дата публикации: 2019-05-08.

Bacterial strains of the Lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract

Номер патента: US12036254B2. Автор: Andrea BIFFI. Владелец: Lac2biome Srl. Дата публикации: 2024-07-16.

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

Номер патента: WO2005102374A3. Автор: John Robertson,Robert Harris,Anders Essen-Moller. Владелец: Diamyd Medical Ab. Дата публикации: 2006-03-16.

Use of DDX3X inhibitors for the treatment of pneumovirus infections

Номер патента: US09884812B2. Автор: Andrew Marsh,Andrew Easton,Phillip GOULD. Владелец: University of Warwick. Дата публикации: 2018-02-06.

Bacterial strains of the lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract

Номер патента: EP3870196A1. Автор: Andrea BIFFI. Владелец: Lac2biome Srl. Дата публикации: 2021-09-01.

Neutrophil elastase inhibitors for use in the treatment of fibrosis

Номер патента: EP4419102A1. Автор: Jacqueline PARKIN,Noa G. HOLTZMAN,Annie IM,Steven Z. PAVLETIC,Cody J. PEER. Владелец: Mereo Biopharma 4 Ltd. Дата публикации: 2024-08-28.

Cnx/erp57 inhibitor for use in the treatment or prevention of cancer

Номер патента: EP3917571A1. Автор: Frederic Bard,Anh Tuan Nguyen,Ros MANON. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2021-12-08.

Phytocomplex for prevention of the development of gambling addiction (variants)

Номер патента: RU2757952C1. Автор: Анна Геннадиевна Пономарева,Сергей Сергеевич Мителёв. Владелец: Сергей Сергеевич Мителёв. Дата публикации: 2021-10-25.

Antagonists and agonists of the transferrin receptor-2 for use in the treatment of diseases of the bone

Номер патента: US20240199755A1. Автор: Volker Germaschewski,Martina Rauner,Lorenz HOFBAUER,Uwe Platzbecker,Ulrike Baschant,Igor THEURL. Владелец: Kymab Ltd. Дата публикации: 2024-06-20.

Novel mbp peptides and their use in the treatment of multiple sclerosis

Номер патента: WO2024094562A1. Автор: Roland Martin. Владелец: UNIVERSITAT ZURICH. Дата публикации: 2024-05-10.

Nutraceuticalor pharmaceutical composition for the use in the treatment and/or in the prevention of conditions or diseases characterized by magnesium deficiency

Номер патента: WO2022254414A3. Автор: Umberto DI MAIO. Владелец: NEILOS S.R.L.. Дата публикации: 2023-11-23.

Il-18 binding protein (il-18bp) in the treatment of vexas

Номер патента: WO2023166206A1. Автор: Eduardo Schiffrin,Michael Soldan,Laurence Goffin,Djordje Filipovic,Cyril PORTMANN. Владелец: AB2 BIO SA. Дата публикации: 2023-09-07.

Aav variants for the treatment of dry amd

Номер патента: WO2024118575A2. Автор: Gustavo DE ALENCASTRO,Brigit RILEY,Ruslan GRISHANIN. Владелец: Adverum Biotechnologies, Inc.. Дата публикации: 2024-06-06.

Pyrimidin-2-ylamino-1H-pyrazols as LRRK2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: AU2024204621A1. Автор: Joseph P. Lyssikatos,Javier De Vicente Fidalgo,Anthony A. ESTRADA,Jianwen A. FENG,Zachary K. Sweeney. Владелец: Denali Therapeutics Inc. Дата публикации: 2024-07-18.

Neutrophil elastase inhibitors for use in the treatment of fibrosis

Номер патента: AU2022373971A1. Автор: Jacqueline PARKIN,Noa G. HOLTZMAN,Annie IM,Steven Z. PAVLETIC,Cody J. PEER. Владелец: Mereo Biopharma 4 Ltd. Дата публикации: 2024-04-04.

Neutrophil elastase inhibitors for use in the treatment of fibrosis

Номер патента: CA3234399A1. Автор: Jacqueline PARKIN,Noa G. HOLTZMAN,Annie IM,Steven Z. PAVLETIC,Cody J. PEER. Владелец: Mereo Biopharma 4 Ltd. Дата публикации: 2023-04-27.

Method and means for selection of anti-idiotype antibodies and their use for the diagnosis, monitoring, treatment and/or prevention of cancer, autoimmune or infectious disease

Номер патента: AU2792789A. Автор: Heinz Kohler,Symal Raychaudhuri. Владелец: IDEC Inc. Дата публикации: 1989-07-05.

A pharmaceutical combination for use in the treatment of cancer

Номер патента: CA3099494A1. Автор: Detlev Schuppan,Sebastian ROSIGKEIT,Ernst-Otto BOCKAMP. Владелец: Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz. Дата публикации: 2019-11-14.

A pharmaceutical combination for use in the treatment of cancer

Номер патента: EP3790582A1. Автор: Detlev Schuppan,Sebastian ROSIGKEIT,Ernst-Otto BOCKAMP. Владелец: Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz. Дата публикации: 2021-03-17.

A pharmaceutical combination for use in the treatment of cancer

Номер патента: AU2019266497A1. Автор: Detlev Schuppan,Sebastian ROSIGKEIT,Ernst-Otto BOCKAMP. Владелец: Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz. Дата публикации: 2020-11-26.

Pharmaceutical topical composition for use in the treatment and/or in the prevention of infections of skin lesions

Номер патента: WO2012153288A1. Автор: Carla Labruzzo. Владелец: Soveta Baltica Uab. Дата публикации: 2012-11-15.

Met inhibitors for enhancing radiotherapy efficacy

Номер патента: CA2769991C. Автор: Rita De Santis,Paolo Maria Comoglio,Fiorella Petronzelli,Carla Boccaccio. Владелец: Metis Precision Medicine Sb Srl. Дата публикации: 2018-05-15.

GATA-3 INHIBITORS FOR USE IN THE TREATMENT OF TH2-DRIVEN ASTHMA

Номер патента: US20190062737A1. Автор: Renz Jonas,Bille Joachim. Владелец: . Дата публикации: 2019-02-28.

ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE

Номер патента: US20180193417A1. Автор: Weston-Davies Wynne H. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2018-07-12.

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism

Номер патента: US20170196936A1. Автор: Wynne H. Weston-Davies. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2017-07-13.

Combination therapy with merestinib and anti-pd-l1 or anti-pd-1 inhibitors for use in the treatment of cancer

Номер патента: WO2018022438A1. Автор: Sau-Chi Betty Yan,David Arlen SCHAER,Richard A. WALGREN. Владелец: ELI LILLY AND COMPANY. Дата публикации: 2018-02-01.

FURINE INHIBITORS FOR USE IN THE TREATMENT OF FIBROSIS AND CICATRIZATION.

Номер патента: ES2355094T3. Автор: Mark W. J. Ferguson,G. Fachklinik Hornheide Dep. Cancer Res. BRUNNER. Владелец: Renovo Ltd. Дата публикации: 2011-03-22.

Trem-1 inhibitor for use in the treatment of a subject suffering from a coronavirus infection

Номер патента: CA3180293A1. Автор: Marc Derive,Margarita SALCEDO-MAGGUILLI,Jean-Jacques GARAUD,Simon Lambden,Aurelie OLIVIER. Владелец: Inotrem SA. Дата публикации: 2021-12-09.

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism

Номер патента: CA2951175A1. Автор: Wynne H Weston-Davies. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2015-12-10.

Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease

Номер патента: CA2988313A1. Автор: Wynne H Weston-Davies. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2016-12-15.

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism

Номер патента: EP3151851B1. Автор: Wynne H Weston-Davies. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2021-12-01.

DOMINANT, NEGATIVE TNF-ALPHA INHIBITOR FOR USE IN THE TREATMENT OF NEUROLOGICAL CNS DISORDERS

Номер патента: DK2892547T3. Автор: Malu Tansey,David Szymkowski,Lesley Probert. Владелец: Xencor Inc. Дата публикации: 2020-10-26.

Furin inhibitors for use in the treatment of fibrosis and scarring

Номер патента: EP1556080B1. Автор: Mark W. J. Ferguson,G. Fachklinik Hornheide Dep. Cancer Res. BRUNNER. Владелец: Renovo Ltd. Дата публикации: 2010-11-03.

An androgen receptor or estradiol receptor inhibitor for use in the treatment of cancerous or non-cancerous conditions

Номер патента: CA2853671A1. Автор: Satu Vainikka,Mark ECCLESTON,George Steven MORRIS. Владелец: Valirx Plc. Дата публикации: 2013-05-10.

ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES IN CAT POLYMORPHISM PATIENTS

Номер патента: DK3151851T3. Автор: Wynne H Weston-Davies. Владелец: Volution Immuno Pharmaceuticals SA. Дата публикации: 2022-02-28.

Pyrimidin-2-ylamino-1H-pyrazols as LRRK2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: AU2017286653B2. Автор: Joseph P. Lyssikatos,Javier De Vicente Fidalgo,Anthony A. ESTRADA,Jianwen A. FENG,Zachary K. Sweeney. Владелец: Denali Therapeutics Inc. Дата публикации: 2021-11-04.

Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: IL263484B1. Автор: . Владелец: Denali Therapeutics Inc. Дата публикации: 2023-10-01.

Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: IL263484B2. Автор: . Владелец: Denali Therapeutics Inc. Дата публикации: 2024-02-01.

Pyrimidin-2-ylamino-1H-pyrazols as LRRK2 inhibitors for use in the treatment of neurodegenerative disorders

Номер патента: AU2022202372B2. Автор: Joseph P. Lyssikatos,Javier De Vicente Fidalgo,Anthony A. ESTRADA,Jianwen A. FENG,Zachary K. Sweeney. Владелец: Denali Therapeutics Inc. Дата публикации: 2024-04-04.

Vegfr gene expression inhibitor for use in the treatment of psoriasis

Номер патента: EP4344700A1. Автор: Qi Zhen,ZHUO Li,Weiwei Chen,Yirui Wang,Liangdan Sun. Владелец: Individual. Дата публикации: 2024-04-03.

Neutrophil elastase inhibitors for use in the treatment of fibrosis

Номер патента: IL312002A. Автор: Jacqueline PARKIN,Annie IM,Noa G Holtzman,Steven Z Pavletic,Cody J Peer. Владелец: Cody J Peer. Дата публикации: 2024-06-01.

PROCEDURE FOR THE PREPARATION OF A BACTERY PREPARATION FOR PREVENTION OF SALMONELLA INFECTIONS BY REMOVAL

Номер патента: DK152381B. Автор: Esko Viljo Nurmi,Carita Elisabeth Schneitz,Pirjo Helena Maekelae. Владелец: Farmos Oy. Дата публикации: 1988-02-22.

Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs)

Номер патента: US20240301074A1. Автор: Nathalie Ivanoff,Ahmed Karim FARAG,Sree KURUP,Xiujiang LI,Sutirtha MUKHOPADHYAY,Usha RANGANATHAN. Владелец: Boehringer Ingelheim Pharmaceuticals Inc. Дата публикации: 2024-09-12.

PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa

Номер патента: US12037387B2. Автор: Derrick Ryan Witcher,Kristine Kay Kikly,Dipak Ratilal Patel. Владелец: Eli Lilly and Co. Дата публикации: 2024-07-16.

Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa

Номер патента: MY197879A. Автор: Derrick Ryan Witcher,Kristine Kay Kikly,Dipak Ratilal Patel. Владелец: Lilly Co Eli. Дата публикации: 2023-07-22.

Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs)

Номер патента: WO2024187058A1. Автор: Nathalie Ivanoff,Ahmed Karim FARAG,Sree KURUP,Xiujiang LI,Sutirtha MUKHOPADHYAY,Usha RANGANATHAN. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-09-12.

Method and remedy for treatment and prevention of benign prostatic hyperplasia

Номер патента: RU2764850C1. Автор: Дмитрий Евгеньевич Лукин,Владимир Григорьевич Беспалов. Владелец: Миронова Людмила Владимировна. Дата публикации: 2022-01-21.

Bispecific antibodies for use in treatment of hidradenitis suppurativa

Номер патента: US20240294626A1. Автор: Richard Stein,Jiri Kovarik,Yu Tang,Christian Loesche,Sabine Beck,Michael Kiffe,Margarida Rodrigues,Frank WALDRON-LYNCH. Владелец: NOVARTIS AG. Дата публикации: 2024-09-05.

Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa

Номер патента: CA3117142A1. Автор: Derrick Ryan Witcher,Kristine Kay Kikly,Dipak Ratilal Patel. Владелец: Eli Lilly and Co. Дата публикации: 2020-04-30.

Complex of myelin lipids of central and peripheral nervous system of animals for treatment and prevention of neurodegenerative demyelinating disorders and methods for its application

Номер патента: RU2761617C2. Автор: Жаудат Гафурович Умеров,Эмма Жаудатовна Соболева,Надия Жаудатовна Умерова. Владелец: Надия Жаудатовна Умерова. Дата публикации: 2021-12-13.

Bispecific antibodies for use in treatment of hidradenitis suppurativa

Номер патента: EP4359436A1. Автор: Richard Stein,Jiri Kovarik,Yu Tang,Christian Loesche,Sabine Beck,Michael Kiffe,Margarida Rodrigues,Frank WALDRON-LYNCH. Владелец: NOVARTIS AG. Дата публикации: 2024-05-01.

Citrullinated antigen-specific chimeric antigen receptors for targeting regulatory t cells to treat hidradenitis suppurativa

Номер патента: WO2024064640A2. Автор: Joshua BEILKE,Leonard DRAGONE. Владелец: Sonoma Biotherapeutics, Inc.. Дата публикации: 2024-03-28.

Bispecific antibodies for use in treatment of hidradenitis suppurativa

Номер патента: CA3219360A1. Автор: Richard Stein,Jiri Kovarik,Yu Tang,Christian Loesche,Sabine Beck,Michael Kiffe,Margarida Rodrigues,Frank WALDRON-LYNCH. Владелец: NOVARTIS AG. Дата публикации: 2022-12-29.

Citrullinated antigen-specific chimeric antigen receptors for targeting regulatory t cells to treat hidradenitis suppurativa

Номер патента: WO2024064640A3. Автор: Joshua BEILKE,Leonard DRAGONE. Владелец: Sonoma Biotherapeutics, Inc.. Дата публикации: 2024-05-16.

Insect protein composition for the prevention and treatment of ostearthritis

Номер патента: US20240226184A1. Автор: Aman Paul,Nuria Martin Tome,Arpita CHAKRABORTY. Владелец: Protix BV. Дата публикации: 2024-07-11.

Insect protein composition for the prevention and treatment of conditions related to intestinal oxidative stress damage

Номер патента: US20240261339A1. Автор: Aman Paul,Nuria Martin Tome,Arpita CHAKRABORTY. Владелец: Protix BV. Дата публикации: 2024-08-08.

Papd5 and papd7 inhibitors for treating a hepatitis b infection

Номер патента: EP4219767A1. Автор: Song Yang,Xingchun Han,Hassan JAVANBAKHT,Henrik Mueller,Yongguang Wang. Владелец: F Hoffmann La Roche AG. Дата публикации: 2023-08-02.

Serine protease inhibitors for suppressing or preventing anaphylactic reaction

Номер патента: US20230099101A1. Автор: Amnah YAMANI,Simon P. Hogan. Владелец: University of Michigan. Дата публикации: 2023-03-30.

Compounds, compositions and methods for the treatment or prevention of hair loss

Номер патента: GB2595502A. Автор: Chopra Sunil. Владелец: Individual. Дата публикации: 2021-12-01.

Method for the treatment or prevention of osteoarthritis

Номер патента: AU2017249631B2. Автор: Tim Johannes Maria Welting,Marjolein Maria Johanna CARON. Владелец: UNIVERSITEIT MAASTRICHT. Дата публикации: 2024-08-22.

Drug for the treatment and/or prevention of endometriosis

Номер патента: RU2759836C2. Автор: Кристина МАДЖОНИ. Владелец: Джонас С.Р.Л.. Дата публикации: 2021-11-18.

Methods of using pigment epithelium derived factor (pedf) for the treatment and prevention of agent-induced gonadal or uterine toxicity

Номер патента: EP3125924A1. Автор: Dana Chuderland,Ruth Shalgi,Hadas BAR-JOSEPH,Keren GOLDBERG,Irit BEN-AHARON,Salomon M. STEMMER. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2017-02-08.

Methods of using pigment epithelium derived factor (pedf) for the treatment and prevention of agent-induced gonadal or uterine toxicity

Номер патента: US20170202916A1. Автор: Dana Chuderland,Ruth Shalgi,Hadas BAR-JOSEPH,Keren GOLDBERG,Irit BEN-AHARON,Salomon M. STEMMER. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2017-07-20.

A combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of autoimmune diseases

Номер патента: EP3990016A1. Автор: Reginald M. Gorczynski,Geoffrey William Hoffmann. Владелец: NETWORK IMMUNOLOGY Inc. Дата публикации: 2022-05-04.

The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections

Номер патента: WO2010035292A8. Автор: Roberto Burioni,Massimo Clementi. Владелец: NATIMAB THERAPEUTICS S.r.l.. Дата публикации: 2010-07-01.

Methods and compositions for the treatment or prevention of parkinson's disease

Номер патента: WO2016138392A1. Автор: Ole Isacson. Владелец: The McLean Hospital Corporation. Дата публикации: 2016-09-01.

Synthetic antimicrobial peptides and their applications for the treatment and prevention of musculoskeletal infections

Номер патента: WO2018133887A1. Автор: Vaclav Cerovsky,Ondřej Nešuta,Pavel MELICHERCIK. Владелец: Fakultni Nemocnice V Motole. Дата публикации: 2018-07-26.

Synthetic antimicrobial peptides and their applications for the treatment and prevention of musculoskeletal infections

Номер патента: EP3570868A1. Автор: Vaclav Cerovsky,Ondřej Nešuta,Pavel MELICHERCIK. Владелец: Fakultni Nemocnice V Motole. Дата публикации: 2019-11-27.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: US20230346825A1. Автор: István PUSKÁS,Abdula Kurkayev. Владелец: Cyclolab Cyclodextrin Research and Development Laboratory Ltd. Дата публикации: 2023-11-02.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: US20220096528A1. Автор: Lajos Szente,István PUSKÁS,Tamas SOHAJDA. Владелец: Cyclolab Cyclodextrin Research and Development Laboratory Ltd. Дата публикации: 2022-03-31.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: EP4221722A1. Автор: István PUSKÁS,Abdula Kurkayev. Владелец: Cyclolab Cyclodextrin Research and Development Laboratory Ltd. Дата публикации: 2023-08-09.

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Номер патента: WO2022070092A1. Автор: Lajos Szente,István PUSKÁS,Tamas SOHAJDA. Владелец: CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTD.. Дата публикации: 2022-04-07.

Combination for treatment and prevention of cancer

Номер патента: WO2024213745A1. Автор: Dipti THAKKAR,Piers INGRAM,Namita Gandhi,Lisa OOI,Jerome BOYD-KIRKUP,Kwek Kon YEW. Владелец: CLEGG, Richard Ian. Дата публикации: 2024-10-17.

Use of probiotics in the treatment and/or prevention of atopic dermatitis

Номер патента: RU2757453C2. Автор: ЛОПЕЗ Висент Мануэль НАВАРРО,БОСКА Ана Адела РАМИРЕЗ,ОРКУИН Хосе Мануэль ПЕРЕЗ,ВИДАЛ Даниэль РАМОН,МАРТИНЕЗ Сальвадор ЖЕНОВЕС,КУАДРОС Мария Эмпар ЧЕНОЛЛ,КОРТЕС Франциско Мануэль КОДОНЕР. Владелец: Коротт, С.Л.. Дата публикации: 2021-10-15.

Compositions and methods for the treatment or prevention of tuberculosis

Номер патента: US20190151429A1. Автор: Zhimin Guo,Thomas H. King,Ian M. Orme. Владелец: Globeimmune Inc. Дата публикации: 2019-05-23.

Pharmaceutical composition for treatment and/or prevention of malignant tumours

Номер патента: RU2746123C2. Автор: Такаюки ФУДЗИТА,Фумиёси ОКАНО. Владелец: Торэй Индастриз, Инк.. Дата публикации: 2021-04-07.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: AU2023249891A1. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: F Hoffmann La Roche AG. Дата публикации: 2024-08-08.

Compositions comprising secreted extracellular vesicles of cells expressing nfatc4 useful for the treatment of cancer

Номер патента: US20190117688A1. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2019-04-25.

Compositions comprising secreted extracellular vesicles of cells expressing nfatc4 useful for the treatment of cancer

Номер патента: EP3436056A1. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2019-02-06.

Compositions comprising secreted extracellular vesicles of cells expressing NFATC4 useful for the treatment of cancer

Номер патента: US11154598B2. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Université de Paris. Дата публикации: 2021-10-26.

Compositions comprising secreted extracellular vesicles of cells expressing nfatc4 useful for the treatment of cancer

Номер патента: WO2017167788A1. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2017-10-05.

Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Номер патента: AU2023249891A9. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Alexandre Antoine Bernard SOSTELLY,Simon Bertrand Marie BUATOIS,Antoine Paul Maxence SOUBRET. Владелец: F Hoffmann La Roche AG. Дата публикации: 2024-08-15.

Compounds for treatment or prevention of liver diseases

Номер патента: CA3103145C. Автор: YAN Yang,Pengfei Li,Min Zhang,Jie Gu,Xi CHENG,Dongfang Shi,Changjin FU,Weiwei Gong,Wenqing Jin. Владелец: Jiangsu Atom Bioscience and Pharmaceutical Co Ltd. Дата публикации: 2023-08-08.

Hox peptides as pbx modulators for the treatment of cancer

Номер патента: EP1909811B1. Автор: Richard George L. Dpt of Basic Med Science MORGAN,Jastinder Department of Basic Med. Science SOHAL. Владелец: St Georges Enterprises Ltd. Дата публикации: 2012-02-01.

Anti-cd40 antibodies for use in treatment of hidradenitis suppurativa

Номер патента: CA3125886A1. Автор: Pascal Espie,James Rush,Christian Loesche,Lukas Roth,Grazyna Wieczorek. Владелец: NOVARTIS AG. Дата публикации: 2020-07-16.

Composition and use thereof for the treatment of benign and malign diseases

Номер патента: WO2015000946A1. Автор: Rupert Temper. Владелец: Cellquantum Ag. Дата публикации: 2015-01-08.

1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto

Номер патента: EP3292114A1. Автор: Yifeng Xiong,Juerg Lehmann,Graeme Semple,Albert S. Ren,Andrew J. Grottick,Henry Korman,Didier Jc Bagnol. Владелец: Arena Pharmaceuticals Inc. Дата публикации: 2018-03-14.

1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto

Номер патента: US20160318911A1. Автор: Yifeng Xiong,Juerg Lehmann,Graeme Semple,Albert S. Ren,Andrew J. Grottick,Henry Korman. Владелец: Arena Pharmaceuticals Inc. Дата публикации: 2016-11-03.

1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto

Номер патента: PH12017501961A1. Автор: Yifeng Xiong,Juerg Lehmann,Graeme Semple,Albert S Ren,Henry Korman,Andrew J Grottick,Didier Jc Bagnol. Владелец: Arena Pharm Inc. Дата публикации: 2018-03-26.

Compositions and methods for the treatment or prevention of oxalate-related disorders

Номер патента: EP3468572A1. Автор: Anna Sjögren,Elisabeth LINDNER,Maria Akerman,Orla MCCALLION. Владелец: OXTHERA INTELLECTUAL PROPERTY AB. Дата публикации: 2019-04-17.

Compositions and methods for the treatment or prevention of oxalate-related disorders

Номер патента: US20190125807A1. Автор: Anna Sjögren,Elisabeth LINDNER,Maria Akerman,Orla MCCALLION. Владелец: OXTHERA INTELLECTUAL PROPERTY AB. Дата публикации: 2019-05-02.

Treatment and prevention of cancer using her3 antigen-binding molecules

Номер патента: WO2024208881A1. Автор: Dipti THAKKAR,Piers INGRAM,Konrad PASZKIEWICZ,Namita Gandhi,Jerome BOYD-KIRKUP,Weiyi TOY,Khang LUU,Kevin Fongching CHAU. Владелец: CLEGG, Richard Ian. Дата публикации: 2024-10-10.

Compound for treatment or prevention of liver diseases

Номер патента: NZ771735A. Автор: YAN Yang,Pengfei Li,Min Zhang,Jie Gu,Xi CHENG,Dongfang Shi,Changjin FU,Weiwei Gong,Wenqing Jin. Владелец: Jiangsu Atom Bioscience and Pharmaceutical Co Ltd. Дата публикации: 2024-07-26.

Methods for treatment or prevention of asthma by administering il-4r antagonist

Номер патента: RU2690675C2. Автор: Аллен РЕЙДИН,Нейл ГРЭХЕМ,Мариус АРДЕЛЕАНУ,Стефан К. КИРКЕССЕЛИ,Судип Кунду,Джеффри МИНГ,Росс Э. РОКЛИН,Намита ГАНДХИ,Стивен ВАЙНШТЕЙН,ХЭМИЛТОН Дженнифер ДЭВИДСОН. Владелец: Ридженерон Фармасьютикалз Инк.. Дата публикации: 2019-06-05.

Treatment of hidradenitis suppurativa

Номер патента: US20240025989A1. Автор: Evangelos J. Giamarellos-Bourboulis,Stanley A. Kim. Владелец: Janssen Biotech Inc. Дата публикации: 2024-01-25.

Treatment of hidradenitis suppurativa

Номер патента: US20230235042A1. Автор: John Simard,Bruce Randazzo,Yanli Zhuang,Bhaskar Srivastava,Karen Keefe,Swaroopa Paratkar,Emesto MUNOZ. Владелец: Janssen Biotech Inc. Дата публикации: 2023-07-27.

Treatment and prevention of cancer using her3 antigen-binding molecules

Номер патента: WO2023017151A9. Автор: Jerome Douglas BOYD-KIRKUP,Dipti THAKKAR,Piers INGRAM,Konrad PASZKIEWICZ,Shreya KAR. Владелец: CLEGG, Richard Ian. Дата публикации: 2024-06-06.

Maqui berry extracts for use in the treatment or prevention of bone disorders

Номер патента: EP3930739A1. Автор: Keiko Suzuki,Bernd BONNLÄNDER,Stefanie LANG. Владелец: Anklam Extrakt Gmbh. Дата публикации: 2022-01-05.

Maqui berry extracts for use in the treatment or prevention of bone disorders

Номер патента: US20220143117A1. Автор: Keiko Suzuki,Bernd BONNLÄNDER,Stefanie LANG. Владелец: Anklam Extrakt Gmbh. Дата публикации: 2022-05-12.

Maqui berry extracts for use in the treatment or prevention of bone disorders

Номер патента: WO2020173968A1. Автор: Keiko Suzuki,Bernd BONNLÄNDER,Stefanie LANG. Владелец: Anklam Extrakt Gmbh. Дата публикации: 2020-09-03.

Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals

Номер патента: US20060121094A1. Автор: Mark Geach. Владелец: Individual. Дата публикации: 2006-06-08.

Compounds and methods for the treatment of ocular disorders

Номер патента: EP4232458A1. Автор: Yair Alster,Robert M. Burk,Hila Barash,Charles Bosworth,Omer Rafaeli,Mark Richard Stewart,Ian Holmes,Marc GLEESON,Soultana KATSINA. Владелец: Azura Ophthalmics Ltd. Дата публикации: 2023-08-30.

Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes

Номер патента: AU2024216458A1. Автор: Maria DEL CARMEN LIDON,Consuelo GARCIA,Raquel Delgado,Núria ALMIÑANA,Albert Soley,Catalina RODRÍGUEZ,Gemma MOLA,Mauricio VALERIO. Владелец: Lubrizol Advanced Materials Inc. Дата публикации: 2024-09-19.

Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin

Номер патента: WO2012051518A3. Автор: Gary Lee,Eric Richard Sjoberg. Владелец: AMICUS THERAPEUTICS, INC.. Дата публикации: 2012-06-21.

Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin

Номер патента: US20130252906A1. Автор: Gary Lee,Eric Richard Sjoberg. Владелец: Amicus Therapeutics Inc. Дата публикации: 2013-09-26.

Synthetic apelin mimetics for the treatment of heart failure

Номер патента: US09982017B2. Автор: Frédéric ZECRI,Qi-Ying Hu,Hidetomo Imase,Andrei Golosov,Philipp Grosche,Hongjuan Zhao. Владелец: NOVARTIS AG. Дата публикации: 2018-05-29.

Use of a promoter of t-cell expansion and an inducer of cd40 stimulation in the treatment or prevention of a pathologic state

Номер патента: US20070231299A1. Автор: Susan Wilson,William Murphy,Bruce Blazar,Robert Wiltrout. Владелец: Novartis Vaccines and Diagnostics Inc. Дата публикации: 2007-10-04.

Compounds and methods for the treatment of dermal and ocular disorders

Номер патента: WO2024134266A1. Автор: Sophie Caroline Williams,Yair Alster,Robert M. Burk,Charles Bosworth,Omer Rafaeli,Mark Richard Stewart,Ian Holmes,Marc GLEESON,Jonathan DUNN,Alexander James Nicholls. Владелец: Azura Ophthalmics Ltd.. Дата публикации: 2024-06-27.

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

Номер патента: US7368106B2. Автор: Susan Wilson,William J. Murphy,Bruce Blazar,Robert Wiltrout. Владелец: University of Minnesota. Дата публикации: 2008-05-06.

Composition for the prevention or treatment of obesity or lipid related metabolic deseases

Номер патента: WO2011118953A2. Автор: Soon-Hoe Kim,Seul-Ki Lee,Sang-jin Lee,Tae-Ho Lee,Mi-Won Son,Sang-Zin Choi,Yong-Sung Sohn,Nam-Joon Baek,Jin-Seok Jeong. Владелец: Dong-A Pharm.Co., Ltd.. Дата публикации: 2011-09-29.

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

Номер патента: US20030068299A1. Автор: Susan Wilson,William Murphy,Bruce Blazar,Robert Wiltrout. Владелец: Individual. Дата публикации: 2003-04-10.

Composition for the prevention or treatment of obesity or lipid related metabolic deseases

Номер патента: WO2011118953A3. Автор: Soon-Hoe Kim,Seul-Ki Lee,Sang-jin Lee,Tae-Ho Lee,Mi-Won Son,Sang-Zin Choi,Yong-Sung Sohn,Nam-Joon Baek,Jin-Seok Jeong. Владелец: Dong-A Pharm.Co., Ltd.. Дата публикации: 2012-01-12.

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

Номер патента: US09913903B2. Автор: David A. Ross,Thomas Barnett. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2018-03-13.

Monoclonal human antibody against alpha-toxine from s. aureus and its application in treatment or prevention of abscess formation

Номер патента: RU2529946C2. Автор: Майкл РУДОЛЬФ,Хольгер КОХ. Владелец: Аридис Фармасьютикале, ИНК. Дата публикации: 2014-10-10.

Monoclonal human antibody against alpha-toxine from s. aureus and its application in treatment or prevention of abscess formation

Номер патента: RU2529946C9. Автор: Майкл РУДОЛЬФ,Хольгер КОХ. Владелец: Аридис Фармасьютикалс, ИНК. Дата публикации: 2015-03-27.

Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection

Номер патента: WO2024126293A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-06-20.

Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection

Номер патента: WO2024126294A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-06-20.

Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions

Номер патента: WO2016097213A1. Автор: Augusto Silva Gonzalez,José Alberto García Sanz. Владелец: Althia Health, S.L. Дата публикации: 2016-06-23.

Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions

Номер патента: US20180011095A1. Автор: Augusto Silva Gonzalez,José Alberto García Sanz. Владелец: Althia Health SL. Дата публикации: 2018-01-11.

Composition for treatment and / or prevention of diseases of oral cavity, method for its preparation and use

Номер патента: RU2747983C1. Автор: Светлана Константиновна Матело,Александр Владимирович Гроссер,Татьяна Владимировна Купец. Владелец: Светлана Константиновна Матело. Дата публикации: 2021-05-18.

A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease

Номер патента: EP4445913A2. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Jun-ichi NISHIMURA,Erica WINTER,Joy C. HSU. Владелец: Osaka University NUC. Дата публикации: 2024-10-16.

A pharmaceutical composition for use in the treatment or prevention of a C5-related disease and a method for treating or preventing a C5-related disease

Номер патента: AU2024216280A1. Автор: Kenta HARAYA,Zenjiro Sampei,Koichiro Yoneyama,Norihito Shibahara,Yoshinori Tsuboi,Kenji SHINOMIYA,Taku FUKUZAWA,Katrijn BOGMAN,Jean Eric CHAROIN. Владелец: F Hoffmann La Roche AG. Дата публикации: 2024-09-12.

Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury

Номер патента: EP4392056A2. Автор: Carol FEGHALI-BOSTWICK. Владелец: Medical University of South Carolina Foundation. Дата публикации: 2024-07-03.

A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease

Номер патента: EP4223774A3. Автор: Kenta HARAYA,Zenjiro Sampei,Koichiro Yoneyama,Norihito Shibahara,Yoshinori Tsuboi,Kenji SHINOMIYA,Taku FUKUZAWA,Katrijn BOGMAN,Jean Eric CHAROIN. Владелец: F Hoffmann La Roche AG. Дата публикации: 2023-09-27.

A pharmaceutical composition for use in the treatment or prevention of a C5-related disease and a method for treating or preventing a C5-related disease

Номер патента: AU2024205486A1. Автор: Kenji SHINOMIYA,Keisuke GOTANDA,Jun-ichi NISHIMURA,Erica WINTER,Joy C. HSU. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2024-08-22.

Pharmaceutical composition for treatment and/or prevention of malignant tumors

Номер патента: RU2755894C2. Автор: Такаюки ФУДЗИТА,Фумиёси ОКАНО. Владелец: Торэй Индастриз, Инк.. Дата публикации: 2021-09-22.

Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (als)

Номер патента: EP4132538A1. Автор: Luc Dupuis,Immaculada Sanjuan Ruiz,Gina PICCHIARELLI. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2023-02-15.

Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (ALS)

Номер патента: AU2021253184A1. Автор: Luc Dupuis,Immaculada Sanjuan Ruiz,Gina PICCHIARELLI. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2022-10-27.

Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (als)

Номер патента: US20240024513A1. Автор: Luc Dupuis,Immaculada Sanjuan Ruiz,Gina PICCHIARELLI. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-01-25.

Treatment and prevention of cancer using her3 antigen-binding molecules

Номер патента: EP4396238A1. Автор: Dipti THAKKAR,Piers INGRAM,Jennifer L Craigen,Siyu GUAN,Gavin Halbert,Jerome BOYD-KIRKUP,Nigel Westwood,Harriet WALTERS. Владелец: Hummingbird Bioscience Holdings Ltd. Дата публикации: 2024-07-10.

Treatment and prevention of cancer using vista antigen-binding molecules

Номер патента: EP4401772A1. Автор: Dipti THAKKAR,Piers INGRAM,Konrad PASZKIEWICZ,Siyu GUAN,Eric Rowinsky,Bhushan DHARMADHIKARI,Jerome BOYD-KIRKUP. Владелец: Hummingbird Bioscience Holdings Ltd. Дата публикации: 2024-07-24.

Compositions and methods for the inhibition of nerve growth factor and the treatment/prevention of atrial fibrillation

Номер патента: US20240271142A1. Автор: Rishi Arora. Владелец: Northwestern University. Дата публикации: 2024-08-15.

Porous carbon particles for use in the treatment or prevention of liver disease

Номер патента: US09844568B2. Автор: Rajiv Jalan,Carol Angela Howell,Sergey Victorovich Mikhalovsky,Susan Rachel Sandeman,Jane MACNAUGHTAN. Владелец: University of Brighton. Дата публикации: 2017-12-19.

Probiotic strains for treatment and/or prevention of diarrhea

Номер патента: RU2642320C2. Автор: ХУУ Мари ХУОНГ,Жан ФИОРАМОНТИ,Мария УРДАЧИ. Владелец: Эколь Насьональ Сюперьёр Де Сьянс Агрономик Де Бордо Акитэн (Бордо Сьянс Агро). Дата публикации: 2018-01-24.

Isolation of pluri potent stem cells from amniotic fluid and use thereof in the treatment or prevention of autoimmune diseases

Номер патента: WO2012014247A1. Автор: Paolo Puccetti,Francesca Fallarino,Rita Romani,Irene Pirisinu,Gabriella Rosi,Emilio Donti. Владелец: Universita' Degli Studi Dl Perugia. Дата публикации: 2012-02-02.

Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analogues

Номер патента: ZA201908355B. Автор: Ulrik Mouritzen,Kim SONNE,Peter Glerup,Palle Bekker Jeppesen. Владелец: Zealand Pharma As. Дата публикации: 2024-06-26.

Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences

Номер патента: EP1478387A1. Автор: Klas Norrby. Владелец: Individual. Дата публикации: 2004-11-24.

Dosage regimes for the administration of glucagon-like-peptide-2 (GLP-2) analogues

Номер патента: AU2024202486B2. Автор: Ulrik Mouritzen,Kim SONNE,Peter Glerup,Palle Bekker Jeppesen. Владелец: Zealand Pharma As. Дата публикации: 2024-07-18.

Isolation of pluri potent stem cells from amniotic fluid and use thereof in the treatment or prevention of autoimmune diseases

Номер патента: EP2598632A1. Автор: Paolo Puccetti,Francesca Fallarino,Rita Romani,Irene Pirisinu,Gabriella Rosi,Emilio Donti,Giovanni BISTONI. Владелец: Universita degli Studi di Perugia. Дата публикации: 2013-06-05.

Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analogues

Номер патента: EP4424362A2. Автор: Ulrik Mouritzen,Kim SONNE,Peter Glerup,Palle Bekker Jeppesen. Владелец: Zealand Pharma As. Дата публикации: 2024-09-04.

Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: WO2011101881A2. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore Di Sanita'. Дата публикации: 2011-08-25.

Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: EP2536424A2. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore di Sanita ISS. Дата публикации: 2012-12-26.

Use of rho gtpase activating toxins for the treatment and/or prevention symptomatology associated with rett syndrome

Номер патента: WO2011101881A3. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore Di Sanita'. Дата публикации: 2011-10-27.

Treatment or prevention of a disease or disorder

Номер патента: AU2021382120A9. Автор: René HOLM,Steven M. VESOLE,Guenter Karl Wilhelm KRAUS. Владелец: Janssen Sciences Ireland ULC. Дата публикации: 2024-09-26.

Method for the treatment and/or prevention of damaged keratin

Номер патента: ZA202006807B. Автор: SIVLER Petter,RAVICHANDRAN Ranjithkumar. Владелец: Petter Sivlér. Дата публикации: 2024-02-28.

Application of peptide ggf2 in treatment or prevention of heart failure in mammals

Номер патента: RU2536938C2. Автор: Энтони КАДЖАНО,Аниндита ГАНГУЛИ,Дженнифер АЙАСИ,Том ПЭРРИ. Владелец: Акорда Терапьютикс, Инк.. Дата публикации: 2014-12-27.

Insect protein composition for the prevention and treatment of conditions related to intestinal oxidative stress damage

Номер патента: CA3219293A1. Автор: Aman Paul,Nuria Martin Tome,Arpita CHAKRABORTY. Владелец: Protix BV. Дата публикации: 2022-12-01.

Insect protein composition for the prevention and treatment of ostearthritis

Номер патента: EP4346856A1. Автор: Aman Paul,Nuria Martin Tome,Arpita CHAKRABORTY. Владелец: Protix BV. Дата публикации: 2024-04-10.

Insect protein composition for the prevention and treatment of conditions related to intestinal oxidative stress damage

Номер патента: EP4347016A1. Автор: Aman Paul,Nuria Martin Tome,Arpita CHAKRABORTY. Владелец: Protix BV. Дата публикации: 2024-04-10.

Insect protein composition for the prevention and treatment of ostearthritis

Номер патента: CA3219340A1. Автор: Aman Paul,Nuria Martin Tome,Arpita CHAKRABORTY. Владелец: Individual. Дата публикации: 2022-12-01.

Means and methods for the treatment of cataract and presbyopia

Номер патента: WO2009044294A3. Автор: Karl-Heinz Krause,Lena Serrander. Владелец: Lena Serrander. Дата публикации: 2009-05-22.

Compositions comprising methyl cyclodextrins for the treatment and/or prevention of hepatic steatosis

Номер патента: AU2021374726A9. Автор: Daniel Wils,Caroline PERREAU. Владелец: Roquette Freres SA. Дата публикации: 2024-09-26.

Nucleocapsid-specific antibodies and methods for the treatment and prevention of sars-cov-2 infection therewith

Номер патента: US20240218056A1. Автор: VIII Pablo Penaloza-MacMaster. Владелец: Northwestern University. Дата публикации: 2024-07-04.

Composition and method for the treatment and prevention of enteric bacterial infections

Номер патента: US20140112938A1. Автор: Gottfried Lichti,Grant Thomas Rawlin,Roy Michael Robins-Browne. Владелец: Immuron Ltd. Дата публикации: 2014-04-24.

Probiotic for the treatment of infertility and recurrent pregnancy loss

Номер патента: CA3179833A1. Автор: Rebeca Arroyo Rodriguez,Leonides Fernandez Alvarez,Juan Miguel Rodriguez Gomez,Irma CASTRO NAVARRO,Claudio ALBA RUBIO. Владелец: Individual. Дата публикации: 2021-12-16.

Probiotic for the treatment of infertility and recurrent pregnancy loss

Номер патента: EP4166151A1. Автор: Rebeca Arroyo Rodriguez,Leonides Fernandez Alvarez,Juan Miguel Rodriguez Gomez,Irma CASTRO NAVARRO,Claudio ALBA RUBIO. Владелец: Biosearch SA. Дата публикации: 2023-04-19.

Compounds and methods for treating or preventing disease conditions associated with alpha-1-antirypsin

Номер патента: US20150265671A1. Автор: Gary Lee,Eric Richard Sjoberg. Владелец: Amicus Therapeutics Inc. Дата публикации: 2015-09-24.

Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin

Номер патента: US9867862B2. Автор: Gary Lee,Eric Richard Sjoberg. Владелец: Amicus Therapeutics Inc. Дата публикации: 2018-01-16.

Methods of treating or preventing spinal muscular atrophy

Номер патента: US20240318182A1. Автор: Lilly East,Kenneth Swope Loveday,Fengju Judy Bai,Wildon R. Farwell. Владелец: Biogen MA Inc. Дата публикации: 2024-09-26.

Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin

Номер патента: US09867862B2. Автор: Gary Lee,Eric Richard Sjoberg. Владелец: Amicus Therapeutics Inc. Дата публикации: 2018-01-16.

Tau protein stimulating agent and a therapeutic or preventive agent and a therapeutic or preventive food composition for treating diseases caused by deficiency of tau protein

Номер патента: RU2742658C2. Автор: Йоити ИСИИ,Такаюки НЕМОТО,Такеси ОКАМОТО. Владелец: Велл Стоун Ко.. Дата публикации: 2021-02-09.

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

Номер патента: WO2014100857A9. Автор: Graham Vesey,Ross Arthur DAVEY,Christopher John WEIR. Владелец: Northern Sydney Local Health District. Дата публикации: 2015-07-09.

Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery

Номер патента: EP3658159A1. Автор: Sjoerd Arie Pieter VAN BERKEL. Владелец: Ams Advanced Medical Supplements BV. Дата публикации: 2020-06-03.

Arthrospira for use in the treatment of diseases

Номер патента: EP4199941A1. Автор: Friedrich Jung,Jan-Heiner Küpper. Владелец: BRANDENBURGISCHE TECHNISCHE UNIVERSITAET COTTBUS. Дата публикации: 2023-06-28.

Discovery and use of immunogenic peptides for the treatment and prevention of cancers

Номер патента: WO2022066828A1. Автор: Preethi Gunaratne,Brandon Mistretta,Sakuni Rankothgedera,Micah Castillo,Isabelle Bedrosian. Владелец: UNIVERSITY OF HOUSTON SYSTEM. Дата публикации: 2022-03-31.

Compositions for the treatment of ebv associated diseases or conditions

Номер патента: AU2022228701A1. Автор: Christoph Hess,Bojana MÜLLER-DUROVIC,Glenn BANTUG. Владелец: UNIVERSITAET BASEL. Дата публикации: 2023-09-14.

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING

Номер патента: US20240317847A1. Автор: Jörg Müller,Ernst Weber,Stephan MÄRSCH,Jenny FITTING,Mathias Gehrmann,Jan Tebbe,Mark Trautwein,Christian Votsmeier,Katharina FILARSKY,Philipp Ellinger,Frank Sacher,Ralf Lesche,Maik Stefan Wilhelm OBENDORF,Patrick Michael SMITH,Marcus Karlstetter. Владелец: Bayer AG. Дата публикации: 2024-09-26.

Polypeptide epitopes of s. aureus and respective monoclonal antibodies for the treatment of infections and immune-diagnosis

Номер патента: EP4361262A3. Автор: Alexander Klimka,Oleg Krut,Martin Krönke. Владелец: Individual. Дата публикации: 2024-08-14.

Method of preventing gastrointestinal diseases in animals or people, method of treating gastrointestinal diseases in animals or people and medication for treatment or prevention of gastrointestinal diseases in animals or people

Номер патента: RU2412241C2. Автор: Бенедикт САС,ХЕМЕЛЬ Йохан ВАН,Ян ВАНДЕНКЕРКХОВЕ,Эрик ПЕЙС,Хай Менг ТАНЬ,Чеа-юн СЕ,Чанийилпарампу РАМЧАНД,Джерри ВАРГИЗ. Владелец: Кемин Индастриз, Инк.. Дата публикации: 2011-02-20.

Sipa-1 gene and sipa-1 inhibitor for the treatment, prevention, and diagnosis of cancer

Номер патента: WO2006084027A3. Автор: Kent Hunter,Douglas R Lowy,Xiaolan Qian. Владелец: Xiaolan Qian. Дата публикации: 2007-08-02.

Variants of the human atm protein for the treatment of diseases related to at least one mutation of the atm gene

Номер патента: WO2023152668A1. Автор: Mauro Magnani,Michele MENOTTA,Anastasia RICCI,Federica BIANCUCCI. Владелец: Università Degli Studi Di Urbino Carlo Bo. Дата публикации: 2023-08-17.

Variants of the human atm protein for the treatment of diseases related to at least one mutation of the atm gene

Номер патента: AU2023217975A1. Автор: Mauro Magnani,Michele MENOTTA,Anastasia RICCI,Federica BIANCUCCI. Владелец: Quince Therapeutics SpA. Дата публикации: 2024-09-12.

Rifabutin analogs for the treatment of disease

Номер патента: WO2023198597A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2023-10-19.

Rifabutin analogs for the treatment of disease

Номер патента: AU2022422187A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2024-05-30.

Rifabutin analogs for the treatment of disease

Номер патента: CA3238540A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2023-06-29.

Rifabutin analogs for the treatment of disease

Номер патента: WO2023118319A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2023-06-29.

Rifabutin analogs for the treatment of bacterial diseases

Номер патента: WO2024165591A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Nawaz Khan,Kevin ANTRAYGUES,Mathieu MAINGOT,Alessia MICHELOTTI,Aurore DRENEAU,Line HOFMANN,Marija MILJKOVIC. Владелец: BioVersys AG. Дата публикации: 2024-08-15.

Rifabutin analogs for the treatment of disease

Номер патента: AU2023251806A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2024-09-12.

Rifamycin derivatives for the treatment of diseases

Номер патента: CA3241296A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Bruna GIOIA,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2023-08-03.

Rifamycin derivatives for the treatment of diseases

Номер патента: WO2023144297A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Bruna GIOIA,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2023-08-03.

Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases

Номер патента: EP2632933A1. Автор: Paul Kosma,Ulrich Jordis,Laszlo Czollner,Dirk Classen-Houben,Bernhard Kueenburg. Владелец: Onepharm Research and Development GmbH. Дата публикации: 2013-09-04.

Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

Номер патента: US20220372028A1. Автор: Caroline Springer,Richard Marais,Dan Niculescu-Duvaz,Haoran TANG,Leo Leung,Deborah SMITHEN,Cedric CALLENS. Владелец: Institute of Cancer Research. Дата публикации: 2022-11-24.

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

Номер патента: EP3416956A1. Автор: Caroline Springer,Richard Marais,Dan Niculescu-Duvaz,Haoran TANG,Leo Leung,Deborah SMITHEN,Cedric CALLENS. Владелец: Institute of Cancer Research. Дата публикации: 2018-12-26.

Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

Номер патента: US20210040078A1. Автор: Caroline Springer,Richard Marais,Dan Niculescu-Duvaz,Haoran TANG,Leo Leung,Deborah SMITHEN,Cedric CALLENS. Владелец: Institute of Cancer Research. Дата публикации: 2021-02-11.

Isoquinoline derivatives and their use for the treatment of parasitic infections

Номер патента: EP4003524A1. Автор: Nils Griebenow,Hans-Georg Schwarz,Bernd Alig,Walter Hübsch,Wei Zhuang,Iring Heisler,Kirsten Borngen,Daniel Kulke,Claudia Bohm,Isa Jana Irina Janssen. Владелец: Bayer Animal Health GmbH. Дата публикации: 2022-06-01.

Rifamycin derivatives for the treatment of diseases

Номер патента: AU2023211105A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Bruna GIOIA,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2024-06-13.

Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases

Номер патента: WO2012020021A1. Автор: Paul Kosma,Ulrich Jordis,Laszlo Czollner,Dirk Classen-Houben,Bernhard Kueenburg. Владелец: ONEPHARM RESEARCH & DEVELOPMENT GMBH. Дата публикации: 2012-02-16.

Rifabutin analogs for the treatment of disease

Номер патента: WO2024068926A1. Автор: SERGIO Lociuro,Olivier Defert,Nicolas Willand,Marilyne Bourotte,Glenn E. Dale,Marc Gitzinger,Vincent Trebosc,Kevin ANTRAYGUES,Mathieu MAINGOT. Владелец: BioVersys AG. Дата публикации: 2024-04-04.

Method for the prognosis and/or treatment of acute promyelocytic leukemia

Номер патента: CA3024361A1. Автор: Lucia Altucci,Joost Hendrik Adriaan Martens,Antonello Mai. Владелец: Epi-C Srl. Дата публикации: 2017-11-23.

Implantable devices that generate low intensity electric fields for the treatment of atherosclerotic disease and prevention of ischemic vascular events and methods of manufacture

Номер патента: US9492652B2. Автор: Arthur Jay Moss,Ilan Goldenberg. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2016-11-15.

4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-3,6-dihydropyridine-1-(2h)-carboxamide derivatives as limk and/or rock kinases inhibitors for use in the treatment of cancer

Номер патента: EP4157844B1. Автор: Sylvain Routier,Christian Andres,Pascal Bonnet,Helene Benedetti,Samia ACI-SECHE,Béatrice VALLÉE-MÉHEUST,Karen PLÉ,Sandrine RUCHAUD,Abdennour BRAKA,Anthony CHAMPIRÉ,Patrick VOURC'H. Владелец: Universite de Tours. Дата публикации: 2024-07-10.

Implantable Devices That Generate Low Intensity Electric Fields For The Treatment of Atherosclerotic Disease And Prevention of Ischemic Vascular Events and Methods of Manufacture

Номер патента: US20130190848A1. Автор: Moss Arthur Jay,Goldenberg Ilan. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2013-07-25.

Methods for the treatment of ventricular dysrhythmia and prevention of venticular fibrillation

Номер патента: ZA847547B. Автор: William Eugene Hageman,Michael John Zelesko. Владелец: McNeilab Inc. Дата публикации: 1986-05-28.

Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION

Номер патента: CY1109537T1. Автор: Rainer Henning,Peter Petzelbauer,Sonja Reingruber. Владелец: Fibrex Medical Research & Development Gmbh. Дата публикации: 2014-08-13.

NOTCH INHIBITORS FOR USE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Номер патента: US20210363121A1. Автор: Botta Bruno,Screpanti Isabella,Tottone Luca,Zhdanoskaya Nadezda,Ingallina Cinzia,Giulimondi Francesca,Quaglio Deborah,Palermo Rocco,Mori Mattia,Ghirga Francesca. Владелец: . Дата публикации: 2021-11-25.

NOTCH INHIBITORS FOR USE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Номер патента: US20190337916A1. Автор: Botta Bruno,Screpanti Isabella,Tottone Luca,Zhdanoskaya Nadezda,Ingallina Cinzia,Giulimondi Francesca,Quaglio Deborah,Palermo Rocco,Mori Mattia,Ghirga Francesca. Владелец: . Дата публикации: 2019-11-07.

Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer

Номер патента: WO2016001789A1. Автор: HONG Shen,Ping Chen,John Charles Kath,Mason Alan Pairish,Hengmiao Cheng,Mehran Jalaie,Suvi Tuula Marjukka Orr. Владелец: PFIZER INC.. Дата публикации: 2016-01-07.

Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders

Номер патента: EP1455787B1. Автор: Michael Robert Wiley,Christopher William Murray,Daniel Jon Sall,Jolie Anne Bastian,Stephen Clinton Young. Владелец: Eli Lilly and Co. Дата публикации: 2005-06-22.

4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-3,6-dihydropyridine-1-(2h)-carboxamide derivatives as limk and/or rock kinases inhibitors for use in the treatment of cancer

Номер патента: EP3915990A1. Автор: Sylvain Routier,Pascal Bonnet,Helene Benedetti,Samia ACI-SECHE,Béatrice VALLÉE-MÉHEUST,Karen PLÉ,Sandrine RUCHAUD,Abdennour BRAKA,Anthony CHAMPIRÉ. Владелец: Universite dOrleans. Дата публикации: 2021-12-01.

Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders

Номер патента: AU2002366563A1. Автор: Michael Robert Wiley,Christopher William Murray,Daniel Jon Sall,Jolie Anne Bastian,Stephen Clinton Young. Владелец: Eli Lilly and Co. Дата публикации: 2003-06-23.

Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombosis

Номер патента: DE60204800D1. Автор: Robert Wiley,William Murray,Clinton Young,Jon Sall,Anne Bastian. Владелец: Eli Lilly and Co. Дата публикации: 2005-07-28.

Quinazoline-derived HCK inhibitors for use in the treatment of MYD88 mutated diseases

Номер патента: AU2021284369A1. Автор: Li Tan,Nathanael S. Gray,Guang Yang,Sara Jean Buhrlage,Steven P. TREON,Jinhua Wang,Zachary R. HUNTER. Владелец: Dana Farber Cancer Institute Inc. Дата публикации: 2023-01-19.

Heterocyclic egfr inhibitors for use in the treatment of cancer

Номер патента: WO2022271613A1. Автор: Natasja Brooijmans,Joseph L. Kim,John Emmerson Campbell,Kevin J. Wilson,Emanuele Perola,Meredith Suzanne Eno,Douglas Wilson,Brett D. WILLIAMS,Christopher De Savi,Thomas A. DINEEN,Aysegul OZEN. Владелец: BLUEPRINT MEDICINES CORPORATION. Дата публикации: 2022-12-29.

Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: US20100056550A1. Автор: Jason M. Cox,Hong Dong. Владелец: Individual. Дата публикации: 2010-03-04.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis

Номер патента: US12016790B2. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: Bone Health Technologies Inc. Дата публикации: 2024-06-25.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: US20220087844A1. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: TheraNova LLC. Дата публикации: 2022-03-24.

Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: US20190133801A1. Автор: Daniel R. BURNETT,Jose Gutierrez,Shane Mangrum,Evan S. Luxon,Marcie HAMILTON,Alex YEE,Timothy TIGNER. Владелец: TheraNova LLC. Дата публикации: 2019-05-09.

Apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis

Номер патента: WO2024191855A2. Автор: Derek Hillstrom,Jeanette Numbers,Michael Jaasma,Chandlyr Jackson,Nari SHIN,Veda VULIGONDA,Laura YECIES,Catherine Jameson,Scott NOH,Sydney LANG,Hannah KMETZ,Abby MCMONIGAL. Владелец: Bone Health Technologies, Inc.. Дата публикации: 2024-09-19.

Heteroaryl-substituted pyrrole derivatives and pharmaceuticals thereof, and their use for the treatment or prophylaxis of diseases which can be treated or prevented by inhibiting the production of inflammatory cytokines in a mammal

Номер патента: NZ505924A. Автор: Tomio Kimura,Kazumasa Aoki,Akira Nakao,Shigeru Ushiyama,Takaichi Shimozato,Nobuyuki Ohkawa. Владелец: Sankyo Co. Дата публикации: 2001-11-30.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: WO2010015421A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin. Дата публикации: 2010-02-11.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: EP2367848A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2011-09-28.

Compounds and methods for the treatment of dermal and ocular disorders

Номер патента: WO2023067387A3. Автор: Yair Alster,Robert M. Burk,Hila Barash,Charles Bosworth,Omer Rafaeli,Mark Richard Stewart,Ian Holmes,Marc GLEESON,Jonathan DUNN,Elisa PILEGGI,Alexander James Nicholls,Soultana KATSINA. Владелец: Azura Ophthalmics Ltd.. Дата публикации: 2023-06-29.

Compounds and methods for the treatment of dermal and ocular disorders

Номер патента: EP4419502A2. Автор: Yair Alster,Robert M. Burk,Hila Barash,Charles Bosworth,Omer Rafaeli,Mark Richard Stewart,Ian Holmes,Marc GLEESON,Jonathan DUNN,Elisa PILEGGI,Alexander James Nicholls,Soultana KATSINA. Владелец: Azura Ophthalmics Ltd. Дата публикации: 2024-08-28.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: US20110224135A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Univesitat zu Lubeck. Дата публикации: 2011-09-15.

Methods of treating of hidradenitis suppurativa

Номер патента: WO2023196916A1. Автор: Shao-Lee LIN,Paul PELOSO. Владелец: Acelyrin, Inc.. Дата публикации: 2023-10-12.

Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion

Номер патента: US20130244933A1. Автор: Stefan Becker,Heinrich Terlau,Rocio Finol-Urdaneta,Walter Raasch. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2013-09-19.

N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system

Номер патента: US09920053B2. Автор: Susanna Cremonesi,Fabrizio Micheli,Teresa SEMERARO,Luca Tarsi,Colin Leslie,Tim LUKER. Владелец: Chronos Therapeutics Ltd. Дата публикации: 2018-03-20.

Heteroalicyclic derivatives and their use in the treatment of cns disorders

Номер патента: AU2023207848A1. Автор: VENKATESWARLU Jasti,Ramkumar Subramanian,Ramakrishna Nirogi,Anil Karbhari Shinde,Pradeep Jayarajan,Abdul Rasheed Mohammed,Vijay Sidram Benade,Vinod Kumar GOYAL,Santosh Kumar Pandey,Narsimha BOGARAJU. Владелец: SUVEN LIFE SCIENCES LTD. Дата публикации: 2024-07-04.

Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatitis delta virus infection

Номер патента: WO2024213635A1. Автор: Antoine Alam,Xavier MARNIQUET,Pascal Bernard JALAGUIER,Kara Lynn CARTER. Владелец: EVOTEC INTERNATIONAL GMBH. Дата публикации: 2024-10-17.

Benzothieno[2,3-d]pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases

Номер патента: EP1802633B1. Автор: Jacques Dumas,Roger Smith,Qian Zhao,Chengzhi Zhang,Dongping Fan,Yingfu Li,Georgiy Bondar,Jason Duquette. Владелец: Bayer Schering Pharma AG. Дата публикации: 2011-08-03.

Methods of diagnosing, treating, or preventing plasma cell disorders

Номер патента: EP2073843A2. Автор: Adam M. Boruchov,Raymond L. Comenzo. Владелец: SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH. Дата публикации: 2009-07-01.

Methods of diagnosing, treating, or preventing plasma cell disorders

Номер патента: WO2008033571A3. Автор: Adam M Boruchov,Raymond L Comenzo. Владелец: Raymond L Comenzo. Дата публикации: 2008-06-26.

Hoof spraying arrangement, method for the cleaning of a hoof and use thereof in the treatment and prevention of hoof infections in animals

Номер патента: WO2024218107A1. Автор: Jan van Geest. Владелец: Intracare B.V.. Дата публикации: 2024-10-24.

Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia

Номер патента: EP2817673A1. Автор: Michael John Collins,Brett Ashley DAVIS,Atanu Ghosh,Scott Andrew READ. Владелец: Queensland University of Technology QUT. Дата публикации: 2014-12-31.

Salt of ivabradine and process for the preparation thereof

Номер патента: US09856221B2. Автор: Michael Lynch,Gilles Briault,David Lafargue,Patrick COINTEPAS. Владелец: Laboratoires Servier SAS. Дата публикации: 2018-01-02.

Benzimidazole derivatives for the modulation of sting

Номер патента: WO2024130341A1. Автор: John Feutrill,Scott Raymond WALKER,Benjamin Joseph MORROW,Matthew Lloyd DENNIS,Anthony Nicholas CUZZEPE. Владелец: Aculeus Therapeutics Pty Ltd. Дата публикации: 2024-06-27.

High-potency sweetener composition for treatment and/or prevention of autoimmune disorders and compositions sweetened therewith

Номер патента: WO2007061907A2. Автор: Indra Prakash,Grant E. Dubois. Владелец: The Coca-Cola Company. Дата публикации: 2007-05-31.

High-potency sweetener composition for treatment and/or prevention of autoimmune disorders, compositions and beverages sweetened therewith

Номер патента: EP1959762A2. Автор: Indra Prakash,Grant E. Dubois. Владелец: Coca Cola Co. Дата публикации: 2008-08-27.

Heterocyclic compounds as ent inhibitors and compounds for use in the treatment of cancers

Номер патента: WO2024134541A1. Автор: Michael Rowley,Michael Deligny,Stefano Crosignani,Erica Joke Katelijne Heleen HOUTHUYS. Владелец: Iteos Belgium SA. Дата публикации: 2024-06-27.

Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2587800C. Автор: Anthony Mastracchio,Jason M. Cox,Scott D. Edmondson. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2012-06-12.

Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes

Номер патента: CA2570807C. Автор: Suresh Singh,Ying-Duo Gao,Ann E. Weber,Tesfaye Biftu,Danqing Dennis Feng. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-12-06.

Method for controlling pathogens and/or preventing diseases resulting from the presence of the pathogens in and/or on seeds

Номер патента: US20210378163A1. Автор: Devin Michaud,Fadi Dagher,Pooneh PEYVANDISANI,Amir HAMIDI. Владелец: Agri Neo Inc. Дата публикации: 2021-12-09.

Method for controlling pathogens and/or preventing diseases resulting from the presence of the pathogens in and/or on seeds

Номер патента: CA3121267A1. Автор: Devin Michaud,Fadi Dagher,Pooneh PEYVANDISANI,Amir HAMIDI. Владелец: Agri Neo Inc. Дата публикации: 2020-06-04.

Methods for the treatment of ventricular dysrhythmia and prevention of ventricular fibrillation

Номер патента: US4725604A. Автор: Michael J. Zelesko,William E. Hageman. Владелец: McNeilab Inc. Дата публикации: 1988-02-16.

1-monoglyceride of c12 fatty acid for the treatment or prevention of infectious plant diseases

Номер патента: WO2024165554A1. Автор: Maria BLASCO BIGATÁ. Владелец: Mbp 4 Life, S.L.. Дата публикации: 2024-08-15.

Use of germ flour of certain fruits for the manufacture of food products useful for the treatment of phytate deficiency states

Номер патента: US20020136817A1. Автор: Antonia Costa Bauza,Feliciano Grases Freixedas. Владелец: INDUSTRIAS AGRICOLAS DE MALLORCA SA. Дата публикации: 2002-09-26.

Process for the thermomechanical surface treatment of flat webs of material, particularly those made of paper and carton, by using adhesive agents

Номер патента: CA2253191A1. Автор: Joachim Werres,Bernd Reinhardt. Владелец: Individual. Дата публикации: 1997-11-06.

In vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing a solid tumor

Номер патента: EP4150346A1. Автор: Antoine ITALIANO,Sophie COUSIN. Владелец: Bergonie Institute. Дата публикации: 2023-03-22.

In vitro method for the prognosis of disease progression in a patient that suffers from or is at risk of developing a solid tumor

Номер патента: WO2021228986A1. Автор: Antoine ITALIANO,Sophie COUSIN. Владелец: Bergonie Institute. Дата публикации: 2021-11-18.

Microbicidal agents containing 3- (2,2-difluorobenzodioxol-4-yl) -4-cyanopyrrole derivatives, process for their preparation, process for controlling or preventing attacks on culture plants by phytopathogenic microorganisms, and using the 4-cyanopyrrole derivatives for control and / or preventive prevention of microorganism infestations on vegetable or stockpile products

Номер патента: DK169161B1. Автор: Josef Ehrenfreund,Robert Nyfeler. Владелец: Ciba Geigy AG. Дата публикации: 1994-09-05.

PI3K Inhibitor for Use in the Treatment of Bone Cancer or for Preventing Metastatic Dissemination Primary Cancer Cells into the Bone

Номер патента: US20140213583A1. Автор: De Giovanni Carla,Lollini Pier-Luigi,Nanni Patrizia. Владелец: NOVARTIS AG. Дата публикации: 2014-07-31.

Cahgt1p inhibitors for use in the treatment of candidiasis

Номер патента: WO2013017691A1. Автор: Reinhard WÜRZNER,Iwona LESIAK-MARKOWICZ. Владелец: Medizinische Universität Innsbruck. Дата публикации: 2013-02-07.

Cahgt1p inhibitors for use in the treatment of candidiasis

Номер патента: EP2739652A1. Автор: Reinhard WÜRZNER,Iwona LESIAK-MARKOWICZ. Владелец: Medizinische Universitaet Innsbruck. Дата публикации: 2014-06-11.

Method for detecting polymorphisms in the ABCB1 gene associated with a lack of response to a CNS-active medicament and medicament comprising an ABCB1 inhibitor for use in the treatment of CNS related diseases.

Номер патента: EP1756310B1. Автор: Manfred Uhr,Florian Holsboer,Elisabeth Binder,Bertram MÜLLER-MYHSOK. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2012-12-05.

Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

Номер патента: US20060014800A1. Автор: Sepehr Sarshar,Bruno Tse. Владелец: Auspex Pharmaceuticals Inc. Дата публикации: 2006-01-19.

Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

Номер патента: WO2005011573A3. Автор: Sepehr Sarshar,Bruno Tse. Владелец: Bruno Tse. Дата публикации: 2005-05-12.

Compositions and methods for the treatment of Pierce's Disease

Номер патента: US20090158470A1. Автор: Goutam Gupta. Владелец: Individual. Дата публикации: 2009-06-18.

Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides

Номер патента: US09970068B2. Автор: Irina Tcherepanova,Aijing Starr,Brad Lackford. Владелец: Merix Bioscience Inc. Дата публикации: 2018-05-15.

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation

Номер патента: US20020198188A1. Автор: John Clifford,Minghua Sun,Eugene Kelleher,Jose Halperin,Ying-Duo Gao,Adel Moussa,Carlo Brugnara,Rudolf Fluckiger,Richard Lombardy,Emile Bellott,Reem Haidar,Yesh Sachdeva,Heather Taft. Владелец: Childrens Medical Center Corp. Дата публикации: 2002-12-26.

Methods for screening for a compound useful in the treatment or prevention of lymphocytic disorders, for inhibiting lymphocyte activity and preventing or treating lymphocytic disorders

Номер патента: WO2003089664A1. Автор: Adrien Beaudoin,Ouhida Benrezzak. Владелец: BIOFLASH INC.. Дата публикации: 2003-10-30.

Use of 14-3-3- Proteins in Treatment and Prevention of Neurodegeneration

Номер патента: US20090186365A1. Автор: Talene Alene Yacoubian,David G. Standaert. Владелец: Individual. Дата публикации: 2009-07-23.

Use of 14-3-3-Proteins in Treatment and Prevention of Neurodegeneration

Номер патента: US20110183341A1. Автор: Talene Alene Yacoubian,David G. Standaert. Владелец: UAB RESEARCH FOUNDATION. Дата публикации: 2011-07-28.

Non brain penetrant a2a inhibitors and methods for use in the treatment of cancers

Номер патента: US20200102319A1. Автор: Stefano Crosignani. Владелец: Iteos Belgium SA. Дата публикации: 2020-04-02.

Compositions and methods for the treatment of cardiovascular diseases

Номер патента: WO2014118649A3. Автор: Mahesh KANDULA. Владелец: CELLIXBIO PRIVATE LIMITED. Дата публикации: 2017-03-23.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: MY178467A. Автор: FORD John,ROUND Patrick,KASTELEIN John,KAWAGUCHI Atsuhiro,TOMIYASU Koichi,OKA Kozo. Владелец: Mitsubishi Tanabe Pharma Corp. Дата публикации: 2020-10-14.

Protease inhibitors for use in the treatment of psoriasis

Номер патента: AU2003204149A1. Автор: . Владелец: Biotech Australia Pty Ltd. Дата публикации: 2003-06-12.

Method and device for producing fine aerosols with prevention of atomizer clogging

Номер патента: RU2636522C1. Автор: Феликс Гансович Карих,Гульнара Фагимовна Мухаметзянова. Владелец: федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ). Дата публикации: 2017-11-23.

Energometabolic composition for stimulation of exchange processes, prevention of hypomicroelementosis and diarrhea in piglets

Номер патента: RU2555005C2. Автор: Алексей Алексеевич Евглевский,Елена Павловна Евглевская,Татьяна Алексеевна Евглевская,Виктор Сергеевич Попов,Жанна Геннадьевна Петрова,Анатолий Иванович Бледнов,Геннадий Евгеньевич Петров,Иван Андреевич Геков. Владелец: Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" (ФГБНУ Курский НИИ АПП). Дата публикации: 2015-07-10.

PIPERAZINOTRIAZINES AS PI3K INHIBITORS FOR USE IN THE TREATMENT ANTIPROLIFERATIVE DISORDERS

Номер патента: US20130040912A1. Автор: Cmiljanovic Vladimir,Cmiljanovic Natasa,Giese Bernd,Wymann Matthias. Владелец: UNIVERSITY OF BASEL. Дата публикации: 2013-02-14.

Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus

Номер патента: AU2012218004A1. Автор: Johannes Wilhelmus J. Thuring. Владелец: Elanco Animal Health Ireland Ltd. Дата публикации: 2013-08-08.

Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for use in the Treatment of Neurodegenerative Disorders

Номер патента: MY195679A. Автор: Joseph P Lyssikatos,Jianwen A Feng,Anthony A Estrada,Zachary K Sweeney,Vicente Fidalgo Javier De. Владелец: Denali Therapeutics Inc. Дата публикации: 2023-02-03.

METHODS FOR TREATING OR PREVENTING IL-1BETA RELATED DISEASES

Номер патента: US20120003226A1. Автор: Scannon Patrick J.,Solinger Alan M.,Bauer Robert J.. Владелец: XOMA TECHNOLOGY LTD.. Дата публикации: 2012-01-05.

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS

Номер патента: US20120003227A1. Автор: SUKHATME VIKAS P.,CHAN CHUNKONG BARDEN. Владелец: . Дата публикации: 2012-01-05.

SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS

Номер патента: US20120003273A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION

Номер патента: US20120004160A1. Автор: Dickson Marion Catherine,Janssen Richard Antonius Jozef,De Groot Anton,Lekkerkerker Annemarie Nicolette,Meldrum Eric Charles,Thompson Nicola,Ray Keith Paul,Boyce Susan Heather. Владелец: . Дата публикации: 2012-01-05.

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Номер патента: US20120004202A1. Автор: KLEY Joerg,ROTH Gerald Juergen,LEHMANN-LINTZ Thorsten,Park John Edward,Heckel Armin,CHAUDHARY Nveed. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2012-01-05.

TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD

Номер патента: US20120004203A1. Автор: MEIBOM Daniel,Li Volkhart Min-Jian,Delbeck Martina,LUSTIG Klemens,VON NUSSBAUM Franz,KARTHAUS Dagmar,ANLAUF Sonja. Владелец: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT. Дата публикации: 2012-01-05.

RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF EXPRESSION OF MITOCHONDRIAL GLYCEROL-3 PHOSPHATE ACYLTRANSFERASE 1 (MTGPAT1)

Номер патента: US20120004276A1. Автор: Straarup Ellen Marie,Lindholm Marie. Владелец: . Дата публикации: 2012-01-05.

Novel composition and methods for the treatment of psoriasis

Номер патента: US20120003246A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

CB2 RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN

Номер патента: US20120004222A1. Автор: Wu Zhicai,Green Ahren I.,Hartnett Jonh C.. Владелец: . Дата публикации: 2012-01-05.

COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION

Номер патента: US20120004288A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

Номер патента: US20120004312A1. Автор: Hewitt William,Vasella Daniel Lucius,Webb Randy Lee. Владелец: . Дата публикации: 2012-01-05.

COMPOSITION FOR THE PREVENTION AND TREATMENT OF ALOPECIA, OR FOR HAIR GROWTH

Номер патента: US20120004439A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

Compositions and Methods for the Treatment of Ophthalmic Disease

Номер патента: US20120003275A1. Автор: Donello John E.,Schweighoffer Fabien J.,Rodrigues Gerard A.,McLaughlin Anne P.,Mahé Florence. Владелец: . Дата публикации: 2012-01-05.

METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS

Номер патента: US20120004133A1. Автор: Lakatta Edward G.,Wang Mingyi,Fu Zongming,Van Eyk Jennifer. Владелец: . Дата публикации: 2012-01-05.

USE OF ANTI-90K MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF TUMORS AND METASTASES THEREOF

Номер патента: US20120003157A1. Автор: Iacobelli Stefano. Владелец: . Дата публикации: 2012-01-05.

USE OF ANTIBODIES FOR THE VACCINATION AGAINST CANCER

Номер патента: US20120003232A1. Автор: . Владелец: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG. Дата публикации: 2012-01-05.

COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANDER

Номер патента: US20120003204A1. Автор: . Владелец: INSECT BIOTECH CO., LTD.. Дата публикации: 2012-01-05.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.